PROGRESS IN
HETEROCYCLIC CHEMISTRY Volume 18
Related Titles of Interest Books CARRUTHERS: Cycloaddition Reactions in Organic Synthesis CLARIDGE: High-Resolution NMR Techniques in Organic Chemistry FINET: Ligand Coupling Reactions with Heteroatomic Compounds GAWLEY & AUBÉ: Principles of Asymmetric Synthesis HASSNER & STUMER: Organic Syntheses Based on Name Reactions KATRITZKY: Advances in Heterocyclic Chemistry KATRITZKY & POZHARSKII: Handbook of Heterocyclic Chemistry, 2nd Edition LEVY & TANG: The Chemistry of C-Glycosides LI & GRIBBLE: Palladium in Heterocyclic Chemistry, 2nd Edition (in Press) MATHEY: Phosphorus-Carbon Heterocyclic Chemistry: The Rise of a New Domain McKILLOP: Advanced Problems in Organic Reaction Mechanisms OBRECHT: Solid Supported Combinatorial and Parallel Synthesis of Small-Molecular-Weight Compound Libraries PELLETIER: Alkaloids; Chemical and Biological Perspectives SESSLER & WEGHORN: Expanded Contracted and Isomeric Porphyrins WONG & WHITESIDES: Enzymes in Synthetic Organic Chemistry Major Reference Works BARTON, NAKANISHI, METH-COHN: Comprehensive Natural Products Chemistry BARTON & OLLIS: Comprehensive Organic Chemistry KATRITZKY & REES: Comprehensive Heterocyclic Chemistry I CD-Rom KATRITZKY, REES & SCRIVEN: Comprehensive Heterocyclic Chemistry II KATRITZKY, METH-COHN & REES: Comprehensive Organic Functional Group Transformations SAINSBURY: Rodd’s Chemistry of Carbon Compounds TROST & FLEMING: Comprehensive Organic Synthesis Journals BIOORGANIC & MEDICINAL CHEMISTRY BIOORGANIC & MEDICINAL CHEMISTRY LETTERS CARBOHYDRATE RESEARCH HETEROCYCLES (distributed by Elsevier) PHYTOCHEMISTRY TETRAHEDRON TETRAHEDRON: ASYMMETRY TETRAHEDRON LETTERS Full details of all Elsevier Science publications, and a free specimen copy of any Elsevier Science journal, are available on request at www.elsevier.com or from your nearest Elsevier Science office.
PROGRESS IN
HETEROCYCLIC CHEMISTRY Volume 18 A critical review of the 2005 literature preceded by two chapters on current heterocyclic topics Editors
GORDON W. GRIBBLE Department of Chemistry, Dartmouth College, Hanover, New Hampshire, USA and
JOHN A. JOULE The School of Chemistry, The University of Manchester, Manchester, UK
Amsterdam – Boston – London – New York – Oxford – Paris San Diego – San Francisco – Singapore – Sydney – Tokyo
Elsevier The Boulevard, Langford Lane, Kidlington, Oxford OX5 1GB, UK Radarweg 29, PO Box 211, 1000 AE Amsterdam, The Netherlands
First edition 2007 Copyright © 2007 Elsevier Ltd. All rights reserved No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means electronic, mechanical, photocopying, recording or otherwise without the prior written permission of the publisher Permissions may be sought directly from Elsevier’s Science & Technology Rights Department in Oxford, UK: phone (+44) (0) 1865 843830; fax (+44) (0) 1865 853333; email:
[email protected]. Alternatively you can submit your request online by visiting the Elsevier web site at http://elsevier.com/locate/permissions, and selecting Obtaining permission to use Elsevier material Notice No responsibility is assumed by the publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made British Library Cataloguing in Publication Data A catalogue record for this book is available from the British Library Library of Congress Cataloging-in-Publication Data A catalog record for this book is available from the Library of Congress ISBN-13: ISBN-10: ISBN-13: ISBN-10: ISSN:
978-0-08-045025-4 (Hardcover) 0-08-045025-3 978-0-08-045026-1 (ISHC members edition) 0-08-045026-1 0959-6380
For information on all Elsevier publications visit our website at books.elsevier.com Printed and bound in The Netherlands 07 08 09 10 11
10 9 8 7 6 5 4 3 2 1
v
Contents Foreword
x
Editorial Advisory Board Members
xi
Chapter 1:
1
The Diels-Alder cycloadditions of 3,5-dibromo-2-pyrone and its derivatives
Heui-Yeon Kim and Cheon-Gyu Cho, Department of Chemistry, Hanyang University, Seoul, Korea 1.1 1.2 1.2.1 1.2.2 1.2.3 1.3 1.4 1.5
Overview of the Diels–Alder chemistry of 2-pyrone 3,5-Dibromo-2-pyrone [4+2] Cycloadditions of 3,5-dibromo-2-pyrone Synthesis and cycloadditions of substituted monobromo-2-pyrones Intramolecular Diels-Alder cycloadditions of 2-pyrones Conclusion Acknowledgements References
Chapter 2:
1 6 6 14 21 24 24 25
Recent developments in the chemistry of nucleosides
27
Jean-Luc Girardet and Stanley A. Lang, Valeant Research & Development, 3300 Hyland Avenue, Costa Mesa, California, USA. 2.1 2.2 2.2.1 2.2.1.1 2.2.1.2 2.2.1.3 2.2.1.4 2.2.1.5 2.2.2 2.2.2.1 2.2.2.2 2.2.2.3 2.2.3 2.2.3.1 2.2.3.2 2.3 2.4 2.5
Introduction Sugar chemistry Hydrogen and oxygen substitutions Modifications at C-1’ Modifications at C-2’ Modifications at C-3’ Modifications at C-4’ Modifications at C-5’ Ring-oxygen substitution Substitution with carbon Substitution with sulfur Substitution with nitrogen Nucleosides with bicyclic sugars Spiro nucleosides Bicyclic nucleosides Combinatorial approaches Conclusion References
Chapter 3:
27 28 29 29 29 32 33 34 38 38 40 41 42 42 44 46 49 49
Three-membered ring systems
Part 1:(2004)
55
Albert Padwa, Emory University, Atlanta, Georgia, USA and Shaun Murphree, Allegheny College, Meadville, Pennsylvania, USA 3.1.1 3.1.2 3.1.2.1 3.1.2.2 3.1.3 3.1.3.1 3.1.3.2 3.1.4
Introduction Epoxides Preparation of epoxides Reactions of epoxides Aziridines Preparation of aziridines Reactions of aziridines References
55 55 55 62 69 69 74 78
Part 2:(2005)
81
Stephen C. Bergmeier and Damon D. Reed, Department of Chemistry & Biochemistry, Ohio University, Athens, Ohio, USA 3.2.1 3.2.2 3.2.2.1 3.2.2.2 3.2.3
Introduction Epoxides Preparation of epoxides Reactions of epoxides Aziridines
81 81 81 87 95
vi 3.2.3.1 3.2.3.2 3.2.4
Contents
Preparation of aziridines Reactions of aziridines References
Chapter 4:
95 97 103
Four-membered ring systems
106
Benito Alcaide, Departamento de Química Orgánica I, Facultad de Química, Universidad Complutense de Madrid, Madrid, Spain and Pedro Almendros, Instituto de Química Orgánica General, CSIC, Madrid, Spain. 4.1 4.2 4.3 4.4 4.5 4.6 4.7 4.8
Introduction Azetidines and azetes Monocyclic 2-azetidinones (β-lactams) Fused polycyclic β-lactams Oxetanes, dioxetanes, oxetes and 2-oxetanones (β-lactones) Thietanes, β-sultams, and related systems Silicon and phosphorus heterocycles. miscellaneous References
Chapter 5:
Five-membered ring systems
Part 1.
Thiophenes and Se/Te Analogues
106 106 109 113 115 118 118 120
126
Tomasz Janosik and Jan Bergman, Department of Biosciences at Novum, Karolinska Institute, Novum Research Park, Huddinge, Sweden, and Södertörn University College, Huddinge, Sweden 5.1.1 5.1.2 5.1.3 5.1.4 5.1.5 5.1.6 5.1.7 5.1.8
Part 2.
Introduction Thiophene ring synthesis Reactions of thiophenes Non-polymeric thiophene organic materials Thiophene oligomers and polymers Thiophene derivatives in medicinal chemistry Selenophenes and tellurophenes References
126 126 130 135 137 141 143 144
Pyrroles and benzo derivatives
150
Erin T. Pelkey, Hobart and William Smith Colleges, Geneva, NY, USA. 5.2.1 5.2.2 5.2.2.1 5.2.2.2 5.2.2.3 5.2.3 5.2.3.1 5.2.3.2 5.2.3.3 5.2.4 5.2.4.1 5.2.4.2 5.2.4.3 5.2.5 5.2.5.1 5.2.5.2 5.2.5.3 5.2.5.4 5.2.6 5.2.6.1 5.2.6.2 5.2.6.3 5.2.6.4 5.2.7 5.2.7.1 5.2.8
Part 3.
Introduction Synthesis of pyrroles Intramolecular approaches Intermolecular approaches Transformation of other heterocycles Reactions of pyrroles Substitution at nitrogen Substitution at carbon Functionalization of the side-chain Pyrrole natural products and materials Natural products Macrocycles and oligopyrroles Non-oligomeric materials Synthesis of indoles Intramolecular approaches Intermolecular approaches Transformation of other heterocycles Oxindoles, azaindoles, and carbazoles Reactions of indoles Substitution at nitrogen Substitution at C–2/C–3 Functionalization of the benzene ring Functionalization of the side-chain Indole natural products Natural products References
150 150 151 153 155 156 156 157 159 160 160 161 162 163 163 166 167 167 169 169 170 175 176 177 177 178
Furans and benzofurans
Xue-Long Hou, Shanghai-Hong Kong Joint Laboratory in Chemical Synthesis and State Key Laboratory of Organometallic Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai, China, Zhen Yang, Key Laboratory of Bioorganic Chemistry and Molecular Engineering of the Ministry of Education, Department of Chemical Biology, College of Chemistry, Peking
187
vii
Contents
University, Beijing, China, Kap-Sun Yeung, Bristol-Myers Squibb Pharmaceutical Institute, Wallingford, CT, USA, and Henry N. C. Wong, Department of Chemistry, Institute of Chinese Medicine and Central Laboratory of the Institute of Molecular Technology for Drug Discovery and Synthesis, The Chinese University of Hong Kong, Hong Kong, China and Shanghai-Hong Kong Joint Laboratory in Chemical Synthesis, Shanghai Institute of Organic Chemistry, The Chinese Academy of Sciences, Shanghai, China. 5.3.1 5.3.2 5.3.2.1 5.3.2.2 5.3.3 5.3.3.1 5.3.3.2 5.3.3.3 5.3.3.4 5.3.4
Part 4.
Introduction Reactions Furans Di- and tetrahydrofurans Synthesis Furans Di- and tetrahydrofurans Benzo[b]furans and related compounds Benzo[c]furans and related compounds References
187 188 188 192 194 194 199 203 209 210
With more than One N Atom
218
Larry Yet, Albany Molecular Research, Inc., Albany, New York, USA. 5.4.1 5.4.2 5.4.3 5.4.4 5.4.5 5.4.6 5.4.7
Part 5.
Introduction Pyrazoles and ring-fused derivatives Imidazoles and ring-fused derivatives 1,2,3-Triazoles and ring-fused derivatives 1,2,4-Triazoles and ring-fused derivatives Tetrazoles and ring-fused derivatives References
218 218 225 232 236 240 241
With N and S (Se) atoms
247
Yong-Jin Wu, Bristol Myers Squibb Company, Wallingford, Connecticut, USA and Bingwei V. Yang, Bristol Myers Squibb Company, Princeton, New Jersey, USA 5.5.1 5.5.2 5.5.2.1 5.5.2.2 5.5.2.3 5.5.2.4 5.5.2.5 5.5.2.6 5.5.2.7 5.5.2.9 5.5.2.10 5.5.3 5.5.3.1 5.5.3.2 5.5.3.3 5.5.3.4 5.5.4 5.5.5 5.5.6 5.5.7
Part 6.
Introduction Thiazoles Synthesis of thiazoles and fused derivatives Synthesis of thiazolines Synthesis of 2-imino-thiazolidine and thiazoline derivatives Reactions of thiazoles and fused derivatives Reactions of thiazolines Thiazole intermediates in synthesis Thiazolium-catalyzed and -mediated reactions Thiazole-containing drug candidates New thiazole-containing natural products Isothiazoles Synthesis of isothiazoles by ring-formation Reactions of isothiazoles Isothiazoles as auxiliaries in organic syntheses Biologically interesting isothiazoles Thiadiazoles and selenadiazoles 1,3-Selenazoles, 1,3-selenazolidines and 1,3-tellurazoles Acknowledgement References
247 247 247 252 254 255 257 258 261 264 265 265 265 268 268 270 271 272 273 273
With O and S (Se, Te) atoms
276
R. Alan Aitken and Lynn A. Power, University of St Andrews, UK. 5.6.1 5.6.2 5.6.3 5.6.4 5.6.5 5.6.6 5.6.7 5.6.8
Part 7.
1,3-Dioxoles and dioxolanes 1,3-Dithioles and dithiolanes 1,3-Oxathioles and oxathiolanes 1,2-Dioxolanes 1,2-Dithioles and dithiolanes 1,2-Oxathioles and oxathiolanes Three heteroatoms References
276 279 282 282 283 283 283 284
With O and N atoms
289
Stefano Cicchi, Franca M. Cordero and Donatella Giomi, Università degli Studi di Firenze, Italy. 5.7.1 5.7.2
Isoxazoles Isoxazolines
288 291
Contents
viii 5.7.3 5.7.4 5.7.5 5.7.6 5.7.7 5.7.8
Isoxazolidines Oxazoles Oxazolines Oxazolidines Oxadiazoles References
Chapter 6:
Six-membered ring systems
Part 1.
Pyridines and benzo derivatives
294 298 300 304 306 307
310
Heidi L. Fraser, M. Brawner Floyd, and Darrin W. Hopper, Chemical and Screening Sciences, Wyeth Research, Pearl River, New York, USA 6.1.1 6.1.2 6.1.2.1 6.1.2.2 6.1.2.3 6.1.3 6.1.3.1 6.1.3.2 6.1.4 6.1.4.1 6.1.4.2 6.1.5 6.1.5.1 6.1.6
Introduction Pyridines Preparation of pyridines Reactions of pyridines Pyridine N-oxides and pyridinium Salts Quinolines Preparation of quinolines Reactions of quinolines Isoquinolines Preparation of isoquinolines Reactions of isoquinolines Piperidines Preparations of piperidines References
310 310 310 313 319 322 322 326 328 328 331 333 333 346
Part 2.
Diazines and benzo derivatives
352
Part 3.
Triazines, tetrazines and fused ring polyaza systems
353
Pilar Goya and Cristina Gómez de la Oliva, Instituto de Química Médica (CSIC), Madrid, Spain. 6.3.1 6.3.1.1 6.3.1.2 6.3.1.3 6.3.2 6.3.3 6.3.3.1 6.3.3.2 6.3.4 6.3.5 6.3.6
Part 4.
Triazines 1,2,3-Triazines 1,2,4-Triazines 1,3,5-Triazines Tetrazines Fused [6]+[5] polyaza systems Triazino and tetrazino [6+5] fused systems Purines and related structures Fused [6]+[6] polyaza systems Miscellaneous fused polyaza systems References
353 353 353 357 359 361 361 363 368 369 371
With O and/or S atoms
376
John D. Hepworth, James Robinson Ltd., Huddersfield, UK and B. Mark Heron, Department of Colour and Polymer Chemistry, University of Leeds, Leeds, UK. 6.4.1 6.4.2 6.4.2.1 6.4.2.2 6.4.2.3 6.4.2.4 6.4.2.5 6.4.2.6 6.4.2.7 6.4.2.8 6.4.3 6.4.3.1 6.4.4 6.4.4.1 6.4.4.2 6.4.5 6.4.5.1 6.4.6 6.4.6.1 6.4.7
Introduction Heterocycles containing one oxygen atom Pyrans [1]Benzopyrans and dihydro[1]benzopyrans [2]Benzopyrans and dihydro[2]benzopyrans Pyrylium Salts Pyranones Coumarins Chromones Xanthones and xanthenes Heterocycles containing one sulfur atom Thiopyrans and analogues Heterocycles containing two or more oxygen atoms Dioxins and dioxanes Trioxanes Heterocycles containing two or more sulfur atoms Dithianes and trithianes Heterocycles containing both oxygen and sulfur in the same ring Oxathianes References
376 377 377 380 382 383 384 386 389 390 391 391 393 393 394 395 395 396 396 396
ix
Contents
Chapter 7:
Seven-membered ring systems
402
John B. Bremner, Institute for Biomolecular Science and Department of Chemistry, University of Wollongong, Wollongong, NSW, Australia and Siritron Samosorn Department of Chemistry, Faculty of Science, Srinakharinwirot University, Bangkok, Thailand. 7.1 7.2 7.2.1 7.2.2 7.2.3 7.2.4 7.3 7.3.1 7.3.2 7.3.3 7.4 7.4.1 7.5 7.6 7.7
Introduction Seven-membered systems containing one heteroatom Azepines and derivatives Fused azepines and derivatives Oxepines and fused derivatives Thiepines and fused derivatives Seven-membered systems containing two heteroatoms Diazepines and fused derivatives Dioxepines, dithiepines and fused derivatives Miscellaneous derivatives with two heteroatoms Seven-membered systems containing three or more heteroatoms Systems with N, S and/or O Seven-membered systems of pharmacological significance Future directions References
Chapter 8:
402 402 402 406 411 412 412 412 418 419 425 425 426 427 427
Eight-membered and larger rings
430
George R. Newkome, The University of Akron, Akron, Ohio, USA. 8.1 8.2 8.3 8.4 8.5 8.6 8.7 8.8 8.9 8.10 8.11 8.12 8.13 8.14 8.15 8.16 8.17 8.18 8.19 8.20
Index
Introduction Carbon-oxygen rings Carbon-nitrogen rings Carbon-sulfur rings Carbon-silicon rings Carbon-selenium rings Carbon-oxygen/carbon-nitrogen rings Carbon-nitrogen-oxygen rings Carbon-nitrogen-sulfur rings Carbon-phosphorus-sulfur rings Carbon-phosphorus-nitrogen rings Carbon-selenium-nitrogen rings Carbon-sulfur-oxygen rings Carbon-nitrogen-sulfur-oxygen rings Carbon-nitrogen-metal rings Carbon-phosphorus-metal rings Carbon-oxygen-nitrogen-metal rings Carbon-sulfur-nitrogen-metal rings Carbon-phosphorus-oxygen-metal rings Referencees
430 431 433 436 437 438 438 438 439 440 440 440 441 442 442 443 443 443 443 444
449
x
Foreword This is the eighteenth annual volume of Progress in Heterocyclic Chemistry, and covers the literature published during 2005 on most of the important heterocyclic ring systems. References are incorporated into the text using the journal codes adopted by Comprehensive Heterocyclic Chemistry, and are listed in full at the end of each chapter. This volume opens with two specialized reviews. The first, by Heui-Yeon Kim and Cheon-Gyu Cho covers ‘The Diels-Alder cycloadditions of 3,5-dibromo-2-pyrone and its derivatives'. The second, by Jean-Luc Girardet and Stanley Lang discusses ‘Recent developments in the chemistry of nucleosides’. The remaining chapters examine the 2005 literature on the common heterocycles in order of increasing ring size and the heteroatoms present. In the previous volume, Vol. 17, it was not possible to include a chapter on ‘Three-membered rings’ so this volume has two chapters on this topic: 3.1 covers the literature of 2004 and 3.2 covers the publications of 2005. ‘Diazines and benzo derivatives’ does not appear in this volume; Volume 19 will include two reviews of this topic, one covering the literature of 2005 and one that of 2006. The Index is not fully comprehensive – it includes only systematic heterocyclic ring system names. Thus, wherever a pyrrole is discussed, that would be indexed under 'pyrroles'; wherever 'pyrido[3,4-b]indoles' are mentioned an indexed entry under that name will be found; similarly 'aceanthryleno[1,2-e][1,2,4]triazines', 'azirines', '2H-pyran-2-ones', '1,2,4-triazoles', etc., etc. are listed. But, subjects like '4-ethyl-5-methylpyrrole', '5-acylazirines', '6-alkyl-2H-pyran-2-ones', '3alkylamino-1,2,4-triazoles', are not listed as such in the Index. 'Diels-Alder reaction' or 'Heck coupling' etc., are also not indexed. However, additionally this year, the Contents pages list all the subheadings of the chapters which we hope will considerably improve accessibility for readers. We are delighted to welcome some new contributors to this volume and we continue to be indebted to the veteran cadre of authors for their expert and conscientious coverage. We are also grateful to Joan Anuels of Elsevier Science for supervising the publication of the volume. We hope that our readers find this series to be a useful guide to modern heterocyclic chemistry. As always, we encourage both suggestions for improvements and ideas for review topics. Gordon W. Gribble John A. Joule
xi
Editorial Advisory Board Members Progress in Heterocyclic Chemistry 2005 - 2006 PROFESSOR M. BRIMBLE (CHAIRMAN) University of Auckland, New Zealand
PROFESSOR D. ST CLAIR BLACK University of New South Wales Australia
PROFESSOR H. HIEMSTRA University of Amsterdam The Netherlands
PROFESSOR M.A. CIUFOLINI University of British Columbia Canada
PROFESSOR D.W.C. MACMILLAN California Institute of Technology USA
PROFESSOR T. FUKUYAMA University of Tokyo Japan
PROFESSOR M. SHIBASAKI University of Tokyo Japan
PROFESSOR A. FÜRSTNER Max Planck Institut Germany
PROFESSOR L. TIETZE University of Göttingen, Germany
PROFESSOR R. GRIGG University of Leeds UK
PROFESSOR P. WIPF University of Pittsburgh USA
Information about membership and activities of the International Society of Heterocyclic Chemistry (ISCH) can be found on the World Wide Web at http://webdb.uni-graz.at/~kappeco/ISHC/index.html
This page intentionally left blank
1
Chapter 1 The Diels-Alder cycloadditions of 3,5-dibromo-2-pyrone and its derivatives
Heui-Yeon Kim and Cheon-Gyu Cho* Department of Chemistry, Hanyang University, Seoul, Korea
[email protected]
1.1
OVERVIEW OF THE DIELS-ALDER CHEMISTRY OF 2-PYRONE
As one of the classical 1,3-dienes investigated by Diels and Alder <31A257>, 2pyrones are synthetically useful synthons which can provide various carbocyclic frameworks in the single chemical operation called the Diels-Alder cycloaddition <92TL9111; 99AC47>. However, due to the inherent partial aromatic character, the parent unsubstituted 2-pyrone 1 itself does not undergo cycloadditions as readily as do other cyclic 1,3-dienes. Cycloadditions often require high reaction temperatures which can cause concomittant CO2 extrusion from the bicyclolactone 2, furnishing dihydrobenzenes or aromatized products 3 (Scheme 1). Scheme 1. Diels-Alder cycloaddition of 2-pyrone 1 O 6
O
5
O 3
R
R
O
R
R
- CO2
heat
R
4
1
2
R
3
The reaction sequence in Scheme 1 is a viable synthetic protocol, utilized in the synthesis of various aromatic natural products including lasalocid A <83JACS1988>, rufesine <84JOC4050>, juncusolare <84JOC4033>, among many others. The initially formed bicyclolactone 2 has further synthetic utility, because of the stereochemically controlled rich functionality resulting from the cycloaddition reaction. Some notable applications can be found in total syntheses of taxol <95JACS634>, shikimic acid <86JACS7373>, natural/unnatural sugars and a series of vitamin D3 analogs <95OS231>. Various strategies have been developed to arrest the cycloadditions at the bicyclolactone stage. Performing the reactions in the presence of a Lewis acid or under high pressure can lower the reaction temperature to allow the isolation of the bicyclic lactones. In some cases, using geometrically constrained dienophiles or templates like phenylboronic acid have effectively suppressed the CO2 extrusion. A more widely applicable strategy is matching the electronic demand of the dienophile with that of the 2-pyrone by means of substitution on the 2-pyrone unit, narrowing the energy gap of the frontier orbitals involved in the cycloaddition.
2
H-Y. Kim and C-G. Cho
The cycloadditions of the parent 2-pyrone 1 are not only sluggish, but also often nonselective with respect to both regiochemistry (syn/anti) and stereochemistry (endo/exo). Scheme 2 shows the structures of the four possible isomers. Scheme 2. Regio- and stereochemistry of cycloadducts O
O
O
Z
O
O
O
+
O
Z
O
O +
O
+
Z
Z syn-endo
syn-exo
Z anti-endo
anti-exo
2-Pyrones with either an electron-donating or -withdrawing substituent can undergo faster and more selective reactions than the parent 2-pyrone 1. Therefore, substitution of 2-pyrone has become an important area of investigation. Some selected examples are shown in Scheme 3, where equations 1 and 2 represent normal electron demand and inverse electron demand cycloadditions, respectively. Scheme 3. Electronic matching of the cycloaddition components O
+ EDG
O
normal electron demand D-A
O CO2R
O
EDG CO 2R
(eq. 1)
EDG = -SPh, -OH
O + EWG
O
OR
inverse electron demand D-A
O O
EWG OR
(eq. 2)
EWG = -CO2Me, -SO2Ph
The cycloadditions of 2-pyrones bearing various electron-donating and electronwithdrawing groups with electronically matching dienophiles have been thoroughly discussed in reviews by Posner and co-workers in 1992 <92TL9111> and 1995 <99A47>. The DielsAlder reactions of 2-pyrones with unactivated dienophiles are generally non-selective and will not be discussed in this review. The 2-pyrones 4 and 5 with a bromine atom substituted at the C3 or C5 position, respectively, are particularly versatile 1,3-diene synthons, which can readily undergo [4+2] cycloadditions to give the cycloadducts 6 and 7 with high regio- and endo/exo selectivity under milder conditions than the parent 2-pyrone (Scheme 4) <91TL5295; 92TL7839>. They are viable synthetic equivalents of the parent 2-pyrone as the bromine atom can be reductively removed after cycloaddition. Additionally, they exhibit ambident enophilic character and are capable of undergoing both normal and inverse electron demand cycloadditions.
3
The Diels-Alder cycloadditions of 3,5-dibromo-2-pyrone and its derivatives
Scheme 4. Diels-Alder cycloadditions of 3-bromo-2-pyrone 4 and 5-bromo-2-pyrone 5 O O
O
Z
Br
Br
O
O Z
O
Br
Z
Z = EWG or EDG
4
O O
6
Z
Br
5
7
Additionally, the position of the substituent on the 2-pyrone ring is an important factor in the enophilic reactivity of 2-pyrone, as clearly demonatrated by Liao and coworker (Scheme 5) <00OL2049>. Scheme 5. Cycloadditions of 2-pyrone carboxylates O O
O
O
9, MeOH
CO2Me O
MeO
10 O
80%
O
13
O
5, MeOH rt, 10 h
MeO 2C
82%
12 O
O
5, MeOH
MeO 2C
O
O
14
reflux 15
O
O
5, MeOH
O
53%
O
O
O
MeO2C
reflux, 10 h MeO2C
O
11
O
9 O
O MeO 2C
rt, 8 h
8
O
CO2Me
MeO2C
No Reaction
O
16
O
3-Methoxycarbonyl-2-pyrone 8 and 5-methoxycarbonyl-2-pyrone 11 undergo cycloadditions with 2-methoxyfuran 9 more readily than 4-methoxycarbonyl-2-pyrone 13. On the other hand, no reaction was observed with 6-methoxycarbonyl-2-pyrone 15, even after prolonged heating in MeOH or MeCN (Scheme 5). The lack of reactivity of 15 was attributed to the steric repulsion of the C6-methyl ester with the incoming dienophile during the formation of the corresponding transition state. This conclusion is based on semiempirical calculations of the transition states leading to the DA product 16 (AM1 and PM3). Table 1. Cycloadditions of 4-halo-2-pyrones. O O
O
CO2Me 50 - 70 oC
X
14 d
entry
2-pyrone
1 2 3
17 (X = Cl) 18 (X = Br) 19 (X = I)
X
O
O
X
O
O X
O
O CO2Me X
O
CO2Me 5-endo
CO Me 6-endo 2
5-exo
5-endo:6-endo:5-exo:6-exo 41:48:2:9 44:45:4:7 39:47:6:8
6-exo
CO2Me
combined yield 70% 78% 93%
4
H-Y. Kim and C-G. Cho
In a similar context, Afarinkia and coworkers have shown that 2-pyrones with a Cl, Br or I substituent at the C4 position have marginal enophilic reactivity, only undergoing cycloadditions with electron-deficient dienophiles <05JOC1122>. For example, the reaction of 4-bromo-2-pyrone 18 with excess methyl acrylate provided a mixture of syn/anti and endo/exo isomers in 78% combined yield after heating at 50 – 70 °C for two weeks with no solvent (Table 1). By increasing the temperature, the reaction of 18 with methyl acrylate provided the bicyclic lactone, which underwent CO2 extrusion, to afford a cyclohexadiene intermediate. A second cycloaddition reaction then occurred with the dienophile to furnish barrelenes 20 (Scheme 6). Scheme 6. Formation of barrelenes 20 O
O
O
Z 100
Br 18
O
oC
Br
Z
Z
Z
Z
Z
Br
Br
20
Z = CO2Me
The cycloadditions of 5-aryl-2-pyrone 21 and 6-aryl-2-pyrone 24 with vinylene carbonate 22 further demonstrate the importance of the substitution pattern of the 2-pyrone (Scheme 7) <00TL4955; 00TL7583>. While the cycloaddition of 21 furnished the cycloadduct 23, the reaction of 24 with vinylene carbonate could not be arrested at the cycloadduct stage and only the phenol 25 was isolated, in low yield. Scheme 7. Diels-Alder cycloadditions of 5-aryl-2-pyrone and 6-aryl-2-pyrone O O
O
100 oC
O O
Ar
O
O
+
22
O O
5d 87%
21
Ar =
O
23
MeO OMe
OH O
O
O +
110 O
O 22 Ar' 24
oC
O Ar' =
10 d
O
32%
O 25
O
An additional example can be found in the cycloadditions of 5-(indol-2-yl)-2-pyrone 26 with various electron-rich and electron-poor dienophiles reported by Passarella and coworkers (Scheme 8) <00T5205>. While the normal electron demand cycloadditions with electron-deficient dienophiles proceeded under solely thermal conditions, reactions with electron-rich dienophiles required the presence of SiO2 or lanthanide shift agents, such as Eu(FOD)3 and Pr(FOD)3.
5
The Diels-Alder cycloadditions of 3,5-dibromo-2-pyrone and its derivatives
Scheme 8. Cycloadditions of 5-(indol-2-yl)-2-pyrone 26 O O
O O
catalyst +
Z
5 h to 7 d
NSEM
Z NSEM
Z = CHO, COMe, OR, SR 26
27
The highly substituted 6-aryl-2-pyrones 28 react with acetophenones 29 in a stepwise base-induced formal cycloaddition reaction. The reaction proceeds via a sequential Michael and aldol reaction in the presence of an alkali metal hydroxide. In this case, the formal cycloadduct 31 extrudes CO2, providing the diene 32, which subsequently undergoes dehydration to afford aromatic products 33 (Scheme 9) <03TL3363>. Scheme 9. Formal stepwise cycloadditions of 6-aryl-2-pyrones 28 O
R
O O
+ Y
O
KOH
X
DMF
Y
X O
O
Y
28
X
O
OH
R' R
29
O
R' X Y
R
30
31 R' Y
OH
- CO2
X - H2 O
R
32
R
R'
R' 33
The cycloaddition of 3-hydroxy-2-pyrone 34 with an electron-deficient dienophile can be catalyzed by triethylamine as illustrated in Scheme 10 <95TL5939; 00TL8317>. Reaction with methyl acrylate provided cycloadduct 37 as a mixture of endo/exo-isomers (11:1) in 98% yield after 12 h at ambient temperature. No cycloaddition was observed when the reaction was conducted in the absence of base. Scheme 10. Base-catalyzed Diels-Alder cycloaddition of 3-hydroxy-2-pyrone 34
O
O
Et3N
O
CO2Me
O
O
O HNEt3
- Et3N
O OH
O
OH 34
O
O
35
Et3NH
36
CO2Me
37
CO2Me
6
H-Y. Kim and C-G. Cho
The asymmetric Diels-Alder cycloadditions of 2-pyrones have recently attracted much attention. Albeit much remains to be explored, a few successful strategies have been reported, which have been systematically addressed in a recent review <99AC47>. We have found that 3,5-dibromo-2-pyrone 38 undergoes both normal and inverse electron demand cycloadditions more readily than mono-bromo-2-pyrones and these reactions proceed with greater regio- and stereoselectivity (Scheme 11). Moreover, bromides can be selectively functionalized to generate an array of new 2-pyrone synthons, exhibiting much greater applicability than their mono-bromo counterparts. This review is focused on the chemistry of 3,5-dibromo-2-pyrone and derivatives thereof. Scheme 11. The Diels-Alder cycloadditions of 3,5-dibromo-2-pyrone O O
O O
Z = electron donating or withdrawing group
Z Br endo-adduct
Br 38
Br
Z
+ Br
O
1.2
3,5-DIBROMO-2-PYRONE
1.2.1
[4+2] Cycloadditions of 3,5-dibromo-2-pyrone
O
+
Br Z
Br exo-adduct
3,5-Dibromo-2-pyrone was first reported by Pirkle and coworkers <69JOC2239> in 1969, and was prepared from 2-pyrone 1, via either a 3-step sequence that involved two successive brominations, followed by elimination of HBr, or a four-step process comprised of a bromination, HBr elimination and photochemical bromination reaction, followed by a second HBr elimination (Scheme 12). Scheme 12. Preparation of 3,5-dibromo-2-pyrone 38 reported by Pirkle and coworkers O O
O
Br2
O
O
O
O
Et3N
Br
Br
O Br
38
Br
Br + Br
Br Br
Br Br2 heat
1
O
Et3N O - HBr Br
O
O Br
Br2 hv
Br Br
O
O Br
No synthetic applications of 38 had since been reported, presumably due to its difficult preparation. We found that it can be efficiently prepared in single step from the commercially available coumalic acid 39 (Scheme 13) <01TL1065; 02JOC290>, in which coumalic acid undergoes concomitant aromatic bromination and bromo-decarboxylation reactions <97JOC199; 94JOC3543>.
The Diels-Alder cycloadditions of 3,5-dibromo-2-pyrone and its derivatives
7
Scheme 13. One-step synthetic protocol for 3,5-dibromo-2-pyrone from coumalic acid O HO2C
O
CCl4, MeCN (2:1) 39
O
NBS (3 eq), LiOAc, Bu4NBr
O
Br
65 - 76%
Br 38
Both 3-bromo-2-pyrone 4 and 5-bromo-2-pyrone 5 can also be prepared from 2-pyrone-3carboxylic acid 40 and coumalic acid 39 in one step, albeit in moderate yields, utilizing the same protocol, varying only the equivalents of NBS employed in the reaction (Scheme 14). Scheme 14. Synthesis of 3-bromo-2-pyrone 4 and 5-bromo-2-pyrone 5 O
O CO2H
40
O
CCl4, MeCN (2:1) 42%
39
O Br
4 O
same as the above
O
HO2C
O
NBS (1.2 eq), LiOAc, Bu4NBr
35%
O
Br 5
The results of the DA cycloadditions of 3,5-dibromo-2-pyrone 38 are summarized in Table 2 <02JOC290>. Only the endo products are shown for clarity (a; 5-endo, b; 5-exocycloadduct). Except for the entries 2, 6 and 9, using toluene as the solvent generally provided better results than CH2Cl2 with respect to chemical yields, endo/exo ratios and reaction rates. 3,5-Dibromo-2-pyrone proved to be more reactive than either 3-bromo-2pyrone or 5-bromo-2-pyrone in both normal and inverse electron demand cycloadditions. For example, 3,5-dibromo-2-pyrone with methyl methacrylate, methyl crotonate and benzyl vinyl ether provided 41a, 47a and 51a in 84%, 82% and 69% yields (entries 1, 7 and 11), while the same reactions with mono-bromo-2-pyrones 4 or 5 gave the corresponding cycloadducts in 30 – 40% yields under the same reaction conditions. The two bromine atoms act in an additive manner to enhance the reactivity. Because 5-bromo-2-pyrone had been previously shown to be more reactive than 3-bromo-2-pyrone <92TL9111>, the reactivity order of the bromo-2-pyrone series is the following: 3,5-dibromo-2-pyrone > 5-bromo-2-pyrone > 3bromo-2-pyrone. Notably, the cycloaddition of 3,5-dibromo-2-pyrone is more stereoselective than monobromo-2-pyrone counterparts 4 and 5. For instance, cycloadditions with acrylonitrile and benzyl vinyl ether provided the cycloadducts 44 and 51 in endo/exo ratios of 76:24 and 100:0 (entries 4 and 11), respectively, while 5-bromo-2-pyrone 5 afforded the corresponding cycloadducts in ratios of 54:46 and 67:33, respectively. Intriguingly, the cycloadditions with dimethyl fumarate and dimethyl maleate furnished an identical mixture of two diastereomers, in slightly different ratios (entries 8 and 9 in Table 2). Comparison of the coupling patterns of their 1H NMR spectra to other structurally related bicyclolactones, as well as performing decoupling experiments, established the relative stereochemistry of 49a and 49b, which was ultimately confirmed by their single crystal X-ray crystallographic analyses (Figure 1).
8
H-Y. Kim and C-G. Cho
Table 2. Reaction of 3,5-dibromo-2-pyrone with various dienophiles. entry
dienophile
endo:exo
conditions
yielda
endo-adduct O
O 1
OCH3
toluene, 100
oC,
5h
94:6 Br
O 2
CH2Cl2, 50 oC, 12 h
H
O toluene, 100 oC, 5 h
84%
42a
71%b
43a
84%
44a
90%
45a
92%
46a
84%
47a
82%
48a
80%
49a (same as 48a)
79%
Br
O CO2Me Br
O
95:5 Br
3
41a
O
O
CH2OH
O Br
94:6 Br
O COMe O Br
4
toluene, 100 oC, 12 h
CN
76:24 Br
O CN O
5 O
O
N Et
toluene, 100 oC, 12 h
76:24 Br O O
O 6
OCH3
CH2Cl2, 100 oC, 24 h
86:14
Br OCH3
toluene, 100 oC, 4 d
MeO2C
CO2Me
toluene, 100 oC, 3 d
O CO2Me
Me O CO2Me O Br
52:48
CO 2Me CO2Me
Br
9
MeO2C
CO2Me
toluene, 100 oC, 3d
Me
O Br
62:38 Br
8
NEt
O Br
O 7
Br O
64:36
O O Br 10
OEt
CH2Cl2, 50 oC, 2 d
86:14
50a
75%
51a
69%
OEt
Br O
O Br 11
OBn
toluene, 100 oC, 3d
100:0 Br
OBn
a) total isolated yield (endo + exo), b) the cycloadduct was reduced with NaBH4
The Diels-Alder cycloadditions of 3,5-dibromo-2-pyrone and its derivatives
9
Figure 1. ORTEP representations of the X-ray crystal structures of 49a and 49b, respectively.
Apparently, the stereochemistry of dimethyl maleate was not preserved during the cycloaddition, implying that the cycloaddition proceeded in a stepwise, rather than a concerted fashion <98BKCS957>. Monitoring the reaction progress by TLC and GC indicated the appearance of dimethyl fumarate from the reaction mixture comprised of 3,5dibromo-2-pyrone and dimethyl maleate after a few hours. The concentration of dimethyl fumarate increased during the course of the reaction, and slowly decreased as the cycloaddition progressed. Additionally, no cis-trans isomerization was observed when dimethyl maleate was heated alone in toluene. Although not isolated, 1H NMR and GC analysis of the reaction mixture indicated the existence of cis-disubstituted bicyclolactones. Based upon this evidence, the cycloaddition of 3,5-dibromo-2-pyrone with dimethyl maleate is reversible, proceeding through zwitterionic intermediates, 49-endo-1 and 49-exo-1, in which C-C bond rotation takes place to afford sterically less congested 49-endo-2 and 49exo-2, respectively (Scheme 15). The reverse reactions from 49-endo-2 and 49-exo-2 would then furnish dimethyl fumarate.
Scheme 15. Proposed mechanistic pathways O +O
Br CO2Me
Br MeO
O
O
Br O 49-endo-1
+O
+O
BrO OMe CO2Me 49-endo-2
O +O
Br CO Me 2
Br CO Me 2
O Br 49-exo-1
OMe
Br MeO
O 49-exo-2
Because of the higher reactivity, 3,5-dibromo-2-pyrone can undergo the D-A cycloaddition with sterically hindered silyl enol ethers as summarized in Table 3 <02TL8193>.
10
H-Y. Kim and C-G. Cho
Table 3. D-A cycloaddition of 38 with silyl enol ethers dienophile
entry
cycloadduct
combined yield
O
OTBS
O Br
1
OTMS
endo:exo
conditions
Br
93:7
85%
tol, 100 oC, 24 h
99:1
86%
tol, 100 oC, 48 h
99:1
73%
tol, 100 oC, 24 h
99:1
89%
tol, 100 oC, 72 h
35:65
85%
O OTBS O Br
2
tol, 100 oC, 24 h 52a
53a OTBS
Br
O OTMS O Br
3
54a OTMS
Br
O OTBS O Br
4
55a Br OTMS
O OTMS O Br
5
56a Br
OTMS
The reactions provided tricyclolactones 52a – 56a in good yields and endo/exo selectivity except entry 5, in which the formation of the exo-isomer prevailed. The resultant cycloadducts can be readily manipulated into bicyclic triols as exemplified with 54a. Reductive removal of tertiary alkyl bromide (vide infra) and reductive cleavage of the lactone afforded 58 in good overall yield (Scheme 16).
Scheme 16. O O
O Br
Bu3SnH
O
HO H
LAH/THF
AIBN/benzene Br
54a
OTBS
88%
H
OTBS
Br Br
57
OTBS
84%
H OH 58
The bromine atoms present in the cycloadducts (Table 2) can be independantly functionalized. Treatment of cycloadduct 41a with 2.4 equiv of Bu3SnH removed both vinyl and tert-alkyl bromides to furnish 59 in 75% yield (Scheme 17), while reaction with 1.2 equiv of Bu3SnH removed only the tertiary alkyl bromide at the bridgehead (C4) to afford 60 in 74% yield. The vinyl bromide can be readily functionalized utilizing Pd-catalyzed coupling reactions <02TL5591>.
11
The Diels-Alder cycloadditions of 3,5-dibromo-2-pyrone and its derivatives
Scheme 17. Selective functionalizations of cycloadduct 41a O O H
59
O
O Bu3SnH (2.4 eq)
H
O
AIBN, PhH, reflux
CO 2Me
Br
75%
41a
Bu3SnH (1.2 eq)
Br CO2Me
H
O
AIBN, PhH, reflux Br
74%
CO2Me 60
"Pd" CO 2Me
PhSnBu3 or PhB(OH)2
82% O
MeO2C
CO2Me
61
O
O Br
O
O Ph
62
TMS
SnBu3 65%
60-72%
Br
O
Br
O
O
CO2Me
CO2Me
86%
64
63
Br CO2Me
TMS
As seen in 61 and 63, various 1,3-diene functionalities can now be readily incorporated into the bicyclolactone. Summarized in Table 3 are the results of the cycloaddition of 63 with various dienophiles <02TL5591>. Notably, cycloaddition proceeded in a highly regio- and stereoselective fashion to provide, in all cases, virtually a single diastereomer out of four possible isomers <01OL2949>. Interestingly, the reaction of nor-Br-bicyclic diene 66 with Nethylmaleimide afforded a mixture of two diasteromers 67-endo and 67-exo in a ratio of 62:38 (Scheme 18, representations in an alternative orientation for clarity). Table 4. Cycloadditions of 63 with various dienophiles entry
dienophile
cycloadduct
conditions
yield
O CO2Me
MeO2C O
100 oC, 8 h
1
65a
MeO 2C CO2Me EtN NEt
2
100 oC, 30 h
O
O O
O O
O
O 100 oC, 48 h
3
O
O
O
Br
O
70%
CO2Me Br CO2Me
65b
66%
Br CO2Me
65c
58%
O O
O 4
100 oC, 24 h
O
O
Br 65d CO2Me
61%
12
H-Y. Kim and C-G. Cho
Scheme 18. Cycloaddition of nor-Br bicyclic diene 66 O H
O
Z
+
Et N
100 oC, 30 h 66%
O
66
O
O
O
Z = CO2Me
H
+ H H
O
H
O
NEt
O
O
H H Z O 67-endo (62 : 38)
H H Z NEt 67-exo O
Although it is not entirely clear, there may be a steric repulsion between the bridgehead Br and the carbonyl group of the incoming dienophile (N-ethylmaleimide), which destabilizes the corresponding exo-transition state. Another interesting effect of having a bridgehead Br is that it prevents the aromatization of the initially formed cycloadduct. The nor-Br cyclic diene 66 furnished aromatized cycloadducts 68 and 69, in which the cycloadduct was dehydrogenatively aromatized by the excess dienophile, in each case (Scheme 19, representations in an alternative orientation for clarity). In constrast, the same reaction with 63 bearing the bridgehead Br stopped at the initial cycloaddition stage (entries 1, 3, Table 4). Scheme 19. Cycloadditions of nor-Br bicyclic diene 66 O
O MeO2C
MeO 2C
100 oC, 8 h, 70%
H
O
CO2Me
MeO2C
CO 2Me
O
O
H O
O
CO2Me 68
O O
66 o
100 C, 48 h, 58%
O
H
CO 2Me
69
The reaction of 38 with styrenes 70 provided aryl-substituted bicyclolactones 71 with good endo/exo selectivity (Table 5, actual ratios not shown) <02BKCS1021>. Table 5. Cycloaddition of 38 with styrenes O O
O +
Br entry 1 2 3 4 5 6 7 8
Br
70 70a (Ph) 70b (2-BrC6H4) 70c (4-BrC6H4) 70d (2-MeOC6H4) 70e (4-MeOC6H4) 70f [[2,3-(MeO)2C6H3] 70g [2,4-(MeO)2C6H3] 70h [3,4-(MeO)2C6H3]
O
toluene
Ar
Ar
100 oC
70
38
Br
time
71 (yield)
entry
5h 15 h 12 h 6h 5h 12 h 3h 10 h
71a (90%) 71b (96%) 71c (79%) 71d (87%) 71e (86%) 71f (99%) 71g (90%) 71h (94%)
9 10 11 12 13 14 15 16
Br 70
71 time
70i [1,4-(MeO)2C6H3] 5 h 70j [1,3,4-(MeO)3C6H2] 8 h 70k (4-Me2NC6H4) 6h 70l (4-MeCONHC6H4) 9 h 70m (2-pyridyl) 13 h 70n (3-pyridyl) 7h 70o (4-pyridyl) 9h 70p (2-thienyl) 5h
71 (yield) 71i (85%) 71j (80%) 71k (98%) 71l (99%) 71m(60%) 71n (93%) 71o (82%) 71p (94%)
13
The Diels-Alder cycloadditions of 3,5-dibromo-2-pyrone and its derivatives
The mixture of endo/exo cycloadducts were directly treated with base to trigger a one-pot, three-step reaction sequence, involving lactone opening, HBr elimination and aromatization to give the corresponding biaryl compounds 74 in good yields (Scheme 20) <02BKCS1021>. The resultant biaryls can be readily applied to the generation of the sartan class of therapeutics such as irbesartan, losartan, valsartan, candesartan and temisartan, currently used as angiotension II antagonists. Scheme 20. One-pot, three-step synthesis of 2-carboxy-biaryls O
Br
R Br
O
R NaOMe
R
R - H2 O
- HBr
Br
CO2Me
CO2Me
MeO2C
71
OH HO Br 72
Br 73
Br 74
The tribromocycloadduct 71b (Scheme 21) can be used in the synthesis of novel polycyclic skeletons. Stille coupling reaction with excess vinyltributyltin installed both diene and dienophile groups, which underwent intramolecular Diels-Alder (IMDA) cycloaddition in a tandem fashion to furnish 76 as a single diastereomer in 65% yield <03JOC10191; 96CR167>. Scheme 21. Tandem coupling-IMDA cycloaddition of 71b. excess
Br Br
Br O
H
SnBu3
Br
O Pd(PPh3)4, tol reflux
O 71b
Br
O
O
O
75
76
R1 Br Br
Br O O
+
71b R2
R1
R2
Br
"Pd" M
"Pd"
O
M = SnBu3 or B(OH)2
R1
R2
M
Br
O
78
R1 H
O
Br
O
Br
O
O 79
80
Because the initial oxidative addition of Pd(0) is faster with the aryl bromide than the vinyl bromide, the vinyl groups can be selectively coupled to give 78, by using one equivalent of organo-stannane or boronic acid. Coupling with a second equivalent of organo-
14
H-Y. Kim and C-G. Cho
stannane or boronic acid provided 79, which also underwent an IMDA cycloaddition reaction in the same pot affording benzotetracyclolactones 80.
1.2.2
Synthesis and cycloadditions of substituted monobromo-2-pyrones
Palladium-catalyzed coupling reactions of 38 (Scheme 22) take place regioselectively at C3. Subsequent studies have shown that the oxidative addition of the catalytically active “Pd(0)” occurs faster at this carbon because of its lower electron density, relative to C5, indicated by the 13C NMR spectrum <05CC431; 00ACR314>. Scheme 22. Regioselective Pd-catalyzed coupling reactions of 3,5-dibromo-2-pyrone O
O
113.8
100.0
Br
Br
+
O
"Pd"
"R" (electrophiles)
R
Br
38
O
81
Sonogashira coupling with various alkynes 82 (Scheme 23) generated an array of 3alkynyl-5-bromo-2-pyrones 83 in good yields <02OL1171>. Under these conditions, no C5alkynylated 2-pyrone products were observed. Scheme 23. Sonogashira coupling reactions of 3,5-dibromo-2-pyrone O
O
Br
Br
O
Pd(PPh3)2Cl2, CuI, Et3N
O
R
+
dioxane, rt
82
Br
38
R
83
R = TMS, TIPS, Ph, CH2OH, CH2Ph, n-Bu, 1-cyclohexenyl, (CH2)4
Scheme 24. Cycloadditions of 3-(TMS-ethynyl)-5-bromo-2-pyrone O CO2Me O
TMS
Br 83a
O CO2Me 84-endo (87:13) O
OBn
Br
84-exo O
TMS
O
OBn
+ Br
TMS
O
toluene/100 oC 71%
CO2Me
+ Br
TMS
O
toluene/100 oC 63%
O
O
TMS
OBn 85-endo
Br (74:26)
85-exo
15
The Diels-Alder cycloadditions of 3,5-dibromo-2-pyrone and its derivatives
The resultant 3-alkynyl-5-bromo-2-pyrones 83 are potent ambident dienes, undergoing cycloadditions with both electron-rich and electron-poor dienophiles. As exemplied in Scheme 24, 3-[(trimethylsilyl)-ethynyl]-5-bromo-2-pyrone 83a underwent efficient cycloaddition with benzyl vinyl ether, as well as with methyl acrylate, to afford the corresponding cycloadducts 84 and 85, respectively. Cycloaddition of 3-ethynyl-5-bromo-2-pyrone 86 (Scheme 25) with 2-substituted styrenes provided cycloadduct 87-endo, which have been elaborated to polycarbocycle 9 0 <03TL4439> via a carbopalladation/trapping process <03OL845; 89JACS3454>. During this process, oxidative addition of “Pd(0)” occurs regioselectively at the aryl carbon, which then undergoes an addition reaction across the triple bond. The vinyl palladium 89 was subsequently trapped with either organotins or organoboronic acids to give 90. Opening of the lactone ring with NaOMe then furnished a series of tetrahydrofluorenes. Scheme 25. Cyclocarbopalladation of 87-endo O
O
Br
R'
X
Br O
heat
H
R'-M, "Pd"
Br O
O 86 +
O
87-endo PdL2
R'-M
X X = Br, I, OTf
PdL2I
PdL2X
Br O O
90
M = SnR3, B(OH)2
H Br O
88
89
O
Similarly, the Pd-catalyzed stannylation of 3,5-dibromo-2-pyrone 38 (Scheme 26) provided 3-(trimethylstannyl)-5-bromo-2-pyrone 91 exclusively. Coupling with various arylhalides furnished a series of 3-aryl-5-bromo-2-pyrones 92 in good yields <02TL5779>. Scheme 26. Synthesis and coupling reactions of 3-(Me3Sn)-5-bromo-2-pyrone 91. O
Br 38
O
Pd(PPh3)4, (Me3Sn)2
Br
THF, 100 oC, 2 h 67%
O Br
O SnMe3
91
ArX, CuI Pd(PPh3)2Cl2 DMF, 50 oC, 3 h X = I, Br
O Br
O Ar
92
Ar = Ph, 4-O2NC6H4, 2-O2NC6H4, 2-MeO2CC6H4, 4-MeOC6H4, 4-FC6H4, 3-IC6H4, 4-NCC6H4, 4-MeCOC6H4, 4-PhCOC6H4, 1-naphthalenyl, 2-thienyl, 3-quinolinyl
We also found that the C3 carbon of 38 (Scheme 26) can be selectively coupled with various organotin reagents 93 to produce the 3-substituted pyrones 81 in good yields <02TL5779>.
16
H-Y. Kim and C-G. Cho
Scheme 27. The Stille coupling reactions of 3,5-dibromo-2-pyrone 38 O
O
Br
O
Pd(PPh3)4, CuI +
Br
Br
toluene, 100 oC
93
R
81
38 R =
EtO
O
R-SnBu3
O
MeO2C
N
(Z = CN, OMe, CO2Me) Z
The ambident enophilic character of the resultant 3-aryl-5-bromo-2-pyrone 81 was demonstrated by the easy cycloadditions of 3-phenyl-5-bromo-2-pyrone 94 (Scheme 28) with both methyl acrylate (MA) and benzyl vinyl ether (BVE), affording the corresponding cycloadducts 95 and 96 in good yields with varying endo/exo selectivity. Scheme 28. D-A cycloadditions of 94 with MA and BVE. O CO 2Me O
O
O
+
tol, 100 oC, 7 h 87%
O
O
Br
CO2Me 95-endo (>99:1)
CO2Me Br
95-exo
O Br
OBn
O
O
94
O
+
tol, 100 oC, 12 h 99%
Br
OBn 96-endo
(70:30)
OBn Br
96-exo
Stannylated 2-pyrones 91 and 98 (Scheme 29) are competent 1,3-dienes, reacting with methyl acrylate to afford the stannylated bicyclolactones. However, 91 and 98 do not react with the electron-rich dienophile BVE. Scheme 29. Cycloadditions of 91 and 98. O
O SnMe3
O
CO2Me
O
tol, 100 oC, 24 h Br 91
97%
SnMe3 CO2Me +
Br
CO2Me
O
O SnMe3
O
+ SnMe3 98
CO2Me 97-exo
(90:10)
O SnMe3
tol, 100 oC, 24 h 54%
SnMe3
O Br
97-endo
O O
O
CO2Me
Br 99-endo
(68:32)
SnMe3 CO2Me
Br 99-exo
17
The Diels-Alder cycloadditions of 3,5-dibromo-2-pyrone and its derivatives
2-Pyrone derivatives containing a 2-pyridyl substituent at C3 can undergo Lewis-acid catalyzed DA cycloadditions with electron-rich dienophiles. Shown in Scheme 30 is the ZnBr2 catalyzed cycloaddition of 100 with BVE. After 48 hours at -20 °C, the reaction afforded endo-cycloadduct 102 as only product in 81% yield. Scheme 30. ZnBr2-catalyzed D-A cycloaddition of 100 with BVE. O
N
Br
O
ZnBr2 (0.1 eq)
O
O Br
CH2Cl2 -20 oC
100
O
ZnBr2 N
OBn
O
81% Br
101
N OBn
102
Under the reaction conditions, 3-(2-furyl)-5-bromo-2-pyrone and 3-(2-thienyl)-5-bromo2-pyrone also undergo ZnBr2-catalyzed D-A cycloadditions with BVE, but not as readily as does 100. After 12 hours at ambient temperature, cycloaddition products were produced in 30 - 40% yield. Mono-coordinating Lewis acids, such as BF3 etherate, did not promote the reaction. Additionally, no cycloaddition products were observed with electron-deficient methyl acrylate under identical reaction conditions. The 3-(2-pyridyl)-5-aryl-2-pyrones 103a – 103d (Scheme 31) also underwent smooth ZnBr2-catalyzed cycloaddition reactions with BVE to give the endo-cycloadducts 104a – 104d with no detectable amount of exo-adduct in each case. Scheme 31. ZnBr2-catalyzed D-A cycloaddition of 103a – 103d with BVE. O
O
N ZnBr2, THF
O
+
OR' R' = Et, Bn
R 103a - 103d N R=
O
N
rt, 48 h 55 - 73% endo:exo > 99:1 O
R
OR' 104a -104d
S
The Pd-catalyzed amination reactions <98AC(E)2046; 01JOC2560> of 3,5-dibromo-2pyrone 38 provided an array of structurally novel 2-pyrones with primary and secondary, aromatic and aliphatic amines at C3 in a highly regioselective manner (Scheme 32) <03TL95>. The 3-amino-5-bromo-2-pyrones 106 were expected to favor normal electron demand cycloadditions, compared to the parent 3,5-dibromo-2-pyrone, because of the presence of the electron-donating amino group. Summarized in Table 6 are the results of the cycloadditios of 3-phenylamino-5-bromo-2-pyrone 106a with various electron-deficient dienophiles (only exo-adducts were shown for clarity) <04TL1683>. Attempted cycloaddition of 106a with electron-rich BVE gave only traces of cycloaddition products, even after prolonged heating at 100 oC. Unlike the parent 3,5-dibromo-2-pyrone or other 2-pyrone derivatives, 3phenylamino-
18
H-Y. Kim and C-G. Cho
Scheme 32. Pd-catalyzed amination reactions of 3,5-dibromo-2-pyrone O
O
Br
R-NH2
Br
toluene, 110 oC, 0.5 - 5 h
Br
NH2
106
NH2
NH2
NH2
N
N
Me
NH2
NH2
NH2
NH
O NHR
105
38
R-NH2 =
O
Pd(OAc)2, xantphos, Cs 2CO3 +
NH
MeO
NH
nPrNH2
MeN
nBuNH2
Me
Et2NH
-5-bromo-2-pyrone 106a favors the formation of exo-cycloadduct. A simple molecular modeling study suggested that the aryl group imposes an additional steric repulsion with the incoming dienophile, destabilizing the otherwise favorable endo-transition state. Table 6. D-A cycloadditions of 106a with various electron-deficient dienophiles. entry dienophile
% yield entry dienophile (endo:exo)
exo-adduct O
O 1
OCH3
O
O
O NHPh CO2Me
95 (47:53)
6
O NHPh CO2Me
OCH3
107b
Br
Br
O O 2
O NHPh COCH3
CH3 Br
3
Br
4
O
Br
O 5
81 (53:47)
8 MeO2C
O NHPhO
NEt
OCH3 Br
O
NEt 110b
Me
Br
CO2Me 84 (44:56)
9 CO2Me Br
O O NHPh CO2Me
Ph(4-Br) Br CO2Me
109b
O O
7
108b
O O NHPh CN
CN
85 (18:82)
% yield (endo:exo)
exo-adduct
Me O
80 (46:54)
112b
O NHPh Ar
83 (76:24)
O
113b O NHPh CO2Me 81 (10:90) CO2Me 114b O 84 (30:70) O NHPh CO2Me CO 2Me 115b
84 (48:52)
111b
It is noteworthy that the stereochemistry of dimethyl maleate was preserved during the cycloaddition to give cis-disubstituted cycloadducts (entry 9). The cycloaddition of the parent 3,5-dibromo-2-pyrone with the same dienophile was shown to proceed in a stepwise fashion to produce trans-disubstituted cycloadducts (cf. entry 9, Table 2). Contrary to previous results (cf. Table 2), the reactions in CH2Cl2 gave uniformly better results than in toluene, in terms of
19
The Diels-Alder cycloadditions of 3,5-dibromo-2-pyrone and its derivatives
both reaction rates and product yields. Lactone ring opening with NaOMe provided a series of conformationally constrained α-amino acid derivatives <01T6429; 95JACS7904>. In general, the endo/exo stereochemistry of the 2-pyrone cycloadduct can be assigned by the chemical shift of the C5-methine proton. The C5 proton of exo-cycloadduct normally appears at higher field than the proton of endo-cycloadduct, because of the anisotropic shielding effect of the olefin bridge. The trend of the chemical shift in the case of the 3-(Nanilino) derivatives 107b – 115b is completely reversed; the C5-proton of exo-cycloadduct 107b resonates at lower field than that of endo-cycloadduct 107a. The unusual downfield shift of the proton in the exo-adduct is believed to be due to the anisotropic deshielding effect of the neighboring phenyl group. A simple MM2 calculation study suggested that Hb lies in the deshielding cone of phenyl ring. O O
O
H N
O
Ha 3.04 ppm CO2Me
Br
107a-endo
H N CO2Me Hb 3.58 ppm 107b-exo
Br
Figure 2. 1H NMR chemical shifts of Ha and Hb. The 2-pyrone 116 (Scheme 33), containing the weakly electron-donating carbamate group at C3, has been reported to undergo cycloadditions with alkynes in refluxing decalin or tetralin, providing aniline derivatives 118 upon elimination of CO2 and aromatization <04JOC3193>. Scheme 33. Cycloaddition of 116 with various alkynes
O
O
tetralin
NHCOPh
R4
heat R1
116
- CO2
NHCOPh O R4
+ R1
NHCOPh R4
O
R3 R2
R2
117
R1
R3
R3 R
2
118
Because of the special effect of Cu(I) <90JOC5359; 96JACS2748; 06OL1109> and solvent, the Pd-catalyzed Stille coupling reactions of 38 can be altered to take place at C5, rather than C3, as shown in Table 7 <03JACS14288>. Table 7. Regiocontrolled Stille coupling reactions O
O + PhSnBu3
Br
Br
1 2
O
O
Br
conditions Pd(PPh3)4, CuI (0.1 eq), toluene, 100 oC Pd(PPh3)4, CuI (1.0 eq), DMF, 50 oC
Ph
O
O
O
+
94
38
entry
O
conditions
+ Ph
119
Br
Ph
Ph 120
time
94
119
120
0.5 h 2h
94% trace
trace 75%
trace trace
20
H-Y. Kim and C-G. Cho
Suzuki coupling reactions of 38 also proceed in a highly regiocontrolled fashion to provide either C3-coupled or C5-coupled products, depending on the reaction conditions (Table 8) <04SL2197>.
Table 8. Regiocontrolled Suzuki coupling reactions O
O
Br
O
conditions
+ PhB(OH)2
+
Br
Br
Ph
Ph
94
38 entry conditions
Pd(PPh3)4, K2CO3, toluene, 100 oC Pd(PPh3)4, CuI (1.0 eq), Na2CO3, DMF, 50 oC
1 2
O
O
O
Br
O
O + Ph
Ph
119
120
time
94
119
120
4h 4h
81% trace
trace 89%
trace trace
A series of 5-substituted-3-bromo-2-pyrones can be thus readily synthesized as summarized in Figure 3. The resultant 2-pyrones are expected to be potent ambident dienes as exemplified by the cycloadditions of 5-phenyl-3-bromo-2-pyrone with methyl acrylate and benzyl vinyl ether (Scheme 34).
Figure 3. 5-Subsituted-3-bromo-2-pyrones O
O
O
Br 121
O
122 O
O S
Br 126
nBu
Br
O O
Me
125 O
N
O
O
Br 129
O Br
Br
124
O Br
O F
O
Me
134
130 O
Br F
135
O Br
O Br
Z 131: Z = CO 2Me 132: Z = CN, 133: Z = OMe
O
TMS
128 O
O
O Br
Ph
123
O
O Br
O
Br
127 O
O
Br
OEt
O
O
O
136
21
The Diels-Alder cycloadditions of 3,5-dibromo-2-pyrone and its derivatives
Scheme 34. Cycloadditions of 119 with MA and BVE O
O CO2Me
Br
O
O
tol, 100 C, 12 h
O
Ph
85%
CO 2Me 137-endo
Br
(90:10)
CO2Me Ph 137-exo
O
119
Br
O
+
o
O
OBn
O Br
O
Br
+ tol, 100 oC, 12 h 89%
1.2.3
Ph
OBn 138-endo
(80:20)
OBn Ph
138-exo
Intramolecular Diels-Alder cycloadditions of 2-pyrones
The intramolecular Diels-Alder (IMDA) cycloadditions <05CR4779; 02AC(E)1668> of 2-pyrones have not been exhaustively explored, due to the lack of synthetic methods to incorporate requisite tethered dienophiles. Only a few examples can be found in the literature and they have been employed mostly in the synthesis of aromatic compounds. 2-Pyrone-6-carboxylate 139 (Scheme 35) was shown to undergo an IMDA reaction to afford dihydrobenzofuranone 141, upon elimination of CO2 from the initially formed cycloadduct 140 <85CL151>. Analogously, the amide 142 produced 143, which was a key intermediate in syntheses of the natural products (±)-reserpine and (±)-yohimbine <87JACS6124>. Scheme 35. IMDA cycloadditions of 139 and 142 O
O O
O
O
toluene 150 oC
R 139
O
140
O
O 141
OMOM
O BnN
R
66-72%
R - CO2
O
O
O
heat
(±)-reserpine H
93% OMOM
142
N Bn
O 143
(±)-yohimbine
Narasaka and coworkers have reported the IMDA reaction of 3-hydroxy-2-pyrone 34 (Scheme 36) with 4-hydroxy-2-butenoate 144, which was temporarily tethered with phenylboronic acid, to provide a single cycloadduct 147 in 75% yield <91S1171>. This elegant strategy was further elaborated by Nicolaou and coworkers for the synthesis of 151 as the C-ring intermediate in their initial synthetic endeavors towards the total synthesis of taxol <92JCS(CC)1118; 95JACS624>.
22
H-Y. Kim and C-G. Cho
Scheme 36. Temporarily tethered IMDA cycloadditions OH O
O
Ph
144 O
CO2Me
o OH PhB(OH)2, 80 C
34
MeO2C
OH O
O
O
O 145
O B
OH
75% Ph
CO2Me
146 CO 2Me
147
O
Ph
148
O
O
CO2Me
MeO2C O
o OH PhB(OH)2, 80 C
34
OH
O
O
O
O
O
B
O
O O B Ph O
B O
MeO O 61%
OH
O
150 CO2Me
149
OH
O
151
ZnBr2-catalyzed IMDA cycloaddition of the 2-pyrone 152 (Scheme 37), tethered with a chiral enol silaketal, provided (+)-153-exo in 74% yield, along with a small amount of (-)153-endo <95JOC1617>. In this case, the E-geometry of the dienophile was not preserved during the cycloaddition, as in the cycloaddition of 3,5-dibromo-2-pyrone with dimethyl maleate (cf. entry 9, Table 2), implying a stepwise reaction mechanism. The isolated exo product (+)-153 was used as the key intermediate for the asymmetric total synthesis of a 2alkyl-vitamin D3 analog. Scheme 37. IMDA cycloaddition of a silaketal dienophile O
O O
O
O
OO ZnBr2 O Si(i-Pr)2
O
O O O Si (i-Pr)2
O
-30 oC, 4 d
(+)-152
(+)-153-exo
74%
O O
O
O O Si(i-Pr)2
+
(-)-153-endo 15%
Similarly, the 2-pyrone tethered with a chiral alkyl silane 154 (Scheme 38) was found to undergo IMDA cycloaddition to afford dihydrobenzenes 156 as a mixture of two diastereomers (de = 36%) in a combined yield of 78% after 2.5 hours at 140 °C <98TL4261>. Scheme 38. IMDA cycloaddition of 154 with alkyl silane tether O
O R'N Me R Si
O
O
o
140 C 2.5 h
154
O
O
- CO2 Me
O R'N
Si
155 R
R'N Si Me
R
156
23
The Diels-Alder cycloadditions of 3,5-dibromo-2-pyrone and its derivatives
With the establishment of the regioselective Pd(0)-catalyzed coupling of 3,5-dibromo-2pyrone, dienophilic groups can be readily tethered to the 2-pyrone unit. Various alkynes 157 (Scheme 39) bearing a terminal acrylate were successfully coupled regioselectively at the C3 position to generate the 2-pyrones 158 with good regioselectivity and chemical yields. The Sonogashira coupling reaction of the alkyne is faster than the possibly competing Heck reaction of the acrylate under these reaction conditions. Heating in toluene at 110 °C overnight provided IMDA-produced tricyclolactones 159 <04TL5857>. While 158a gave a mixture of endo/exo-adducts (60:40), 158b, 158c and 158d afforded only the corresponding endo-adducts with no detectable exo-cycloadducts. It is postulated that the alkynyl tether in 158a is not long enough to allow the proper orbital overlap for an endo-transition state. Scheme 39. Preparation and IMDA cycloadditions of tethered 2-pyrones 158. O Br
O
PdCl2(PPh3)2 CuI
n +
O
O
O
O
n
O O
n PhMe
O
O
110 oC
Et3N, DMF, rt Br
Br 38
O Br
overnight
158a (n = 1): 73 % 158b (n = 2): 78 % 158c (n = 3): 69 % 158d (n = 4): 73 %
157a (n = 1) 157b (n = 2) 157c (n = 3) 157d (n = 4)
O 159a: 31% (60:40) 159b: 51% (100:0) 159c: 55% (100:0) 159d: 66% (100:0)
The IMDA cycloadditions of the systems containing a substituted acrylate, i.e. 160 (Scheme 40), also afforded the corresponding cycloadducts 161, in much lower yields after prolonged reaction times (48 hours). Scheme 40. IMDA cycloaddition of 2-pyrones 160. O
3
O O
3 PhMe
O
O
R
160a: R = Me 160b: R = Ph
O R O
110 oC Br
Br
O
161a: R = Me, 32% 161b: R = Ph, 34%
In the cases of 10- and 11-membered macrocyclic bis-lactones, 159c and 159d (Scheme 41), the selective lactone ring opening with NaOMe occurred on the more strained [2,2,2]bicyclic lactone to provide 162c and 162d. For the 9-membered homolog 159b, opening of the macrolactone was competitive, furnishing 163b, due to the inherent ring strain. Scheme 41. Selective lactone opening reactions with NaOMe. O n
O O Br
O 159b (n = 2) 159c (n = 3) 159d (n = 4)
NaOMe MeOH, 0 oC
MeO 2C Br HO
O O 162b ~0% 162c 99% 162d 99%
n
MeO2C Br
n OH
+
HO
CO2Me 163b 99% 163c 0% 163d 0%
24
H-Y. Kim and C-G. Cho
Palladium-catalyzed coupling reactions of 38 (Scheme 42) with the alkynyl acrylamide 164 also took place regio- and chemoselectively to generate 165 in good yields. IMDA reaction of 165a gave the cycloadduct in less than 10% yield, forming an 8-membered lactam, while those with longer tethers (165b – 165d) furnished tricyclolactams 166b – 166d in good yields with exclusive endo-selectivity. Scheme 42. Synthesis and IMDA cycloadditions of 2-pyrones tethered with acrylamide O Br
O
+
NH
O
O
NH
O
n PhMe
O NH
110 oC
Et3N, DMF, rt Br
Br 38
O
n
O
PdCl2(PPh3)2 CuI
n
overnight
165a (n = 1): 80% 165b (n = 2): 85% 165c (n = 3): 70% 165d (n = 4): 76%
164a (n = 1) 164b (n = 2) 164c (n = 3) 164d (n = 4)
Br
O 166a: 10% (50:50) 166b: 46% (100:0) 166c: 53% (100:0) 166d: 69% (100:0)
The IMDA reaction of pyrone 167, which bears a chiral tether proceeded in a highly diastereoselective fashion to provide 168a-endo in 68% yield (95% based on a 72% conversion of 167), upon heating at 110 °C in toluene (Scheme 43) <06AG(E)>. Scheme 43. Highly Diastereoselective IMDA cycloaddition of 167 O
O 3
O
O
O
Me
H
110 oC
167
1.3
3
toluene
68 %
Br
O O Br
O
Me +
H
Br O O
O
3
O
168-endo
169-endo
single diastereomer
not observed
Me
H
CONCLUSION
Known since the days of Diels and Alder, 2-pyrones have proven to be versatile 1,3-diene synthons, especially with the incorporation of electronic matching of the cycloaddition partners. First reported almost forty years ago, 3,5-dibromo-2-pyrone had remained largely unexplored until the disclosure of a convenient one-step synthetic protocol. Subsequent studies have shown 3,5-dibromo-2-pyrone is a reactive 1,3-diene and proceeds with greater stereoselectivity in D-A cycloadditions than mono-bromo-2-pyrones. It also exhibits ambident enophilic character, undergoing both normal and inverse electron demand D-A cycloadditions. Additionally, Pd-catalyzed coupling reactions can occur selectively at either the C3 or C5 by simply controlling the reaction conditions. Considering the recent advances in the chemistry towards, and of, substituted-2-pyrones, further expansion of its versatility for diversity- and target-oriented synthetic endeavors seems certain. 1.4
ACKNOWLEDGMENTS
The authors thank the Korean Science and Technology Foundation (KOSEF, R01-2006000-11283-0) for support of our program on the Diels-Alder cycloadditions of 3,5-dibromo-
The Diels-Alder cycloadditions of 3,5-dibromo-2-pyrone and its derivatives
25
2-pyrone and its derivatives. Mr. Douglas C. Beshore at University of Pennsylvania and Dr. Todd D. Nelson at Merck Co. are thanked for their helpful suggestions. 1.5
REFERENCES
31A257 69JOC2239 83JACS1988
O. Diels, K. Alder, Ann. 1931, 490, 257. W.H. Pirkle, M. Dines, J. Org. Chem. 1969, 34, 2239. R.E. Ireland, R.C. Anderson, R. Badoud, B.J. Fitzsimmons, T.J. McGarvey, S. Thaisrivongs, J. Am. Chem. Soc. 1983, 105, 1988. 84JOC4033 D.L. Boger, M.D. Mullican, J. Org. Chem. 1984, 49, 4033. 84JOC4050 D.L. Boger, C.E. Brotherton, J. Org. Chem. 1984, 49, 4050. 85CL151 M. Noguchi, S. Kakimoto, S. Kajigaeshi, Chem. Lett. 1985, 151. 86JACS7373 G.H. Posner, D.G. Wettlaufer, J. Am. Chem. Soc. 1986, 108, 7373. 87JACS6124 S.F. Martin, H. Rüeger, S.A. Williamson, S. Grzejszczak, J. Am. Chem. Soc. 1987, 109, 6124. 89JACS3454 Y. Zhang, E. Negishi, J. Am. Chem. Soc. 1989, 111, 3454. 90JOC5359 L.S. Liebeskind, R.W. Fengl, J. Org. Chem. 1990, 55, 5359. 91S1171 K. Narasaka, S. Shimada, K. Osoka, N. Iwasawa, Synthesis 1991, 1171. 91TL5295 G.H. Posner, T.D. Nelson, C.M. Kinter, K. Afarinkia, Tetrahedron Lett. 1991, 32, 5295. 92JCS(CC)1118 K.C. Nicolaou, J.J. Liu, C.-K. Hwang, W.-M. Dai, R.K. Guy, J. Chem. Soc., Chem. Commun. 1992, 1118. 92TL7839 G.H. Posner, K. Afarinkia, Tetrahedron Lett. 1992, 33, 7839. 92TL9111 K. Afarinkia, T.D. Nelson, M. Vinader, G.H. Posner, Tetrahedron Lett. 1992, 48, 9111. 94JOC3543 A. Graven, K.A. Jorgensen, S. Dahl, A. Stanczak, J. Org. Chem. 1994, 59, 3543. 95JACS624 K.C. Nicolaou, P.G. Nantermet, H. Ueno, R.K. Guy, E.A. Couladouros, E.J. Sorensen, J. Am. Chem. Soc. 1995, 117, 624. 95JACS634 K.C. Nicolaou, J.-J. Liu, Z. Yang, H. Ueno, E.J. Sorensen, C.F. Claiborne, R.K. Guy, C.-K. Hwang, M. Nakada, P.G. Nantermet, J. Am. Chem. Soc. 1995, 117, 634. 95JACS7904 C. Bisang, C. Weber, J. Inglis, C.A. Schiffe, W.F. van Gunsteren, I. Jelesarov, H.R. Bosshard, J.A. Robinson, J. Am. Chem. Soc. 1995, 117, 7904. 95JOC1617 G.H. Posner, C.-G. Cho, T.E.N. Anjeh, N. Johnson, R.L. Horst, T. Kobayashi, T. Okano, N. Tsugawa, J. Org. Chem. 1995, 60, 1617. 95OS231 G.H. Posner, K. Afarinkia, H. Dai, Org. Synth. 1995, 73, 231. 95TL5939 H. Okamura, T. Iwagawa, M. Nakatani, Tetrahedron Lett. 1995, 35, 5939. 96CR167 J.D. Winkler, Chem. Rev. 1996, 96, 167. 96JACS2748 G.D. Allred, L.S. Liebeskind, J. Am. Chem. Soc. 1996, 118, 2748. 97JOC199 S. Chowdhury, S. Roy, J. Org. Chem. 1997, 62, 199. 98AC(E)2046 J.F. Hartwig, Angew. Chem. Int. Ed. 1998, 37, 2046 98BKCS957 C.-G. Cho, G.H. Posner, Bull. Korean Chem. Soc. 1998, 19, 957. 98TL4261 P. Coelho, L. Blanco, Tetrahedron Lett. 1998, 39, 4261. 99AC47 B.T. Woodard, G.H. Posner, Adv. Cycloaddit. 1999, 5, 47. 00ACR314 C. Amatore, A. Jutand, Acc. Chem. Res. 2000, 33, 314. 00OL2049 C.-S. Chen, C.-C. Liao, Org. Lett. 2000, 2, 2049. 00T5205 D. Passarella, G. Lesma, M. Martinelli, A. Silvani, M. Cantò, J. Hidalgo, Tetrahedron 2000, 56, 5205. 00TL4955 K. Afarinkia, J. Berna-Canovas, Tetrahedron Lett. 2000, 41, 4955. 00TL7583 L. László, I. Kádas, T. László, Tetrahedron Lett. 2000, 41, 7583. 00TL8317 H. Okamura, H. Nagaike, T. Iwagawa, M. Nakatani, Tetrahedron Lett. 2000, 41, 8317. 01JOC2560 M.H. Ali, S.L. Buchwald, J. Org. Chem. 2001, 66, 2560. 01OL2949 S.R. Chemler, U. Iserloh, S.J. Danishefsky, Org. Lett. 2001, 3, 2949. 01T6429 F. Clerici, M.L. Gelmi, A. Gambini, D. Nava, Tetrahedron 2001, 57, 6429. 01TL1065 C.-G. Cho, J.-S. Park, I.-H. Jung, Tetrahedron Lett. 2001, 42, 1065. 01TL8193 C.-G. Cho, Y.-W. Kim, W.-K. Kim, Tetrahedron Lett. 2001, 42, 8195. 02AC(E)1668 K.C. Nicolaou, S.A. Snyder, T. Montagnon, G. Vassilikogiannakis, Angew. Chem. Int. Ed. 2002, 41, 1668. 02BKCS1021 S.-H. Min, Y.-W. Kim, S. Choi, K.B. Park, C.-G. Cho, Bull. Korean Chem. Soc. 2002, 23, 1021. 02JOC290 C.-G. Cho, Y.-W. Kim, Y.-K. Lim, J.-S. Park, H. Lee, S. Koo, J. Org. Chem. 2002, 67, 290.
26 02OL1171 02TL5591 02TL5779 02TL9015 03JACS14288 03JOC10191 03OL845 03TL3363 03TL4439 03TL95 04JOC3193 04SL2197 04TL1683 04TL5857 05CC431 05CR4779 05JOC1122 06AC(E) 06OL1109
H-Y. Kim and C-G. Cho
J.-H. Lee, J.-S. Park, C.-G. Cho, Org. Lett. 2002, 4, 1171. H.-S. Lee, D. Kim, H. Won, J.H. Choi, H. Lee, C.-G. Cho, Tetrahedron Lett. 2002, 43, 5591. J.-H. Lee, W.-S. Kim, Y.-Y. Lee, C.-G. Cho, Tetrahedron Lett. 2002, 43, 5779. W.-S. Kim, H.-J. Kim, C.-G. Cho, Tetrahedron Lett. 2002, 43, 9015. W.-S. Kim, H.-J. Kim, C.-G. Cho, J. Am. Chem. Soc. 2003, 125, 14288. S.-J. Pang, S.-H. Min, H. Lee, C.-G. Cho, J. Org. Chem. 2003, 68, 10191. B. Salem, P. Klotz, J. Sluffert, Org. Lett. 2003, 5, 845. D. Sil, A. Goel, V.J. Ram, Tetrahedron Lett. 2003, 44, 3363. S.-H. Min, S.-J. Pang, C.-G. Cho, Tetrahedron Lett. 2003, 44, 4439. J.-H. Lee, C.-G. Cho, Tetrahedron Lett. 2003, 44, 95. K. Kranjc, B. Stefane, S. Polanc, M. Kocevar, J. Org. Chem. 2004, 69, 3193. K.-M. Ryu, A. Gupta, J.-W. Han, C.H. Oh, C.-G. Cho, Synlett 2004, 2197. W.-S. Kim, J.-H. Lee, J. Kang, C.-G. Cho, Tetrahedron Lett. 2004, 45, 1683. J.-T. Shin, S. Shin, C.-G. Cho, Tetrahedron Lett. 2004, 45, 5857. A. Zapf, M. Beller, Chem. Commun. 2005, 4, 431. K.-i. Takao, R. Munakata, K.-i. Tadano, Chem. Rev. 2005, 105, 4779. K. Afarinkia, M.J. Bearpark, A. Ndibwami, J. Org. Chem. 2005, 70, 1122. J.-T. Shin, S.-C. Hong, S. Shin, C.-G. Cho, Angew. Chem. Int. Ed. 2006, submitted Y. Wang, D.J. Burton, Org. Lett. 2006, 8, 1109.
27
Chapter 2
Recent developments in the chemistry of nucleosides Jean-Luc Girardet and Stanley A. Lang Valeant Research & Development, 3300 Hyland Avenue, Costa Mesa, CA 92626
[email protected],
[email protected]
2.1
INTRODUCTION
Nucleosides have been at the forefront of heterocyclic research since they have been identified more than one hundred years ago. It is the work of Emil Fisher and Phoebus Levene at the end of the nineteenth century that contributed to the discovery of what was called at the time the building blocks of life. Several books present in detail the synthesis of nucleosides and their heterocyclic bases and sugar moieties <88MI1; 91MI1; 94MI1; 01MI1>. Most, if not all, nucleoside research in present days is focusing on the quest for bioactive molecules, and this is most certainly due to the important interactions between these types of molecules and living cells <90MI1; 97MI1> and the therapeutic advantage associated with them. In the past four decades, numerous nucleoside analogs were approved by the American Food and Drug Administration (FDA) to treat various cancers and viral infections, including seven over the past eight years: capecitabine (anticancer) in 1998 <99ARMC317>, abacavir sulfate (antiviral) in 1999 <00ARMC331>, tenofovir disoproxil fumarate (antiviral) in 2001 <02ARMC257>, adefovir dipivoxil (antiviral) in 2002 <03ARMC347>, emtricitabine (antiviral) in 2003 <04ARMC337>, azacitidine (anticancer) in 2004 <05ARMC443> and entecavir (antiviral) in 2005. Some of these drug compounds, like capecitabine and azacytidine, incorporate only one or two chemical modifications as compared to a natural ribo- or deoxyribonucleoside. Others, like adefovir, tenofovir and abacavir, are heavily modified. Research on the chemical modifications of the sugar moiety of nucleosides has explored many other modifications, ranging from simple methylation of the ribose sugar to multiple ring systems as seen in many spironucleosides. This chapter will review the recent developments in nucleoside research both in term of chemistry and potential medical use. We will first review modifications brought to the ribose or 2’-deoxyribose moiety of a nucleoside, from C-1’ to C-5’ (nucleoside nomenclature). We will then look at publications on ribose replacement with unnatural sugars, including carba, thia and aza sugars, and then we will review the literature on bicyclonucleosides published in recent years. This chapter will be concluded with a review of recent articles on nucleoside synthesis on solid support, and the challenges associated with this technique applied to nucleoside synthesis.
28
J.-L. Girardet and S.A. Lang
O
O N
O N
NH
N
F
O
N tenofovir disoproxil
N
O
H2N
O
OH
HO
O
O N
S
NH2 N
HO
F
N
N
O
O N
adefovir dipivoxil
2.2
N
O N
O
H2N N
O
O
P O O
N
O O
H2N
abacavir O
N
N
H2N
capecitabine
O
O N
NH
HO OH
N
N
O
O
O P O O
OH
OH emtricitabine
azacitidine
SUGAR CHEMISTRY
In the past few years, sugar modifications have taken a more important role in the chemistry of nucleosides and nucleotides. These ribose or 2’-deoxyribose chemical modifications can be classified in three main categories: addition of a substituent to an unmodified sugar in place of a hydrogen, substitution of a methylene group or oxygen atom, and finally, replacement of the natural sugar by an either unnatural or heavily modified one. All three of these strategies proved successful recently, and allowed the advancement of various nucleoside or nucleotide analogs to the clinic: valopicitabine, the valine ester prodrug of 2’-C-methylcytidine, is scheduled to enter phase III clinical trial in early in 2006 for the treatment of hepatitis C virus (HCV) infections, entecavir was approved in 2005 for the treatment of hepatitis B virus (HBV) infection and a New Drug Application (NDA) has been submitted in January 2006 for telbivudine, or Ldeoxythymidine, also for the treatment of HBV infections. OH
OH
O N
O OH O
NH2
HO
O
N
O
N
HN
N
O
O N
O
HO N
OH
NH
H2N
NH2 valopicitabine
entecavir
telbivudine
29
Recent developments in the chemistry of nucleosides
2.2.1
Hydrogen and Oxygen substitutions
Keeping the core ribose or 2’-deoxyribose intact, and substituting one hydrogen or oxygen with a different atom has been quite popular in the past 5-6 years. These modifications bring minimum changes to the overall conformation of nucleosides, thus increasing the chances of enzymatic recognition and biological activity. Several nucleoside analogs currently in clinical trial belong to this category. 2.2.1.1 Modifications at C-1’ Only a few C-1’ modifications have been reported in the past few years, one of the reasons being the difficulty of obtaining any stereoselectivity at this anomeric position. Cappellacci <02JMC1196> reported the synthesis of 1’-C-methyladenosine 4 starting from the lactone 1 in 6 steps with chiral separation after the last step. A different approach was followed by Kodama <00TL3643; 01CEJ2332; 02JOC7706> who introduced stereoselectively a phenylseleno group at the 1’ position of a nucleoside, followed by formation of the samarium enolate 6 and aldehyde condensation to give 7. A similar strategy was applied to synthesize compound 5 <02TL5657>. No significant antiproliferative activity was reported for any of these analogs. 1) NaH, BnBr, THF BnO
O
HO
O O Ph
2) MeLi, Et2O 3) Ac2O, DMAP, pyr
O 1
1) NH3
2) HCOONH4 10% Pd/C, MeOH, reflux
O Ph
O 2
N
CH3 N OH
HO
EtAlCl2, OAc MeCN
NH2
HN
S
HO
N
HO
O
Cl N
N
3 N NH2
N
OH OH
N
N
5 H N
O O
N SePh
O
N
N CH3
O Ph
N
4
O TIPDS
Cl
N
O
HO
N
CH3
N
O
HO
O
O 6
H N
O O
1) SmI2/THF 2) (CH2O)n 3) NaBH4, MeOH 4) TBAF, THF
O
HO
O
N OH
HO OH 7
2.2.1.2 Modifications at C-2’ A great deal of chemistry was published recently on chemical modifications at the C-2’ position of ribonucleosides. This sudden surge in interest is most certainly due to reported antiHCV activity of 2’-C-methylribonucleosides bearing a purine heterocyclic base. Several routes for the synthesis of the 2’-C-methyl, 2’-C-ethynyl and 2’-C-ethyl sugar were recently reported by Harry-O’kuru <97JOC1754>, Girardet <00JMC3704> and Eldrup <04JMC5284; 04JMC2283>. The reaction of the protected sugars 8, 11, 14 and 17 with 6-chloropurine yielded the protected
30
J.-L. Girardet and S.A. Lang
2’-C-substituted-purine nucleoside, which, after ammonia treatment, afforded 19 in the case of R being an ethyl group. Hattori also published the synthesis of 2’-C-ethynylcytidine with very low stereoselectivity for the β face (8% versus 68% for arabino compound) <98JMC2892>. Also obtained was the 2’-deoxy-2’-C-methylcytidine which derived from 2’-C-methylcytidine through a deoxygenation reaction at the 2’-hydroxyl group <03JOC6799>. A process chemistry article on the synthesis of 2’-methyl sugar and 2’-methyladenosine was published recently by Merck <04JOC6257>. Several publications also reported similar modifications applied to 3-deazapurine analogs <05SL1586; 05TL3883>, thiazole-4-carboxamide adenine dinucleotide analogs <05BMC2045>, toyocamycin and sangivamycin analogs <05BMCL725>, triciribine analogs <04BMCL3517>, as well as a series of 6-substituted purine nucleoside analogs <05BMCL709>. Dess-Martin periodinane, BzO DCM, rt
O
BzO
OBz BzO OH
TIPDS
1) RMgBr, THF, rt
OMe
2) TBAF, THF, rt
O 11
1) RMgBr, THF, rt
O OMe O 14 O OAc Et OBz
17
R OBz
10 1) Ac2O, DMAP, O O HO AcO OMe NEt3, DCM OAc 2) Ac2O, R R HO AcO AcOH, H2SO4, OH OAc rt 12 13 O
HO
2) BzCl, DMAP, DCM 3) H2, Pd/C
DCBO
AcO
OBz
2) BzCl, BzO DMAP, NEt3
O
O
BzO
O
9
O
DCBO
OBz
BzO
8 O
1) MeTiCl3 or RCeCl2 BzO
O
TMSOTf, DBU, MeCN BzO
OMe
HN
15
O Et OBz N
AcO Cl
N
N
2) Ac2O, AcOH, H2SO4, rt
R OBz
HO
N N
1) BzCl, DMAP, DCM BzO
18
N
NH3/dioxane HO
O OAc R OBz
AcO 16
O N
Cl N
Et OH N
HO 19
N NH2 N
A number of fluoroalkyl substitutions were also described in the past few years. Several 2’-Ctrifluoromethyl ribonucleosides were synthesized <01OL1025>; the chemical scheme involved the formation of protected sugar 20 by action of trimethyl(trifluoromethyl)silane on ketone 9. Glycosydation proceeded with the bromo sugar 21, and three 2’-C-trifluoromethyl pyrimidine ribonucleosides were obtained as exemplified with compound 23. More recently, 2’-Cdifluoromethyl uridine was synthesized through a slightly different approach <05JOC7902> involving the use of difluoromethyl phenyl sulfone, followed by hydrogenation of 24 and condensation of silylated uracil. The desired nucleoside 27 was obtained after treatment of 26 with methanolic ammonia.
31
Recent developments in the chemistry of nucleosides
1) CF3SiMe3, TBAF (5%), BzO OBz THF, rt 2) TBAF, rt BzO
O
BzO BzO
O OBz CF3 OBz
O 9
30% HBr in AcOH, 80 oC BzO
Br CF3 OH
BzO
20
21
O
O N
O
BzO
N
O
HO
R1
N
N
NH3, persilylated BzO CF3 CF3 HO R2 OH OH MeOH, 4 oC nucleobase, 22 23 R1=OH or NHBz HgO/HgBr2, benzene or R2=H or Me tol, reflux
O
BzO
O
OBz
PhSO2CF2H, LiHMDS, THF, -78 to 0 oC BzO
BzO
24 O O
BzO
H N
OBz
2) BzCl, CF2SO2Ph BzO DMAP, NEt3, OH DCM, rt H N
O O
O
HO
N
persilylated BzO CF2H nucleobase, OH SnCl4, 26 MeCN, reflux
O
2
OBz
BzO 9
1) 5% Na-Hg, Na2HPO4, MeOH, THF, BzO H , 0 oC
O
O
R2
R1 R1=OH or NH 2 R2=H or Me
NH3, HO MeOH, 4 oC
CF2H OBz 25
O
N
CF2H OH 27
Finally, 2’-C-fluoromethyl uridine was synthesized starting from uridine 28 that was protected with a di-tert-butylsilyl group and oxidized at the 2’-position to give the still protected nucleoside 29 <03OL807>. A Wittig reaction with methyltriphenylphosphonium bromide, followed by a series of protection/deprotections, afforded compound 31. Once again, only examples of pyrimidine nucleosides were given. H N
O O
HO
N
2) DessMartin periodinane, DCM
HO OH 28 O O
O Si
N
O CH2 30
O 1) Cl2SitBu2, AgNO3
MEM N
O
H N
O O
O Si
N
1) methyltriphenyl O phosphonium bromide, K tert-pentoxide, ether 2) MEM-Cl, DIEA, DCM
O O 29
1) MCPBA, DCM 2) KF/HF 3) Ac2O, pyridine 4) B-bromocatecholborane, DCM, rt 5) guanidine/guanidine HCl, MeOH, DCM
O HO
O
N
CFH2 OH
HO 31
H N
O
32
J.-L. Girardet and S.A. Lang
Clark reported the synthesis of 2’-deoxy-2’-fluoro-2’-C-methylcytidine 33 <05JMC5504>. The fluorination proceeded through inversion of configuration of the 2’-hydroxyl group. Elimination product was also observed, as well as 2’-C-methylcytidine. Enzyme-assisted synthesis of 2’-deoxy-2’-fluoroguanosine was reported <99NN687>, while various 2’-deoxy-2’fluoro-D- and L- nucleoside analogs were reported by Shi <05BMC1641>. O O
O Si
N
O NHBz
N
2) DAST, tol, -20 oC 3) NH3 / MeOH
O O
O
HO
1) MeLi, -78 oC
N
NH2
N
HO F 33
32
2.2.1.3 Modifications at C-3’ No significant antiviral activity has been reported for nucleosides bearing a 3’-Cmodification, but several compounds in this class have been shown to posses antitumor properties, the most successful of them being 3’-C-ethynylcytidine (ECyd) <99NN811>. This modified sugar was prepared from D-xylose following a scheme published by Hattori <96JMC5005>. Addition of trimethylsilylacetylene to 34 proceeded stereoselectively to yield sugar 35 after deprotection of the trimethylsilyl group. Glycosidation with cytosine, followed by deprotection with methanolic ammonia afforded compound 38 (Ecyd). A variation in which the benzoyl protecting group was replaced by a tert-butyldimethylsilyl group was later published by Nomura <02T1279>. 3’-Ethynyladenosine was also synthesized via the same chemistry route <00BMCL139>. Several analogs of Ecyd have been prepared with modified nucleobases, including pyrido[2,3-d]pyrimidines <00JMC3704> and various aza- and deazapyrimidines <05BMC1249>. In that first example, the ethynyl group was condensed via a Grignard reaction with ethynyl magnesium bromide. Reverse stereoselectivity (addition from α face) was obtained when the reaction was performed on the 3’-oxonucleoside. A butadiynediyl dimer of the same nucleoside 38 was reported by Jung <03OL383> and was synthesized via palladium coupling of the two ethynyl moieties. The C-3’-allenyl uridine was synthesized using Crabbe reaction <01NNNA1775>.
D-xylose
1) TMSCCH, BuLi, THF, -78 oC BzO
O
TBSO
O O 34
O
2) TBAF, THF, rt 3) BzCl, pyr, rt
1) HCl 20%, MeOH, rt
O O
HO
O 35
O BzO
N persilylated BzO nucleobase, OBz 37 SnCl4, MeCN, reflux
HO
N
O
NH2
N NH3, MeOH
HO 38
OH
O
OAc 2) BzCl, DMAP, BzO o OBz pyr, 100 C 36 3) H2SO4, AcOH
O N
O
BzO
NH2
33
Recent developments in the chemistry of nucleosides
Several 3’-C-methyl nucleosides were also described <00JMC3704; 05JMC4983>. Application to nicotinamide analogs was described <04BMCL4655>. Their synthesis involved intermediates similar as 34 and a Grignard reaction using methylmagnesium bromide. All five natural ribonucleosides were described with a 3’-C-trifluoromethyl group, following a synthesis involving D-xylose as starting material <95NN185; 03NNNA2195>. Their 3’-deoxy version was published by Sharma, and involved a Barton deoxygenation to remove the 3’-hydroxyl group <00NNNA757>. 2.2.1.4 Modifications at C-4’ Modifications at the 4’ position of ribo- and deoxyribonucleosides have drawn attention in the past few years due to several reports of anti-HIV activity and, more recently, anti-HCV activity. Nomura <99JMC2901> described the synthesis of a series of 4’-C-modifications involving the diol intermediate 40. Interestingly, dimethoxytrityl chloride was selective for the 4’-Chydroxymethyl group. This selectivity was also reported by Gunic in his synthesis of 4’-modified analogs of toyocamycin <01BMC163>. 2’-Deoxycytidine and 2’-deoxyuridine derivatives were described, as well as several alkylated uridines <05S1467>. The same chemical strategy was later followed by Kohgo <04NNA671> for the synthesis of 4’-C-ethynyl and cyano modifications of 2’-deoxypurine nucleosides. Haraguchi published a variation involving a 4’,5’unsaturated nucleoside <03OL1399>. In this article, compound 43 was oxidized to its epoxide which was then opened to yield 44. The synthesis of 4’-C-methyl ribonucleosides bearing the five natural heterocyclic bases was published by Griffon and followed previously published procedures <03NNNA707>. Several 4’-C-hydroxymethyl derivatives of various nucleosides were also synthesized <00JMC3704; 01BMC163; 01NNNA747; 01NNNA649>. O N
O
HO
N TBSO 39
1) EDC.HCl, NaBH4, benzene, EtOH DMSO NHBz 2) HCHO, NaOH, dioxane
OTBDPS 1) DMTCl, pyr. rt 2) TBDPSCl, DMF, imid, rt 3) AcOH 80%, rt
NHBz
TBSO 40 OH
O N
O
R
NHBz
TBSO
N
NH2
HO 41
42
O
1) DMDO, DCM, -30 oC
NH
O N
O 2) TMSCN
43
N N
N N
TBDMSO
O O
HO
O
O
HO
OH
OH NC
R= Me, Et, vinyl, Clvinyl, CN, ethynyl O NH
O N
O
TBSO 44
The synthesis of 4’-C-trifluoromethyl derivatives followed a different scheme. Starting from D-ribose, the key intermediate 48 was obtained in five high yielding steps. The stereoselectivity
34
J.-L. Girardet and S.A. Lang
at this stage was 4:1 D-ribo/L-lyxo. The fully acylated sugar 49 was condensed with various heterocyclic bases following a classical Vorbrüggen procedure. Another 4’-fluorinated sugar was obtained by Jung <01JOC2624>. His synthetic strategy involved the formation of the tert-butyl ester 52 followed by an electrophilic addition at the C-4. This reaction delivered the desired deutero compound 53 with a decent yield (43%), but unfortunately, in the case of a fluoro substitution with N-fluoro-benzenesulfonimide, the reaction only yielded the undesired stereoisomer 54 in 48% yield. The removal of the 4’-hydroxymethyl group has also been investigated, using D-erythrose as starting material, yielding the corresponding erythronucleoside <05JMC6430>.
D-ribose
1) DMP, H+ TBDMSO
PDC,
iPrPPh3+I-, BuLi
O
Ac2O, O sieves O OH 46 OTBDMS
OH 2) TBDMSCl, imidazole
TMSCF3, TBAF
1) BzCl, TEA 2) O3 3) TFA
O O OH OH
F3C
2'-deoxythymidine
O
4) Ac2O, pyr
O
1) persilylated nucleobase, TMSOTf
OBz O F3C
OAc
AcO
48 1) MMTCl, Et3N OH 2) TPSCl, ImH O 3) Amberlyst 15 O
4) TEMPO
45
49
2) NaCN, MeOH
OAc
OH
NH O
5.5 eq LDA HO 4.5 eq tBuLi AcOD, MeOD
53
O NH N
O
HO 52 OtBu
NH N
O
OH
1) tBuOH, OtBu EDCI, DMAP O O 2) TBAF
O
D
N
HO
TPSO
O
O
NH
F3C
51 OtBu
O O
50
O N
O O O 47 OTBDMS
O
O
F 5.5 eq LDA 4.5 eq tBuLi NFSI
NH
O
O
N
O
HO 54
2.2.1.5 Modifications at C-5’ Nucleosides modified at their 5’-position can generally not be phosphorylated by cellular nucleoside kinases. This characteristic is sometimes used to design receptor agonists or antagonists without the risk of incorporation of the modified nucleoside into DNA or RNA. The first example of these compounds is capecitabine in which the 5’-hydroxyl group is replaced by a hydrogen atom. Many examples of 5’-deoxynucleosides were published in the past few years <00JMC2438; 04JMC5773; 05JMC7808>, including some incorporating a fluoro atom at C-5’ <05BMCL3361>. Some research involved attaching a phosphonate group to the 5’-carbon to mimic a natural phosphate group, but without the liability of poor enzymatic stability. In the later
35
Recent developments in the chemistry of nucleosides
category, Koh recently published the synthesis of several adenosine monophosphate mimics <05JMC2867>. In this example, diphenyl(triphenyl-phosphoranylidene) methylphosphonate was reacted with the 5’-aldehyde of 55 to yield 56 after reduction of the double bond. Chen used a slight variation of this coupling to make cytidine phosphonate derivative 60 <02JOC9331> as well as the corresponding arabino derivative <02PSS1783>. Several other derivatives of uridine and cytidine have also been described by Jung <00BMC2501>. O O
HO
1) DMSO, DCC, TFA / pyr
N
N BzO 55
OBz N
N
NHBz 2) (PhO)2P(=O)CHPPh3 3) H2, PdC, MeOH
O O N HO 57
OH N
1) NH3, MeOH
N
NHBz 2) H2, PdC, N MeOH
1) NaH, BnOH, DMSO, rt
N
N
NHBz
BzO 56
N
O N O
NHAc 59
HO P HO
OBz N
O N
N
N NH2
HO
1) DMSO, EDC, TFA / pyr
O
O
O
O
BnO P BnO
HO
PhO P PhO
2) LHMDS, HP(=O)(OEt)2, THF, -78 oC 3) TMSBr, DCM, 0 oC to rt, then MeOH
58
OH N
N
OH O HO N O P HO N O HO OH 60
NH2
The synthesis of 5’-C-alkyl and alkenyl nucleosides was reported by Wang <98NN1033; 00JMC2566>. It involved oxidation of the 5’-hydroxyl group of 61, followed by a Grignard reaction with allylmagnesium bromide to give 64 when R is an allyl group, or a Wittig reaction and epoxide formation, followed by nucleophilic ring-opening to yield 64 when R is a cyano group or an amino group. The 5’-deoxy-5’-N-hydroxylaminopyrimidine and purine nucleosides were synthesized via Mitsunobu reaction with benzyloxycarbonyl- and tert-butoxycarbonylprotected hydroxylamine, as exemplified with compound 65 <99JOC9289>. Deprotection via hydrogenation and acidification afforded nucleoside 66 in excellent yield. A carboxylic derivative of all four natural ribonucleosides 67 was synthesized by using TEMPO/BAIB as oxidant <99JOC293>. From this carboxylic acid intermediate, Umino reported the synthesis of N-alkylcarboxamido compounds via displacement of a nitrophenol ester intermediate, made by condensing nitrophenol in the presence of 1-[3-(dimethylamino)propyl]-3-ethylcarbodiimide, with the desired alkylamine to yield compound 68 <01JMC208>.
36
J.-L. Girardet and S.A. Lang
O HO
O
1) DMSO, DCC, TFA / pyr
NH
O N
O NH
O
O
N 2)CH3PPh3 3) MCPBA
TBDMSO 61
62
DMSO, DCC, TFA / pyr
NH3 / MeOH or KCN R
O NH
O
O
N
O
O
TBDMSO 64
PPh3, DBAD BocN DMF / THF adenosine CbzO BocNHOCbz HO
O
OH N
O
R=allyl, CN, NH3
1) H2, PdHN C HO NH2 2) HCl HO
N
N
65
N
O
N
N
NH2
66
OH N
N
O
O B 67 (B = A)
O
67
NH N
63
O
O O
HO
AllylMgBr
TBDMSO
HO
O
TBDMSO
1) 4-nitrophenol 2) RNH2 3) 80% TFA
O
HN R HO
N
NH2
68
B = A, U, C, G
N
OH N
N
A series of more than twenty 5’-deoxy-5’-thio-substituted adenosine derivatives, as exemplified with 65, was described by Kung <05BMCL2829>. The synthesis of these thio derivatives involved 5’-deoxy-5’-chloro as starting material. The article also described the synthesis of 71 obtained from aldehyde 70 following a Wittig reaction with benzyltriphenyl phosphonium chloride. Specific 5’-deoxy-5’-thiocyanates were prepared using the von Braun cyanogen bromide reaction <02JOC1898>. Several 5’-epimuraymycin analogs were synthesized <03BMCL3345; 05T11850>. The synthesis of 5’-deoxy-5’-aziridine derivative of adenosine was described in eight steps from adenosine <05JOC5833>. This synthesis involved two Mitsunobu reactions: one for the amine condensation to give 73, and one for the ring cyclization to yield the target compound 75. O O
RS
N
N NH2
HO OH N 69
O
H
N
O
N 70
O
N
N N(Bz)2
O
N
N NH2
HO OH N
N 71
N
37
Recent developments in the chemistry of nucleosides
EtO O
HO
O
N
N N
O
N
72 EtO
O
N H
O
N
N NH2
74
N
N
1) TFA 2) Et3SiCl, NEt3 3) PhSH, K2CO3
N
N
NH2
O
N
O
N
73
1) LAH 2) PPh3, DEAD, THF
TESO TESO
O
N Ns
O
PPh3, DEAD, THF
NH2
O
NH EtO Ns
O
N
N
N
3) TBAF, TMSOMe, THF
NH2
HO OH N
75
N
Aziridines were also described by Comstock <02T6019>. Lui described the synthesis of 5’functionalized adenosine 78 using rhodium (II) catalyzed 1,3-dipolar addition <01OL2273>. Some unique 5’-deoxy-5’-thiomethyl amino acid derived adenosine derivatives were described by Kehraus <04JMC2243>. 5’-Deoxy-5’-(iodomethylene)adenosine was synthesized by reaction of a sulfone-stabilized phosphonate on a protected adenosine, followed by stannylsulfonylation and iododestannylation to yield compound 79 <06JMC2096>. Several sugar-modified enyne analogs were synthesized by a Sonogashira coupling as shown in 81 <04JMC5251>. The Z analog 82 was also synthesized and is described in the same article. The synthesis of 80 was referenced. One example of DNA methyltransferase click chemistry was published by Weller <05OL2141>. O O
H2N
N O
76 OEt MeO O O
N
N
O
N
80
N
N OO
O
N
N
77
N
I
O
N Me HO
O
O
N N2
O
O O
1) ethyl vinyl ether, Rh2(pfbm)4, tol 2) TFA/H2O; Pd/C, EtOH, NH4COOH NHCbz
O
chloride, toluene, N2 4) MsN3, TEA
N
N
O
N
N NH2
78
I
1) (CH3CO)2, pyr MeO 2) Rapoport's reagent, DCM NH2 3) methyl malonyl
OH N
NH2
HO OH N
N
79
1) TMS-acetylene, CuI, (PPh3)2PdCl2, N DEA
N
N
O N
NH2 2) TBAF, THF HO 3) TFA, H2O
O
N
N NH2
OH N 81
N
N NH2
HO OH N
N 82
N
38
J.-L. Girardet and S.A. Lang
2.2.2
Ring-oxygen substitution
The success of entecavir has boosted the research on carbocyclic nucleosides; three main substitutions exist: oxygen for carbon, oxygen for sulfur and oxygen for nitrogen, the latest being the least popular in term of number of publications. 2.2.2.1 Substitution with carbon Nucleosides with a carbocyclic “sugar” have gained more attention with the success of entecavir as an anti-hepatitis B agent. The synthesis of entecavir itself is already well documented <97BMCL127; 03T9013; 04TL739>. Its 3’-deoxy analog has also been described <04TL739>. Trost published a very nice palladium-catalyzed enantioselective synthesis of several carbanucleosides, with the key step being a palladium(0)-catalyzed enantioselective allylic amination of cis-3,5-dibenzoyloxycyclopent-2-ene with the desired nucleobase <00JACS5947>. Two convergent approaches start from cyclopentenol and lead to carbocyclic analogs of 2’-deoxythymidine, 5-fluoro-2’-deoxyuridine and 5-bromovinyl-2’-deoxyuridine <03NNNA683; 03S2101>. Takagi published the synthesis of 5’-methylenearisteromycin <05OBC1245> because of its similarity with entecavir. The synthesis involved a stereoselective intramolecular radical cyclization as the key step to construct the carbocyclic structure. (+)Aristeromycin 90 was synthesized in eleven steps from compound 83, with the key reaction being a one-pot ring expansion of cyclobutanone 84 <00JOC1865>.
OEt
hν
N + (CO)5Cr
O
O EtO
OBn
Ph 83
O
Ph
Ph
OBn 1) H2, [Rh(COD)dppb]BF4, DMF
N 84
OBn ClCO2Et
OCO2Et
2) DIBAL Ph 86
87
88
OH
Pd(PPh3)4 N
NH2 N
Ph 85
Ph
OH
N
OBn
HN
O N
O
O 1) LDA
Ph
N
O
OBn O O
2) Li2CO3
2) Li2CO3 Ph
OBn
1) TMS(O)I, NaH, O Sc(OTf3), DMF
BnO
O
1) BCl3
N NH2
89
N
N
2) OsO4
N HO 90
N NH2
OH
N
N
N
A different approach was used by Ainai, starting from azidopentane 91 <04JOC655>. (-)Aristeromycin 94 was obtained after building the adenine ring from the reduced form of 93. A third approach published consisted of building a carbocycle from D-ribose, and condensing the
39
Recent developments in the chemistry of nucleosides
chloropurine base via a Mitsunobu coupling <04JOC3993>. Yang also described the synthesis of 5’-homoneplanocin <05JMC5043> and the synthesis of (-)-3-deazaaristeromycin <04TL8981> through a similar route. A new chiral synthesis of 6’-β-fluoroaristeromycin was described using cis-4-acetoxy-2-cyclopentene-1-ol as starting material <05TL7535>. Enzymatic resolution of (±)-1-acetoxy-4-(nitromethyl)-2-cyclopentene provided the desired starting material for the synthesis of carbanucleosides and 5’-nor-1’-homo carbanucleosides <02T9889>. 1) Me2C(OMe)2, MeOOC PPTS
O N3
2) RuCl3.3H2O, NaIO4, then CH2N2
HO OH
N3
O
91
1) LAH 2) TEA, BuOH, 130 oC Cl NH2
O
N
92
NH2
NH O
Cl
N
O
Cl N
93
N
OH
1) (EtO)2CHOAc, reflux, pTsOH
OH O N
2) NH3, EtOH, 90 oC
OH
N
MeOOC NH2
HO 94
OH N
OH
HO
NHPf
N
N
N
H 95
96
OH N N H
Carbapentostatin 96 was synthesized via a one-pot, two steps preparation of the key aldehyde 95 followed by homologation and ring formation by Dieckmann cyclization <03JOC109>. The synthesis of carbocyclic analogs of other compounds of interest, like 2’-methyl nucleoside, was very recently published by Gosselin, starting from 2-cyclopenten-1-one to yield compound 97 <06T906>. Fluoroneplanocin A was synthesized via an electrophilic vinyl fluorination reaction to lead to compound 98 <03JMC201>. Isomers of neplanocin A and 2’-deoxyneplanocin A were also described <05TL1927>. Several methacarba analogs of purine nucleosides were synthesized <00JMC2196>, as shown with adenine analog 99. Jacobson also described more about the design of these analogs <05JMC8103>. Roy published an interesting occurrence during the attempted synthesis of 5’-noraristeromycin <05OL3889>. Several analogs with modified adenine bases were described <99JOC2240>. Lee prepared the novel apio carbocyclic nucleoside analog 100 in a stereoselective manner <05JOC5006>. AMP579, or compound 101, was obtained following an highly stereoselective route involving the condensation of an alkyl sulfonamide with a pyridine synthon <00JOC8114>. Hong described the synthesis the novel carbocyclic analog of 4’-hydroxy nucleoside 102 starting from D-lactose, in thirteen steps <02JOC6837>. Various purine and pyrimidine L-ribofuranoside analogs have been prepared in similar routes starting from (+)-cyclopentanol <99JOC4173>. OH
OH
O
OH
F
NH N HO
O
N
N
N NH2
HO 97
OH
98
OH N
N
N NH2
HO 99
OH N
N
40
J.-L. Girardet and S.A. Lang
NHEt OH N
O
N
N NH2
HO 100
OH N
OH N
S H N
HO
N
101
HO
Cl
N
N NH2
HO
OH N
102
OH N
N
Several new cyclohexenyl carbocycles have been described by Vijgen and Wang <00JMC736; 05JOC4591>. In these examples, the double bond is mimicking the ring oxygen, between C-1’ and C-4’. Condensation of the heterocyclic base was achieved via Mitsunobu reaction. Ueno synthesized benzene analogs in which the purine or pyrimidine base is built from an amino substituent on the benzene ring <05JOC7925>. 2.2.2.2 Substitution with sulfur The popularity of thionucleosides does not match that of carbonucleosides; nonetheless, some interesting chemistry has been published in the past 5 years. One way to synthesize stereoselectively these thionucleosides is via the Pummerer reaction <00JACS7233>. Compound 106 (R/S = 2.7:1), obtained in thirteen steps from the protected ribose 103, was treated with the nucleobase uracil in the presence of trimethylsilyl trifluoromethane sulfonate and triethylamine to yield the nucleoside 107. Final deprotections afforded the desired thionucleoside 108. A variation was recently reported starting from L-arabinose <06TL591>. Another technique for making thionucleosides relies on stereoselective electrophilic glycosidation as exemplified with the reaction of compound 109 with an heterocyclic base and phenylselenium chloride to yield nucleoside 110 <02JOC5919>. Derivatives bearing 4’-thio and 5’-uronamide were described by Jeong <03JMC3775; 06JMC273>. 1) TBDMSCl 2) DIAD, PPh3, 1) 4N HCl, 1) TIPDSCl2 pNitrobenzoic HO OH S O BnO BnO 2) diMeOBzCl dioxane acid OH OMe 2) NaBH4, 3) NaOMe 3) mCPBA BnO HO BnO MeOH 4) TBAF OBn OH OBn 5) MsCl 104 105 103 6) Na2S 7) BCl3 O O O NH NH S 1) TMSOTf, TEA O S S O HO N O N O TIPDS NH TIPDS 1) NH4F, MeOH HO O O O 2) NH3, MeOH ODMBz ODMBz OH NH 108 106 107 O
O O DTPS O 109
S
PhSeCl, CH3CN N
TMSO
N
O DTPS O
OTMS
NH
S N SePh 110
O
41
Recent developments in the chemistry of nucleosides
Several D- and L-β-3’-fluoro-2’,3’-unsaturated-4’-thionucleosides were synthesized by using (diethylamino)sulfur trifluoride on the ketone intermediate 111, followed by a key elimination reaction on the gem-difluoro compound 115 to yield nucleoside 116 bearing the five natural heterocyclic bases <04JMC1631>. The 2’-fluoro derivatives were also described via a slightly different route involving elimination of a phenylselenyl group <02JMC4888; 02OL305; 03JMC389>. Haraguchi described the synthesis of several novel 2’-β-carbo-substituted 2’deoxy-4’-thionucleosides made from 4-thiofuranoid glycals <04OL2645>. OTol
OTol O OMe
2'-deoxy-D-ribose O
OMe
DAST, F F DCM
1) BaCO3, TBAI, MeCN AcO 2) Hg(OAc)2, Ac2O, AcOH
S F F
113
HO
O HN
S
O
HO
O tBuOK, THF
N
F
NH
HN O
S N F
F
O
114
SBn F
112
1) BSA, TMSOTf 2) NH3, MeOH
SBn
F
2) Tf2O, lutidine
111 TolO
OTol OTf
1) BnSH, BF3.OEt2
O
115
NH
116
O
Trifluoromethyl substituted nucleoside 118 was synthesized from α-trifluoromethyl-α,βunsaturated ester 117 <02JOC1016> in eight steps involving the usual Pummerer rearrangement. Compound 119 was synthesized from L-xylose via 2-deoxy-2-C-difluoromethylene-4-thiosugar as a key intermediate <02OL529>. HO
O
COOEt N CF3 O
O
S
H2N
N
S
HO
N
N
O
NH2
HO 117
118
F3C
F
F
119
2.2.2.3 Substitution with nitrogen Very few publications on the synthesis of azanucleosides surfaced in the past 4-6 years. Qiu <05JOC3826> described the synthesis of azanucleoside 121 in fourteen steps from trans-4hydroxyproline 120. The same group published several other articles on various fluorinated derivatives as exemplified with compound 122 <02CCCC1267; 04BMC277; 04S334>. Compounds 123 and 124 were synthesized stereoselectively from a five-membered endocyclic enecarbamate using phenylselenyl bromide as promoter. L-nucleoside derivatives like 125 were described by Varaprasad <99T13345>. HOOC
H N
120
OH
HO F2HC HO
H N
O NH N
121
OH
H N
HO O
O NH N
122
CFn
O n = 1,2,3
42
J.-L. Girardet and S.A. Lang
O
H N
HO
NH N
O
O NH
N
R R = H or Me
123
O
H N
HO
O
O
OH
N OH
R R = H or Me
124
H N
HN
HO 125
2.2.3 Nucleosides with Bicyclic Sugars Nucleosides with a bicyclic sugar ring are often called conformationaly restricted or locked. The two major conformations of natural nucleosides are C-3’-endo and C-2’-endo. The formation of a second ring induces a restriction of the pseudorotational cycle of the ribofuranose puckering. The application of bicyclic nucleosides goes from the synthesis of modified oligonucleotides to enzyme inhibitors. 2.2.3.1 Spiro Nucleosides The 2',5'-bis-O-(tert-butyldimethylsilyl)- β -D-ribofuranosyl]-3'-spiro-5''-(4''-amino-1'',2''oxathiole-2'',2''-dioxide) or TSAO nucleoside series has been prolific in the past few years after the synthesis of the very first TSAO in 1992 and the description of its potent anti-HIV-1 activity. Aza analogs were described by Nguyen Van Nhien <03NNNA939; 05JMC4276>, and involved a cyclization of intermediate 128 with lithium diisopropylamide in tetrahydrofuran. Several N-3substituted analogs were described <03NNNA947; 05JMC6653>, as well as various substitutions at the 4’’-N-amino group of the spiro moiety <01NNNA707; 05JMC1158> and at the 3’’-C position <02JMC3934>. Some derivatives that lack the 4’’-amino group were synthesized <99NN675; 01NNNA711>. A generic structure for these modifications is shown in compound 130. OTBS
NH N
BnO
O
O 126 OTBS NH
N
S NH OTBS O 128
3) MeSO2Cl, pyr, DMAP
O
O
O
O NC
O
O
S O OTBS O O TSAO-T OTBS
1) Ti(OiPr)4, NH3, MeOH 2) TMSCN
O
O
H2N
O
LDA, THF H2N
O
O BnO NC O HN O S O 127 O R2 HN
O NH
O N
S NH OTBS O 129
OTBS
O
O N
O R1 O
R3 N O
S O OTBS O 130
The synthesis of the 4’-spiroannulated ribonucleoside was accomplished by elimination of the 2’-phenylthio group of compound 132 via a controlled oxidation with Davis oxaziridine reagent,
43
Recent developments in the chemistry of nucleosides
followed by heating in xylene to induce a thermal elimination of phenylsulfenic acid <03JOC8614>. Compound 133 was obtained after dihydroxylation with osmium tetroxide. Paquette published the synthesis of 4’-spiroannulated 2’-deoxyribonucleosides to be used as building blocks for DNA synthesis <04JOC7442>. Obtaining stereoselectivity during the Lewisacid promoted glycosidation was challenging, with both anomers of 135 being obtained. In the case of ribonucleosides, the β anomer was obtained selectively <01OL4039; 01OL4043>. The carbocyclic analogs were obtained <05JOC1597; 05S3209>, as well as the thionucleoside analogs in both ribo and 2’-deoxyribo series <03JOC8625; 04JOC7442; 05JOC5655>. Compounds 136 and 137 were synthesized from the same 2’-oxo sugar intermediate <03NNNA1313>. The synthesis of compound 139 was accomplished via Darzens reaction with lithiated methyl bromoacetate on intermediate 138 <00NNNA775>. The reaction was highly stereoselective and high yielding. The synthesis of the spiro[2,3]hexane carbocyclic compound 140 was achieved via enzymatic resolution <04OL2531>.
O O
NH O
OTBS
OTBS
O
O O
OH
134
HO
O
OTBS NH
O N O
1) LiCHBrCOOMe O
2) RNH2
O
O
O
N
N
O
O
137
N
O
139
N NH2
N
OTBS RHN
O
O
HO
NH
NH
O HO
O
O
OTBS 138
OH NH
136
O
O
OH 133
N
NH2 N
135
NH
HO
O O
TBSO
O
O N
2) OsO4, NMO 3) TBAF, THF
N
OH
PhO2S Ph 1) xylene, pyr.
SPh 132
131 SPh
OTBS
O N
OTBS O O N
OTBS
N
140
Spironucleosides at the C-1’ position have also been described. Their resemblance with natural nucleosides seems distant, but they are still categorized as such. 5-Epithiohydantocidin spironucleosides were prepared from glycosylaminoesters and furanoid methyl isothiocyanatoulosonates <06T97>. The spironucleosides 143 and 147 containing the barbituric acid moiety were synthesized from optically active precursors 141 and 144 <02JOC1302>, with compound 143 considerably more stable against ring opening than 147. The related 2’deoxyhydantoin 148 was synthesized via a Horner-Wadsworth-Emmons condensation of the phosphonate with the erythrose derivative, affording a mixture of six isomers that was
44
J.-L. Girardet and S.A. Lang
subsequently cyclized <00EJOC1831>. The 1,4-diazepine derivative 149 was synthesized from a novel cyclopeptide intermediate <04T2213>.
OMe OMe O
O
O
OH
OTBS O
1) (CH2O)n, AcOH, H2SO4
OMe
1) urea, tBuOK
O NH
O 2) TMSCl OMe 2) TMSCl, HO NH TBSO 3) resolution MeOH O O 4) TBSCl 141 142 143 O O NH NH O O H2, PdC OH Br2 Na2CO3 O O OH O NH NH O O O O O O O NH 145 146 144 O N O H O OH O O O NH HN O O O O NH O NH N NH HO HO O O H O O O 147 148 149
2.2.3.2 Bicyclic Nucleosides In recent years, the conformational restriction of nucleoside analogs has been well studied, especially in oligonucleotides and also for enzymatic studies. One of the most described bicyclic ring system has been the 2,5-dioxabicyclo[2.2.1]heptane as shown in compound 152. It was synthesized by intramolecular cyclization of 150 to yield 151, which, after condensation with thymine, gave compound 152 as a mixture of α and β anomers. A stereoselective route involving the nucleoside formation, followed by intramolecular cyclization was published later and yielded the pure β anomer 154 <01JOC8504>. The same bicyclo ring structure 155, but based on the xylo sugar was described by the same author <00JOC5161; 05EJOC2297>. Several more analogs with various heterocyclic bases and substitutions were published, including diaminopurines <04BMC2385; 04JOC3711>, 3’-C-ethynyluridine (EUrd) and 3’-Cethynylcytidine (ECyd) analogs <05BMC1249> and 3’-C-hydroxypropyl derivatives <04JOC6310>.
BnO
O
MsO
SPh
NaH, DMF
O
OH
HN
O HO
O
O 151
NH
O
SPh BnO
BnO 150
H N
O
OBn
N 1) HMDS HO 2) H2, PdC
O 152
O
45
Recent developments in the chemistry of nucleosides
OMs
O
MsO
1) NaH, DMF 2) NaOBz
NH
O N
O
OH
O
HO
NH
O N
3) H2, PdC 4) NH3
BnO
O
HO
NH
O
HO
O
N
O
HO
153
O
O
154
155
Several other bicyclic systems were described in the past few years. The 1’,2’-oxetane constrained adenosine was synthesized in thirteen steps from compound 156 <04JACS11484>. The key step was the intramolecular cyclization of compound 158 after deprotection of its 2’hydroxyl group. A 4,7-dioxabicyclo[4.3.0]nonane skeleton was described, the key step being the cyclization of 161 in the presence of sodium hexamethyldisilazide to give compound 162 in 73% yield. Nucleoside 162 was subsequently deprotected with para-toluene sulfonic acid <06JOC1306>. A 2’,3’-oxetane ring as in 163 was described by Sharma <05JOC4918> and involved a ruthenium-mediated cleavage of a double bond, followed by a substitution at C-2’ to give the arabino configuration. The β anomer was described earlier with a 3’-azido group <01JOC4878>. OTol
OTol 1) HCl, MeOH 2) MsCl
O O O O
O
HMDS, SnCl4
O Br
3) 90% TFA AcO 4) Ac2O 5) 30% HBr
156
N
OTol
OMs OAc 157
H N
N N
O
N
AcO OAc 158
N
NHBz N
N OMs
NHBz NHBz
N 1) NH3, MeOH 2) TIPDSCl2 3) NaHMDS
O
O TIPDS O
N
N
O
HO HO
O 160 OBn
O NH
O N
N N
159 HO
N
N O
OTs OBn
NH2
N
NaHMDS O
NH
O
O
OH
O N
O NH
O N
O
O
HO
BnO OMOP 161
BnO
OMOP 162
O 163
The 2-oxabicyclo[3.1.0]hexane nucleoside 166 was obtained via a Simmons-Smith type cyclopropanation reaction of intermediate 164, followed by glycosidation with several natural heterocyclic bases <05JOC6891; 05NNNA383>. A restricted version of puromycin built on a bicyclo[3.1.0]hexane template was synthesized by Choi via Mitsunobu coupling of a 3-azidosubstituted carbocyclic moiety with 6-chloropurine to give compound 167 <02OL589>.
46
J.-L. Girardet and S.A. Lang
OBn
OH
OBn O O
ZnEt2, CH2I2, tol
165
N
N
O
N(Me)2
H2N
OH 166
O
164
HO NH
N
O
O
2.3
O O
O
N
N
167
COMBINATORIAL APPROACHES
Nucleoside chemistry is traditionally labor intensive and the output of compounds is consequently relatively low. In order to overcome these limitations, several groups have implemented a parallel or combinatorial approach to speed up the synthesis process; this chapter will only discuss the use of solid support for the synthesis of nucleoside libraries, not for the purpose of oligonucleotide synthesis. Chang <05BMC4760> attached a purine dichloride to a Merrifield 3,4-dihydropyran resin, followed by sequential displacement of the two chloro atoms by various amines. The purine heterocyclic bases were then condensed with D,L-ribofuranosides following a classical Vorbrüggen method to yield nucleosides of general formula 171. 2,6-dichloropurine, CSA, DCM, 60 οC
N
N O
O
O
O 169
R1
Cl N
168
N
HN
Cl
N
N R2
N 170
OH 1) HMDS, (NH4)SO4, reflux 2) Tetra-O-acetylribose, TMSOTf, DCE, rt 3) NH3/MeOH
O N
N R1
HO OH N N 171 R2
Gunic <04NNNA495> and Koh <04NNNA501> condensed nucleosides 172, 173 and 174 with a Merrifield 4-methoxytrityl chloride resin. These three nucleosides were already bearing one or two reactive groups ready for further chemical modifications. To prevent side reactions on the highly activated 2- and 6-positions of the purine heterocycle, the only acceptable nonnucleophilic base that could be used for the condensation of the nucleoside with the resin was 2,6-lutidine. Halogen atoms were displaced with various amines and phenols. The authors also described palladium-catalyzed carbon-carbon coupling reactions on their scaffolds. Nucleosides 179, 180 and 181 were released from their support using hexafluoroisopropanol at room temperature, to yield libraries of 1,300 disubstituted and 760 trisubstituted purine nucleosides.
47
Recent developments in the chemistry of nucleosides
MMTr
O
HO
N
N
MeO
OH N 172
OH N 176
N
175 MMTr N
N OH N
R1 O
O
O
HO
N
173
177
F
OH N
NO2
NO2
R1 O
AcO
N
N
N F
R1 O
N
N
2,6-lutidine, THF, rt
O
HO
AcO
N I
Cl
R1 O
Cl
HO
I
HO
N
N
Cl
HO
O
O
N Cl
AcO
N Cl
AcO
OAc N N 174 H2N
OAc N 178
N
HN MMTr
176
177
178
R1 O
HO
HO
N
N
R2
HO OH N 179
R3
O
R1 HO
N
N
O OH N 180
R4
N
N
HO
N
O
O
HO OH N
NH 181
NH
R4
A similar approach was adopted by Epple, who combined the use of Nanokan technology developed by IRORI with a macroporous solid support to synthesize a 25,000 member library from compounds 186 and 187 <03JCC292>. The 5’-hydroxyl group was converted, via a Mitsunobu reaction, into an azido group which was subsequently reduced. The resulting 5’deoxy-5’-amino group was condensed with various carboxylic acids, isocyanates, isothiocyanates and sulfonyl chlorides to lead to a diverse 5’-amino substituted library. The 5’azido group was also reacted with disubstituted alkynes to yield a variety of 1,2,3-triazolyl compounds. A 2’,3’-acetal linkage of the nucleoside to the solid support proved to be compatible
48
J.-L. Girardet and S.A. Lang
with the chemistry involved, and was conveniently cleaved with 5% trifluoroacetic acid-5% water in dioxane at 50 °C.
H
O
O Br
H
O
MeO
OEt K2CO3, DMF, 20h, 50 oC
OH 182
OMe
TMOF, TsOH, MeOH, 5h, rt O O 183
O O 184
OEt
OEt
OH uridine, TsOH, DMF, 15h, 70 mbar, 50 oC
O N O
OEt
N NH
Cl N
O
O
O
R
N
O
O
N
N Cl
N
O
185
N
186
O
O
Compound 188 <03T2297> was obtained by condensation of an aminoglycoside attached on solid support with 2,4,6-trichloro-1,3,5-triazine; this intermediate led to a library size of 1,200 compounds after displacement of the 3- and 5-chloro atoms with various primary and secondary amines and cleavage from the support with 2% trifluoroacetic acid in dichloromethane. Compound 189 was synthesized in a similar way as 176 and 177; it led to a library of more than one thousand nucleosides via substitution of its triisopropylphenyl sulfonyl group <03JCC851>. Very similar compounds were obtained through Sonogashira and Stille reaction to yield 5substituted 2’-deoxyuridine derivatives after release from their base-labile solid linker <04JCC717>.
O
R
N N
O
O
O
O
Cl
O NH
MMTr O
N N
Cl
MMTr O
N
O NH 187
N N
R1
TBDMSO O
O O
188
OTBDMS
189
OMe
OTPS R2
A different strategy was used by Golisade, in which the acyl sulfonamide 192 was used to derivatize the 2’-deoxy-2’amino position of nucleoside 193 <00JCC537>. A library of 30 compounds is reported, with yields ranging from 87 to 98%, and purity between 85 and 98%
49
Recent developments in the chemistry of nucleosides
without the need for chromatography. The derivatization of a 2’,5’-dideoxy-5’amino nucleoside has also been reported; it involves an Ugi reaction with the primary amine while the 2’-hydroxyl group is attached to a polystyrene butyl diethylsilane resin. A 1344 member library based on formula 197 was synthesized <05TL8497>.
O S NH2 O 190
DIC, DIPEA, DMAP, THF, RCOOH
O
HO
N
N NH2 N
193
O NH
O
H2N
N
O
R2COOH R3NC
N
N
O O R S N O R' 192
R1CHO
O O R S N O R' 192
O
HO
THF, 55 oC
HO NH2 N
(Me)3SiCHN2, THF O O R or BrCHCN, NMP, DIPEA S NH O 191
NH2
HO O
R3
H N
NH N
N
R
194
R1
O
N O
R2
HF/pyridine
195
NH N
O R
O
O
O
HO 196
R
None of these libraries of nucleosides have been reported to yield any valuable antiproliferative activity thus far, but it is believed that these compounds will be tested over and over again against multiple targets in the future. 2.4
CONCLUSION
The field of nucleoside chemistry research has been very active since the start of the new millenium. Scores of publications have appeared in the literature, and several new compounds showed enough promise to enter clinical trials. It is likely that this trend will continue for the years to come, as the imagination of scientists and researchers seems to have no limit when it comes to designing novel modifications of molecules known for more than a century. 2.5 88MI1 90MI1
REFERENCES Chemistry of Nucleosides and Nucleotides, ed. L.B. Townsend, Plenum Press: New York, 1988, Vol. 1. Nucleic Acids in Chemistry and Biology, ed. G.M. Blackburn and M.J. Gait, IRL Press: Oxford, 1990.
50 91MI1 94MI1 95NN185 96JMC5005 97MI1 97BMCL127 97JOC1754 98JMC2892 98NN1033 99ARMC317 99JMC2901 99JOC293 99JOC2240 99JOC4173 99JOC9289 99NN675 99NN687 99NN811 99T13345 00ARMC331 00BMC2501 00BMCL139 00JOC1831 00JACS5947 00JACS7233 00JCC537 00JMC736 00JMC2196 00JMC2566 00JMC2438 00JMC3704 00JOC1865 00JOC5161 00JOC8114 00NNNA757 00NNNA775 00TL3643 01MI1 01BMC163
J.-L. Girardet and S.A. Lang
Chemistry of Nucleosides and Nucleotides, ed. L.B. Townsend, Plenum Press: New York, 1991, Vol. 2. Chemistry of Nucleosides and Nucleotides, ed. L.B. Townsend, Plenum Press: New York, 1994, Vol. 3. C. R. Johnson, D. R. Bhumralkar, E. De Clercq Nucleosides, Nucleotides 1995, 14, 185. H. Hattori, M. Tanaka, M. Fukushima, T. Sasaki, A. Matsuda J. Med. Chem. 1996, 39, 5005. Nucleoside Analogs in Cancer Therapy, ed. B.B. Cheson, M.J. Keating and W. Plunkett, Marcel Dekker: New York, 1997. G. S. Bisacchi, S. T. Bachard, J. P. Daris, S. Innaimo, G. A. Jacobs, O. Kocy, P. Lapointe, A. Martel Bioorg. Med. Chem. Lett. 1997, 7, 127. R. E. Harry-O'kuru, J. M. Smith, M. S. Wolfe J. Org. Chem. 1997, 62, 1754. H. Hattori, E. Nozawa, T. Iino, Y. Yoshimura, S. Shuto, Y. Shimamoto, M. Nomura, M. Fukushima, M. Tanaka, T. Sasaki, A. Matsuda J. Med. Chem. 1998, 41, 2892. G. Wang, P. J. Middleton Nucleosides, Nucleotides 1998, 17, 1033. B. Gaudilliere. Annual Reports in Medicinal Chemistry; Academic Press: San Diego, 1999; pp 317. M. Nomura, S. Shuto, M. Tanaka, T. Sasaki, S. Mori, S. Shigeta, A. Matsuda J. Med. Chem. 1999, 42, 2901. J. B. Epp, T. S. Widlanski J. Org. Chem. 1999, 64, 293. M. Cowart, M. J. Bennett, J. F. Kerwin J. Org. Chem. 1999, 64, 2240. P. Wang, L. A. Agrofoglio, M. G. Newton, C. K. Chu J. Org. Chem. 1999, 64, 4173. H. Li, M. J. Miller J. Org. Chem. 1999, 64, 9289. E. Lobaton, S. Velazquez, A. San-Felix, C. Chamorro, V. Tunon, A. Esteban-Gamboa, E. De Clercq, J. Balzarini, M.-J. Camarasa, M.-J. Perez-Perez Nucleosides, Nucleotides 1999, 18, 675. G. V. Zaitseva, A. I. Zinchenko, V. N. Barai, N. I. Pavlova, E. I. Boreko, I. A. Mikhailopulo Nucleosides, Nucleotides 1999, 18, 687. A. Matsuda, M. Fukushima, Y. Wataya, T. Sasaki Nucleosides, Nucleotides 1999, 18, 811. C. V. Varaprasad, D. Averett, K. S. Ramasamy, J. Wu Tetrahedron 1999, 55, 13345. B. Gaudilliere, P. Berna. Annual Reports in Medicinal Chemistry; Academic Press: San Diego, 2000; pp 331. K.-Y. Jung, R. J. Hohl, A. J. Wiemer, D. F. Wiemer Bioorg. Med. Chem. 2000, 8, 2501. D. Tritsch, P. M. Jung, A. Burger, J.-F. Biellmann Bioorg. Med. Chem. Lett. 2000, 10, 139. A. Renard, M. Kotera, M.-C. Brochier, J. Lhomme Eur. J. Org. Chem. 2000, 1831. B. M. Trost, R. Madsen, S. D. Guile, B. Brown J. Am. Chem. Soc. 2000, 122, 5947. T. Naka, N. Minakawa, H. Abe, D. Kaga, A. Matsuda J. Am. Chem. Soc. 2000, 122, 7233. A. Golisade, J. C. Bressi, S. Van Calenbergh, M. H. Gelb, A. Link J. Comb. Chem 2000, 2, 537. J. Wang, M. Froeyen, C. Hendrix, G. Andrei, R. Snoeck, E. De Clercq, P. Herdewijn J. Med. Chem. 2000, 43, 736. K. A. Jacobson, X.-d. Ji, A.-H. Li, N. Melman, M. A. Siddiqui, K.-J. Shin, V. E. Marquez, R. G. Ravi J. Med. Chem. 2000, 43, 2196. G. Wang, R. C. Tam, E. Gunic, J. Du, J. Bard, B. Pai J. Med. Chem. 2000, 43, 2566. A. R. Porcari, R. G. Ptak, K. Z. Borysko, J. M. Breitenbach, S. Vittori, L. L. Wotring, J. C. Drach, L. B. Townsend J. Med. Chem. 2000, 43, 2438. J.-L. Girardet, E. Gunic, C. Esler, D. Cieslak, Z. Pietrzkowski, G. Wang J. Med. Chem. 2000, 43, 3704. B. Brown, L. S. Hegedus J. Org. Chem. 2000, 65, 1865. A. E. Hakansson, A. A. Koshkin, M. D. Sorensen, J. Wengel J. Org. Chem. 2000, 65, 5161. A. W. Sledeski, G. G. Kubiak, M. K. O'Brien, M. R. Powers, T. H. Powner, L. K. Truesdale J. Org. Chem. 2000, 65, 8114. P. K. Sharma, V. Nair Nucleosides, Nucleotides & Nucleic Acids 2000, 19, 757. J. M. Tronchet, I. Kovacs, M. Seman, P. Dilda, E. De Clercq, J. Balzarini Nucleosides, Nucleotides & Nucleic Acids 2000, 19, 775. T. Kodama, S. Shuto, M. Nomura, A. Matsuda Tetrahedron Lett. 2000, 41, 3643. Handbook of Nucleoside Synthesis, ed. H. Vorbrüggen and C. Ruh-Pohlenz, John Wiley & Sons, Inc.: New York, 2001. E. Gunic, J.-L. Girardet, Z. Pietrzkowski, C. Esler, G. Wang Bioorg. Med. Chem. 2001, 9, 163.
Recent developments in the chemistry of nucleosides
01CEJ2332 01JMC208 01JOC2624 01JOC4878 01JOC8504 01NNNA649 01NNNA707 01NNNA711 01NNNA747 01NNNA1775 01OL1025 01OL2273 01OL4039 01OL4043 02ARMC257 02CCCC1267 02JMC1196 02JMC3934 02JMC4888 02JOC1016 02JOC1302 02JOC1898 02JOC5919 02JOC6837 02JOC7706 02JOC9331 02OL305 02OL529 02OL589 02PSS1783 02T1279 02T6019 02T9889 02TL5657 03ARMC347 03BMCL3345 03JMC201 03JMC389 03JMC3775 03JOC109
51
T. Kodama, S. Shuto, M. Nomura, A. Matsuda Chem. Eur. J. 2001, 7, 2332. T. Umino, K. Yoshioka, Y. Saitoh, N. Minakawa, H. Nakata, A. Matsuda J. Med. Chem. 2001, 44, 208. M. E. Jung, A. Toyota J. Org. Chem. 2001, 66, 2624. M. H. Sorensen, C. Nielsen, P. Nielsen J. Org. Chem. 2001, 66, 4878. A. A. Koshkin, J. Fensholdt, H. M. Pfundheller, C. Lomholt J. Org. Chem. 2001, 66, 8504. J.-F. Griffon, J. A. Montgomery, J. A. I. Secrist Nucleosides, Nucleotides & Nucleic Acids 2001, 20, 649. E. Lobaton, S. Velazquez, M.-J. Perez-Perez, M. L. Jimeno, A. San-Felix, E. De Clercq, J. Balzarini, M.-J. Camarasa Nucleosides, Nucleotides & Nucleic Acids 2001, 20, 707. E. Lobaton, S. Velazquez, A. San-Felix, E. De Clercq, J. Balzarini, M.-J. Camarasa Nucleosides, Nucleotides & Nucleic Acids 2001, 20, 711. A. T. Shortnacy-Fowler, K. N. Tiwari, J. A. Montgomery, J. A. I. Secrist Nucleosides, Nucleotides & Nucleic Acids 2001, 20, 747. J. Dauvergne, A. Burger, J.-F. Biellmann Nucleosides, Nucleotides & Nucleic Acids 2001, 20, 1775. N.-S. Li, X.-Q. Tang, J. A. Piccirilli Org. Lett. 2001, 3, 1025. F. Liu, D. J. Austin Org. Lett. 2001, 3, 2273. L. A. Paquette, R. T. Bibart, C. K. Seekamp, A. L. Kahane Org. Lett. 2001, 3, 4039. L. A. Paquette, D. R. Owen, R. T. Bibart, C. K. Seekamp Org. Lett. 2001, 3, 4043. P. Bernardelli, B. Gaudilliere, F. Vergne. Annual Reports in Medicinal Chemistry; Academic Press: San Diego, 2002; pp 257. X.-L. Qiu, J. Yu, X.-K. Fu Collec. Czech. Chem. Commun. 2002, 67, 1267. L. Cappellacci, G. Barboni, M. Palmieri, M. Pasqualini, M. Grifantini, B. Costa, C. Martini, P. Franchetti J. Med. Chem. 2002, 45, 1196. E. Lobaton, F. Rodriguez-Barrios, F. Gago, M.-J. Perez-Perez, E. De Clercq, J. Balzarini, M.-J. Camarasa, S. Velazquez J. Med. Chem. 2002, 45, 3934. Y. Chong, H. Choo, Y. Choi, J. Mathew, R. F. Schinazi, C. K. Chu J. Med. Chem. 2002, 45, 4888. X. Zhang, F.-L. Qing J. Org. Chem. 2002, 67, 1016. A. Renard, J. Lhomme, M. Kotera J. Org. Chem. 2002, 67, 1302. S. Chambert, F. Thomasson, J.-L. Decout J. Org. Chem. 2002, 67, 1898. K. Haraguchi, H. Takahashi, N. Shiina, C. Horii, Y. Yoshimura, A. Nishikawa, E. Sasakura, K. T. Nakamura, H. Tanaka J. Org. Chem. 2002, 67, 5919. J. H. Hong, M. J. Shim, B. O. Ro, O. H. Ko J. Org. Chem. 2002, 67, 6837. T. Kodama, S. Shuto, S. Ichikawa, A. Matsuda J. Org. Chem. 2002, 67, 7706. X. Chen, A. J. Wiemer, R. J. Hohl, D. F. Wiemer J. Org. Chem. 2002, 67, 9331. Y. Choi, H. Choo, Y. Chong, S. Lee, S. Olgen, R. F. Schinazi, C. K. Chu Org. Lett. 2002, 4, 305. M. H. Lim, H. O. Kim, H. R. Moon, M. W. Chun, L. S. Jeong Org. Lett. 2002, 4, 529. Y. Choi, C. George, P. Strazewski, V. E. Marquez Org. Lett. 2002, 4, 589. X. Chen, K.-Y. Jung, D. F. Wiemer, A. J. Wiemer, R. J. Hohl Phos. Sulf. and Silicon 2002, 177, 1783. M. Nomura, T. Sato, M. Washinosu, M. Tanaka, T. Asao, S. Shuto, A. Matsuda Tetrahedron 2002, 58, 1279. L. R. Comstock, S. R. Rajski Tetrahedron 2002, 58, 6019. V. P. Rajappan, X.-q. Yin, S. W. Schneller Tetrahedron 2002, 58, 9889. K. Haraguchi, H. Takahashi, H. Tanaka Tetrahedron Lett. 2002, 43, 5657. C. Boyer-Joubert, E. Lorthiois, F. Moreau. Annual Reports in Medicinal Chemistry; Elsevier: San Diego, 2003; pp 347. A. Yamashita, E. Norton, P. J. Petersen, B. A. Rasmussen, G. Singh, Y. Yang, T. S. Mansour, D. M. Ho Bioorg. Med. Chem. Lett. 2003, 13, 3345. L. S. Jeong, S. J. Yoo, K. M. Lee, M. J. Koo, W. J. Choi, H. O. Kim, H. R. Moon, M. Y. Lee, J. G. Park, S. K. Lee, M. W. Chun J. Med. Chem. 2003, 46, 201. H. Choo, Y. Chong, Y. Choi, J. Mathew, R. F. Schinazi, C. K. Chu J. Med. Chem. 2003, 46, 389. L. S. Jeong, D. Z. Jin, H. O. Kim, D. H. Shin, H. R. Moon, P. Gunaga, M. W. Chun, Y.-C. Kim, N. Melman, Z.-G. Gao, K. A. Jacobson J. Med. Chem. 2003, 46, 3775. J. Z. Ho, R. M. Mohareb, J. H. Ahn, T. B. Sim, H. Rapoport J. Org. Chem. 2003, 68, 109.
52 03JOC6799 03JOC8614 03JOC8625 03JCC292 03JCC851 03NNNA683 03NNNA707 03NNNA939 03NNNA947 03NNNA1313 03NNNA2195 03OL383 03OL807 03OL1399 03S2101 03T2297 03T9013 04ARMC337 04BMC277 04BMC2385 04BMCL3517 04BMCL4655 04JACS11484 04JCC717 04JMC1631 04JMC2243 04JMC2283
04JMC5251 04JMC5284
04JMC5773 04JOC655 04JOC3711 04JOC3993 04JOC6257
04JOC6310 04JOC7442
J.-L. Girardet and S.A. Lang
N.-S. Li, J. A. Piccirilli J. Org. Chem. 2003, 68, 6799. L. A. Paquette, C. K. Seekamp, A. L. Kahane J. Org. Chem. 2003, 68, 8614. L. A. Paquette, F. Fabris, F. Gallou, S. Dong J. Org. Chem. 2003, 68, 8625. R. Epple, R. Kudirka, W. A. Greenberg J. Comb. Chem. 2003, 5, 292. Y. Ding, Q. Habib, S. Z. Shaw, D. Y. Li, J. W. Abt, Z. Hong, H. An J. Comb. Chem. 2003, 5, 851. O. R. Ludef, C. Meier Nucleosides, Nucleotides & Nucleic Acids 2003, 22, 683. J.-F. Griffon, D. Dukhan, C. Pierra, S. Benzaria, A. G. Loi, P. La Colla, J.-P. Sommadossi, G. Gosselin Nucleosides, Nucleotides & Nucleic Acids 2003, 22, 707. A. NguyenVanNhien, C. Tomassi, C. Len, J. L. Marco-Contelles, D. Postel Nucleosides, Nucleotides & Nucleic Acids 2003, 22, 939. M.-C. Bonache, C. Chamorro, S. Velazquez, E. De Clercq, J. Balzarini, M.-J. Camarasa Nucleosides, Nucleotides & Nucleic Acids 2003, 22, 947. B. R. Babu, L. Keinicke, J. Wengel Nucleosides, Nucleotides & Nucleic Acids 2003, 22, 1313. F. Jeannot, G. Gosselin, C. Mathe Nucleosides, Nucleotides & Nucleic Acids 2003, 22, 2195. F. Jung, A. Burger, J.-F. Biellmann Org. Lett. 2003, 5, 383. Q. Dai, J. A. Piccirilli Org. Lett. 2003, 5, 807. K. Haraguchi, S. Takeda, H. Tanaka Org. Lett. 2003, 5, 1399. O. R. Ludef, C. Meier Synthesis 2003, 2101. C. V. Varaprasad, Q. Habib, D. Y. Li, J. Huang, J. W. Abt, F. Rong, Z. Hong, H. An Tetrahedron 2003, 59, 2297. F. E. Ziegler, M. A. Sarpong Tetrahedron 2003, 59, 9013. S. Hedge, J. Carter. Annual Reports in Medicinal Chemistry; Elsevier: San Diego, 2004; pp 337. X.-L. Qiu, F.-L. Qing Bioorg. Med. Chem. 2004, 13, 277. C. Rosembohm, D. S. Pedersen, M. Frieden, F. R. Jensen, S. Arent, S. Larsen, T. Koch Bioorg. Med. Chem. 2004, 12, 2385. K. L. Smith, V. C. Lai, B. J. Prigaro, Y. Ding, E. Gunic, J.-L. Girardet, W. Zhong, Z. Hong, S. Lang, H. An Bioorg. Med. Chem. Lett. 2004, 14, 3517. P. Franchetti, M. Pasqualini, R. Petrelli, M. Ricciutelli, P. Vita, L. Cappellacci Bioorg. Med. Chem. Lett. 2004, 14, 4655. P. I. Pradeepkumar, P. Cheruku, O. Plashkevych, P. Acharya, S. Gohil, J. Chattopadhyaya J. Am. Chem. Soc. 2004, 126, 11484. V. Aucagne, S. Berteina-Raboin, P. Guenot, L. A. Agrofoglio J. Comb. Chem 2004, 6, 717. W. Zhu, Y. Chong, H. Choo, J. Mathews, R. F. Schinazi, C. K. Chu J. Med. Chem. 2004, 47, 1631. S. Kehraus, S. Gorzalka, C. Hallmen, J. Iqbal, C. E. Muller, A. D. Wright, M. Wiese, G. M. Konig J. Med. Chem. 2004, 47, 2243. A. B. Eldrup, C. R. Allerson, C. F. Bennett, S. Bera, B. Bhat, N. Bhat, M. R. Bosserman, J. Brooks, C. Burlein, S. S. Carroll, P. D. Cook, K. L. Getty, M. MacCoss, D. R. McMasters, D. B. Olsen, T. P. Prakash, M. Prhavc, Q. Song, J. E. Tomassini, J. Xia J. Med. Chem. 2004, 47, 2283. S. F. Wnuk, E. Lewandowska, P. R. Sacasa, L. N. Crain, J. Zhang, R. T. Borchardt, E. DeClercq J. Med. Chem. 2004, 47, 5251. A. B. Eldrup, M. Prhavc, J. Brooks, B. Bhat, T. P. Prakash, Q. Song, S. Bera, N. Bhat, P. Dande, P. D. Cook, C. F. Bennett, S. S. Carroll, R. G. Ball, M. Bosserman, C. Burlein, L. F. Colwell, J. F. Fay, O. A. Flores, K. Getty, R. L. LaFemina, J. Leone, M. MacCoss, D. R. McMasters, J. E. Tomassini, D. vonLangen, B. Wolanski, D. B. Olsen J. Med. Chem. 2004, 47, 5284. J. D. Williams, R. G. Ptak, J. C. Drach, L. B. Townsend J. Med. Chem. 2004, 47, 5773. T. Ainai, Y.-G. Wang, Y. Tokoro, Y. Kobayashi J. Org. Chem. 2004, 69, 655. A. A. Koshkin J. Org. Chem. 2004, 69, 3711. M. Yang, W. Ye, S. W. Schneller J. Org. Chem. 2004, 69, 3993. M. M. Bio, F. Xu, M. Waters, J. M. Williams, K. A. Savary, C. J. Cowden, C. Yang, E. Buck, Z. J. Song, D. M. Tschaen, R. P. Volante, R. A. Reamer, E. J. J. Grabowski J. Org. Chem. 2004, 69, 6257. M. Meldgaard, F. G. Hansen, J. Wengel J. Org. Chem. 2004, 69, 6310. L. A. Paquette, C. K. Seekamp, A. L. Kahane, D. G. Hilmey, J. Gallucci J. Org. Chem. 2004, 69, 7442.
Recent developments in the chemistry of nucleosides
04NNNA495 04NNNA501 04NNNA671
04OL2531 04OL2645 04S334 04T2213 04TL739 04TL8981 05ARMC443 05BMC1249 05BMC1641
05BMC2045 05BMC4760 05BMCL709 05BMCL725 05BMCL2829
05BMCL3361 05EJOC2297 05JMC1158 05JMC2867 05JMC4276 05JMC4983 05JMC5043 05JMC5504
05JMC6430
05JMC6653 05JMC7808 05JMC8103 05JOC1597 05JOC3826
53
E. Gunic, R. Amador, F. Rong, J. W. Abt, H. An, Z. Hong, J.-L. Girardet Nucleosides, Nucleotides & Nucleic Acids 2004, 23, 495. Y.-h. Koh, M. B. Landesman, R. Amador, F. Rong, H. An, Z. Hong, J.-L. Girardet Nucleosides, Nucleotides & Nucleic Acids 2004, 23, 501. S. Kohgo, K. Yamada, K. Kitano, Y. Iwai, S. Sakata, N. Ashida, H. Hayakawa, D. Nameki, E. Kodama, M. Matsuoka, H. Mitsuya, H. Ohrui Nucleosides, Nucleotides & Nucleic Acids 2004, 23, 671. L. Bondada, G. Gumina, R. Nair, X. H. Ning, R. F. Schinazi, C. K. Chu Org. Lett. 2004, 6, 2531. K. Haraguchi, N. Shiina, Y. Yoshimura, H. Shimada, K. Hashimoto, H. Tanaka Org. Lett. 2004, 6, 2645. X.-L. Qiu, F.-L. Qing Synthesis 2004, 334. C. Taillefumier, S. Thielges, Y. Chapleur Tetrahedron 2004, 60, 2213. E. Ruediger, A. Martel, N. Meanwell, C. Solomon, B. Turmel Tetrahedron Lett. 2004, 45, 739. M. Yang, J. Zhou, S. W. Schneller Tetrahedron Lett. 2004, 45, 8981. S. Hedge, M. Schmidt. Annual Reports in Medicinal Chemistry; Elsevier: San Diego, 2005; pp 443. P. J. Hrdlicka, J. S. Jepsen, C. Nielsen, J. Wengel Bioorg. Med. Chem. 2005, 13, 1249. J. Shi, J. Du, T. Ma, K. W. Pankiewicz, S. E. Patterson, P. M. Tharnish, T. R. McBrayer, L. J. Stuyver, M. J. Otto, C. K. Chu, R. F. Schinazi, K. A. Watanabe Bioorg. Med. Chem. 2005, 13, 1641. P. Franchetti, L. Cappellacci, M. Pasqualini, R. Petrelli, V. Jayaprakasan, H. N. Jayaram, D. Boyd, M. Jain, M. Grifantini Bioorg. Med. Chem. 2005, 13, 2045. J. Chang, C. Dong, X. Guo, W. Hu, S. Cheng, Q. Wang, R. Chen Bioorg. Med. Chem. 2005, 13, 4760. Y. Ding, J.-L. Girardet, Z. Hong, V. C. Lai, H. An, Y.-h. Koh, S. Z. Shaw, W. Zhong Bioorg. Med. Chem. Lett. 2005, 15, 709. Y. Ding, H. An, Z. Hong, J.-L. Girardet Bioorg. Med. Chem. Lett. 2005, 15, 725. P.-P. Kung, L. R. Zehnder, J. J. Meng, S. W. Kupchinsky, D. J. Skalitzky, M. C. Johnson, K. A. Maegley, A. Ekker, L. A. Kuhn, P. W. Rose, L. A. Bloom Bioorg. Med. Chem. Lett. 2005, 15, 2829. T. D. Ashton, P. J. Scammells Bioorg. Med. Chem. Lett. 2005, 15, 3361. B. R. Babu, Raunak, N. E. Poopeiko, M. Juhl, A. D. Bond, V. S. Parmar, J. Wengel Eur. J. Org. Chem. 2005, 2297. S. deCastro, E. Lobaton, M.-J. Perez-Perez, A. San-Felix, A. Cordeiro, G. Andrei, R. Snoeck, E. DeClercq, J. Balzarini, M.-J. Camarasa, S. Velazquez J. Med. Chem. 2005, 48, 1158. Y.-h. Koh, J. H. Shim, J. Z. Wu, W. Zhong, Z. Hong, J.-L. Girardet J. Med. Chem. 2005, 48, 2867. A. NguyenVanNhien, C. Tomassi, C. Len, J. L. Marco-Contelles, J. Balzarini, C. Pannecouque, E. DeClercq, D. Postel J. Med. Chem. 2005, 48, 4276. P. Franchetti, L. Cappellacci, M. Pasqualini, R. Petrelli, P. Vita, H. N. Jayaram, Z. Horvath, T. Szekeres, M. Grifantini J. Med. Chem. 2005, 48, 4983. M. Yang, S. W. Schneller, B. Korba J. Med. Chem. 2005, 48, 5043. J. L. Clark, L. Hollecker, J. C. Mason, L. J. Stuyver, P. M. Tharnish, S. Lostia, T. R. McBrayer, R. F. Schinazi, K. A. Watanabe, M. J. Otto, P. A. Furman, W. J. Stec, S. E. Patterson, K. W. Pankiewicz J. Med. Chem. 2005, 48, 5504. S. H. Boyer, B. G. Ugarkar, J. Solbach, J. Kopcho, M. C. Matelich, K. Ollis, J. E. Gomez-Galeno, R. Mendonca, M. Tsuchiya, A. Nagahisa, M. Nakane, J. B. Wiesner, M. D. Erion J. Med. Chem. 2005, 48, 6430. M.-C. Bonache, C. Chamorro, S. Velazquez, E. DeClercq, J. Balzarini, F. R. Barrios, F. Gago, M.J. Camarasa, A. San-Felix J. Med. Chem. 2005, 48, 6653. B. C. Bookser, B. G. Ugarkar, M. C. Matelich, R. H. Lemus, M. Allan, M. Tsuchiya, M. Nakane, A. Nagahisa, J. B. Wiesner, M. D. Erion J. Med. Chem. 2005, 48, 7808. K. A. Jacobson, Z.-G. Gao, S. Tchilibon, H. T. Duong, B. V. Joshi, D. Sonin, B. T. Liang J. Med. Chem. 2005, 48, 8103. R. Hartung, L. A. Paquette J. Org. Chem. 2005, 70, 1597. X.-L. Qiu, F.-L. Qing J. Org. Chem. 2005, 70, 3826.
54 05JOC4591 05JOC4918 05JOC5006 05JOC5655 05JOC5833 05JOC6891 05JOC7902 05JOC7925 05NNNA383 05OL2141 05OL3889 05OBC1245 05S1467 05S3209 05SL1586 05T11850 05TL1927 05TL3883 05TL7535 05TL8497 06JMC273 06JMC2096 06JOC1306 06T97 06T906 06TL591
J.-L. Girardet and S.A. Lang
S. Vijgen, K. Nauwelaerts, J. Wang, A. VanAerschot, I. Lagoja, P. Herdewijn J. Org. Chem. 2005, 70, 4591. P. K. Sharma, M. Petersen, P. Nielsen J. Org. Chem. 2005, 70, 4918. J. A. Lee, H. R. Moon, H. O. Kim, K. R. Kim, K. M. Lee, B. T. Kim, K. J. Hwang, M. W. Chun, K. A. Jacobson, L. S. Jeong J. Org. Chem. 2005, 70, 5006. L. A. Paquette, S. Dong J. Org. Chem. 2005, 70, 5655. S. G. Petersen, S. R. Rajski J. Org. Chem. 2005, 70, 5833. J. Gagneron, G. Gosselin, C. Mathe J. Org. Chem. 2005, 70, 6891. J.-D. Ye, X. Liao, J. A. Piccirilli J. Org. Chem. 2005, 70, 7902. Y. Ueno, T. Kato, K. Sato, Y. Ito, M. Yoshida, T. Inoue, A. Shibata, M. Ebihara, Y. Kitade J. Org. Chem. 2005, 70, 7925. J. Gagneron, G. Gosselin, C. Mathe Nucleosides, Nucleotides & Nucleic Acids 2005, 24, 383. R. L. Weller, S. R. Rajski Org. Lett. 2005, 7, 2141. A. Roy, S. W. Schneller Org. Lett. 2005, 7, 3889. C. Takagi, M. Sukeda, H.-S. Kim, Y. Wataya, S. Yabe, Y. Kitade, A. Matsuda, S. Shuto Org. Biomol. Chem. 2005, 3, 1245. G. Rangam, N. Z. Rudinger, H. M. Müller, A. Marx Synthesis 2005, 1467. R. Hartung, L. A. Paquette Synthesis 2005, 3209. K. Sakthivel, P. D. Cook Synlett 2005, 10, 1586. F. Sarabia, L. Martin-Ortiz Tetrahedron 2005, 61, 11850. X.-q. Yin, S. W. Schneller Tetrahedron Lett. 2005, 46, 1927. K. Sakthivel, P. D. Cook Tetrahedron Lett. 2005, 46, 3883. X.-q. Yin, S. W. Schneller Tetrahedron Lett. 2005, 46, 7535. D. Sun, R. E. Lee Tetrahedron Lett. 2005, 46, 8497. L. S. Jeong, H. W. Lee, K. A. Jacobson, H. O. Kim, D. H. Shin, J. A. Lee, Z.-G. Gao, C. Lu, H. T. Duong, P. Gunaga, S. K. Lee, D. Z. Jin, M. W. Chun, H. R. Moon J. Med. Chem. 2006, 49, 273. M. Rapp, T. A. Haubrich, J. Perrault, Z. B. Mackey, J. H. McKerrow, P. K. Chiang, S. F. Wnuk J. Med. Chem. 2006, 49, 2096. M. Sekiguchi, S. Obika, Y. Harada, T. Osaki, R. Somjing, Y. Mitsuoka, N. Shibata, M. Masaki, T. Imanishi J. Org. Chem. 2006, 71, 1306. J. Fuentes, B. A. B. Salameh, M. A. Pradera, F. J. Fernandez de Cordoba, C. Gasch Tetrahedron 2006, 62, 97. G. Gosselin, L. Griffe, J.-C. Meillon, R. Storer Tetrahedron 2006, 62, 906. Y. Yoshimura, T. Kuze, M. Ueno, F. Komiya, K. Haraguchi, H. Tanaka, F. Kano, K. Yamada, K. Asami, N. Kaneko, H. Takahata Tetrahedron Lett. 2006, 47, 591.
55
Chapter 3.1
Three-membered ring systems (2004) Albert Padwa Emory University, Atlanta, GA 30322
[email protected] Shaun Murphree Allegheny College, Meadville, PA 16335
[email protected]
3.1.1
INTRODUCTION
Three-membered heterocycles are invested with a special allure that is derived from their apparent simplicity and spartan architecture. Yet these systems are multifaceted, and the literature continues to provide evidence of their diversity, both in terms of preparative routes and subsequent transformations. These smallest of heterocycles also exhibit a synthetically very useful balance between stability and reactivity. Thus, they are often employed as versatile and selective intermediates. With the potential to introduce two adjacent chiral centers with high atom economy, this methodology rightly deserves a place of prominence in synthetic organic chemistry. The utility of epoxides, for example, in the enantioselective synthesis of oxygensubstituted quaternary carbon centers has been the subject of a recent review <04COC149>. The following is not an exhaustive compilation, but rather a sampling of highlights from the past year’s literature with an emphasis on synthetic utility. The organization follows that of previous years. 3.1.2
EPOXIDES
3.1.2.1 Preparation of Epoxides An important preparative methodology which has developed rapidly over the last few years is the (salen)Mn mediated epoxidation of alkenes (the Jacobsen-Katsuki epoxidation). While the practical utility of this protocol is indisputable, the mechanistic underpinnings have been the matter of some debate. Adding to this ongoing dialectic is a result from a recently published DFT study, which suggests the salen ligand itself is involved in the transition state of the
56
A. Padwa and S. Murphree
epoxidation. In one outcome on a rather complex reaction surface, a covalent bond is formed beween the carbon atom of the substrate and the oxygen atom of the salen framework <04OL59>. A novel immobilized (salen)Mn catalyst has been constructed by incorporating a chiral sulfonato-salen complex into a zinc-aluminum layered double hydroxide (LDH) host. The active catalyst is proposed to exist as an intercalated species spanning the interlayer space (i.e., 1). The complex was shown to promote the selective epoxidation of limonene 2 with molecular oxygen at room temperature in the presence of pivaldehyde and N-methylimidazole under Mukaiyama conditions. The activity of the catalyst is stable even after multiple cycles, and no leaching of manganese has been observed <04CC554>. Recent mechanistic studies suggest that the epoxidation proceeds via the in situ formation of a peracid (i.e., perpivalic acid) through autoxidation of the aldehyde, which subsequently serves as an oxygen donor during the epoxidation <04JOC3453>.
SO3-
O N
1 O2 (75 psi)
O Mn
N
100% conversion 90% chemoselectivity 55% de
pivaldehyde (2.5 eq) N-MeI (0.5 eq) 25°C
Cl O 2
3
SO3-
1
Metal mediated epoxidation is remarkably diverse, with many types of ligand systems being represented. For example, a cytochrome P450 BM-3 mutant (139-3) has been developed using directed evolution, which exhibits high activity towards epoxidation of several non-natural substrates. Thus, exposure of styrene 4 to BM-3 variant 139-3 in phosphate buffer containing methanol and NADPH resulted in the quantitative conversion to styrene oxide 5. For terminal aliphatic alkenes, however, allylic hydroxylation is the predominant process <04T525>. O cytochrome P450 BM-3 139-3 100% yield
phosphate buffer / MeOH NADPH 4
5
Highly efficient small molecular P450 mimics have also been developed. The sterically stabilized metalloporphyrin [Mn(TDCPP)Cl] 6 catalyzes the mild and highly diastereoselective epoxidation of protected cyclohexenol derivative 7 using hydrogen peroxide as the terminal oxidant. The preference for trans-epoxides is rationalized on the basis of non-bonded
57
Three-membered ring systems (2004)
interactions between the allylic substituent on the substrate and the bulky porphyrin ligand; diastereoselectivies increase with steric demand of the substituent <04OL1597>. The same metalloporphyrin has been shown to catalyze the epoxidation of aromatic substrates, which has implications not only in the realm of synthetic methodology, but also with respect to the toxicology of environmental polycyclic aromatic hydrocarbons. Thus, phenanthrene 9 is converted to epoxide 10 in excellent yield in three hours with a catalyst loading of 0.3 mol% <04CC608>. OTBDMS Cl
Cl
H2O2
N
Cl N
Cl
N
O
aq NH4HCO3 CH3CN 25°C
Cl
Mn
OTBDMS
6
N
7
Cl
100% conversion 88% yield 33:1 trans/cis
8
Cl
6 Cl
H2 O 2
Cl
100% conversion 91% selectivity
NH4OAc CH3CN-CH2Cl2 25°C
6
O
9
10
Conventional wisdom holds that these epoxidation reactions occur via oxygen atom transfer directly from the catalyst via the metal-oxo species. As a result of their studies of the structurally similar Mn-corroles, Goldberg and co-workers have proposed that at least a secondary pathway might exist in which the metal-oxo species activates the terminal oxidant through simple Lewis acid catalysis (cf. 12). This hypothesis, which is supported by 18O labeling experiments, would explain the long-recognized but poorly understood impact of the terminal oxidant on the course of these epoxidations <04JA18>. t-Bu
t-Bu
N
t-Bu
t-Bu N
N
MnIII
N N
N
MnV
(Cz)
O
N
t-Bu
t-Bu
O PhIO
Ph
oxygen to be transferred
I
12
t-Bu
t-Bu 11 (Cz)
MnIII
58
A. Padwa and S. Murphree
Metal-catalyzed epoxidations can also work quite efficiently even with very simple ligand systems. For example, 1-octene 13 is converted to its corresponding epoxide in practically quantitative yield within 5 min upon exposure to peracetic acid in the presence of the Mn(II)bipyridyl complex at 0.1 mol% catalyst loading <04OL3119>. O
[MnII(bipy)(CF3SO3)2]
99% conversion 94% yield
CH3CO3H CH3CN 25°, 5 min
13
14
Metal-catalyzed epoxidations are becoming important on the industrial scale, since the ability to use molecular oxygen as the terminal oxidant offers considerable operational and environmental benefits. The crucial feedstock propylene oxide 16 can be produced using molecular oxygen and a catalytic system of palladium(II) acetate and a peroxo-heteropoly compound in methanol <04CC582>. A discussion of some quantum chemical calculations with regard to the industrially relevant peroxometal epoxidation catalysts has recently appeared in the literature <04SCR645>. O2 [(hexyl)4N]3{PO4[W(O)(O2)2]4}
O
Pd(OAc)2 MeOH 100°C (autoclave)
15
43% conversion 82% selectivity
16
In the realm of epoxidations without the use of transition metals, dioxirane-mediated processes are among the most versatile. While the use of stoichiometric amounts of even the simplest dioxiranes can still be experimentally cumbersome, novel catalytic systems continue to emerge. For example, the PEG-immobilized trifluoroacetophenone 17 is a convenient dioxirane precursor that is highly active, soluble in both water and organic solvents, and easily recoverable and reusable. In the presence of Oxone, this ketone mediates the efficient epoxidation of sensitive substrates, such as the BOC-protected aminostyrene 18 <04TL6357>. O
MeO
O
O
BocHN
n
17
O
17 Oxone
CF3
18
water / dioxane 90% yield
BocHN 19
These ketone precursors can also serve as chiral auxiliaries. The dioxirane from the fructosederived ketone 20 converts trisubstituted and trans-disubstitued alkenes (e.g., 22) to the corresponding epoxides in very good yields and enantioselectivities, but is less effective for terminal and cis-disubstituted substrates. Fortunately, the oxazolidino analog 21 exhibits a complementary scope, providing high enantioselectivities for these latter olefins (e.g., 24). The stereochemical outcome of the reaction has been rationalized on the basis of a spiro transition
59
Three-membered ring systems (2004)
state <04ACR488>. Very mild homogeneous conditions have been elaborated for the in situ generation of dioxiranes from ketones using a buffered Oxone solution <04ACR497>. TMS O O
O
O
O
O
O
O
N Ar
Ph 23
22
O
O
O
Oxone 96% ee
Ph
TMS
O
20
O
O 20
20
21
Oxone 91% ee
Ph
Ph 25
24
Page and co-workers have reported a noteworthy advance in asymmetric epoxidations of unfunctionalized olefins using chiral iminium salts, such as 26. In the presence of Oxone neutralized with sodium carbonate, the iminium salt is converted to the corresponding oxaziridium salt, which serves as the oxygen transfer agent. Yields are moderate to good, and enantioselectivities are highly variable, but can reach as high as 95%, as exemplified by the epoxidation of 1-phenyl-3,4-dihydronaphthalene 27. Effective catalyst loadings can also be remarkably low, as shown in the conversion of 1-phenylcyclohexene 29, which proceeded in 91% ee with only 0.5 mol% of the catalyst <04OL1543>. Anhydrous conditions have also been optimized for this system <04JOC3595>. Ph
Ph 26 (5 mol%) Oxone (2 eq)
BPh4
66% yield 95% ee
Na2CO3 CH3CN / H2O
O N
27
O
28
O Ph
Ph
Ph 26 (0.5 mol%) Oxone (2 eq)
26
29
Na2CO3 CH3CN / H2O
O 65% yield 91% ee
30
Remarkably, simple chiral ammonium salts such as 31 can induce modest enantiomeric excess in the Oxone-mediated epoxidation of trisubstituted alkenes. While no in-depth mechanistic models have been proposed, the mode of action is believed to be through the formation of chiral salts with Oxone itself <04AGE1460>.
60
A. Padwa and S. Murphree
Ph Ph Oxone
N Cl
H
H
Ph
Ph
N H
O
O OH
S O
Ph 31 (10 mol%) Oxone (2 eq)
Ph
H
NaHCO3 CH3CN / H 2O
O 29
30
32
31
O
93% yield 41% ee
The same kind of associative event lies at the heart of the catalytic asymmetric epoxidation of enones using the interesting binaphthyl derived spiro ammonium salt 33, which serves as a phase transfer catalyst as well as chiral auxiliary. Using sodium hypochlorite in a biphasic system, this catalyst mediates the high-yielding epoxidation of a variety of electron-deficient trisubstituted and trans-disubstituted olefins with excellent enantioselectivity, as represented by the conversion of enone 34 to the corresponding epoxy ketone 35 <04JA6844>. Ph
Ph
Ph
Ph OH O
Br
33 (3 mol%)
N
Ph
OH Ph
34 Ph
13% NaOCl toluene 0°C 3.5 d
O
O Ph 35
99% yield 92% ee 33
Ph
Ph
Another commonly employed approach for the enantioselective epoxidation of enones is the Juliá-Colonna procedure, which utilizes basic hydrogen peroxide as an oxygen source and polyleucine as a chiral auxiliary. Practical improvements to this protocol have recently been reported. In one modification, poly-(L)-leucine is stirred in a biphasic mixture of water/toluene with tetrabutylammonium bisulfate as a phase-transfer agent. The polyamino acid appears to be the species that consumes hydrogen peroxide from the aqueous medium and serve as a source of oxygen in the organic phase. These reaction conditions accomplished the notable feat of preparing the epoxysulfone 37 in high yield and good optical purity <04TL5073>. Investigators at Bayer reported very similar conditions using silica supported poly-(L)-leucine, which was shown to epoxidize trans-chalcone 38 in excellent yield and enantiomeric excess <04TL5069>.
61
Three-membered ring systems (2004) poly-(L)-leucine (1 mol%) H2O2 / NaOH Bu4NHSO4 toluene RT
TolO2S 36
O
O
37
O
Si supported poly-(L)-leucine
Ph
H2O2 / NaOH TBAB toluene
Ph 38
89% conversion 76% isol'd yield 70% ee
TolO2S
> 99% conversion 92% ee
O
Ph
Ph 39
γ-Hydroxy-α,β-unsaturated esters were shown to undergo diastereoselective epoxidation in the presence of lithium t-butylperoxide, in which the delivery of the epoxide oxygen is guided by the solvent system. Thus, in coordinating solvents such as THF, the predominant product (i.e. 41) is anti; conversely, non-polar solvents such as toluene lead to syn diastereoselectivity. Interestingly, temperature exerts practically no influence on the stereochemical outcome over the range of -80° – 50°C <04TL5359>. O
O
t-BuOOLi
O
OEt
O OEt
OH
+
OEt
OH
OH syn-41
anti-41
40
O
Solvent
anti
syn
THF
75
25
yield 40%
toluene
32
68
53%
Thus far, discussion has centered around the reaction of alkenes with a source of electrophilic oxygen as a route to epoxides [the C=C + O protocol]. However, a second general approach is represented by the reaction of carbonyl compounds with amphophilic carbon centers [the C=O + C protocol]. For example, sulfonium ylides are known to convert aldehydes and ketones to epoxides; much recent work has focused on asymmetric induction using this methodology, a topic which has been the subject of a concise review in the past year <04ACR611>. As an illustration, the D-mannitol derived chiral sulfide 42 serves as a useful chiral auxiliary in the sulfonium methylide epoxidation of aldehydes to provide terminal monosubstituted oxiranes (e.g., 44) in fair to excellent yield and good enantiomeric excess <04CC1076>. Ph
O
Cl
Ph
O
Cl O
O
S 42
O
42 Et2Zn, CH2ICl CH2Cl, DME 25°C
Cl 43
O 96% yield 76% ee
Cl 44
Aldehydes can also be converted to enantioenriched chiral epoxides through the Darzens reaction. Thus, haloimides (e.g., 47) react with benzaldehyde in the presence of a novel phase transfer catalyst 45 derived from BINOL to give 1,2-disubstituted epoxides in good yields with
62
A. Padwa and S. Murphree
high enantioselectivity, and fair diastereoselectivity. The protocol can be applied to both aromatic and aliphatic aldehydes with low catalyst loadings <04TL1845>. O MeO N 2 Br N
MeO 46
45 (2 mol%)
+
RbOH·H2O (2.4 eq) CH2Cl2, 25°C, 1d
NPh2 O 48
O Br
O
82% yield 60% ee cis/trans 8:1
NPh2
45 47
Finally, carbenoid species can be used as the carbon donor in aldehyde epoxidations. Thus, the rhodium carbenoid derived from the cyclic diazoamide 49 and rhodium(II) acetate reacts stereoselectively with aryl aldehydes to provide spiro-indolooxiranes 50 with Z-stereochemistry. The reaction is believed to proceed via the formation of a carbonyl ylide 51, which undergoes stereospecific thermal conrotatory electrocyclization to form the observed epoxide <04SL639>. N2
O O
+
Rh2(OAc)4
O
N
OMe
1,2-dichloroethane 60°C
Ph
84% yield
N O
Ph OMe 49
46
50
OMe O H
N Ph
O 51
3.1.2.2 Reactions of Epoxides The hydrolysis of epoxides is a well-known reaction which can be exploited for various synthetically useful outcomes. Chiral nonracemic epoxides can be prepared from their racemates through the salen-mediated hydrolytic kinetic resolution (HKR). Racemic epichlorohydrin 53 was resolved in the presence of catalyst 52 and a slight excess of water under solvent-free conditions. The catalyst counterion exerts a significant effect on the course of the reaction, presumably due to competitive addition onto the epoxide, an effect which is evident in apparent reaction rates, but not enantioselectivities. Less nucleophilic counterions, such as tosylate, lead to more rapid resolution and lower catalyst loading requirements <04JA1360>.
63
Three-membered ring systems (2004)
52 (0.2 mol%) N
N Cl
Co O
t-Bu
t-Bu
O OAc t-Bu
H2O (0.7 eq)
O
0-4°C, 16 h
OH O
Cl
+
OH
Cl
t-Bu 55
54
53
42% yield (50% max) > 99% ee
52
Chiral diols have been prepared from the desymmetrization of the corresponding meso epoxides using epoxide hydrolases (EHs). As a general trend, microbial EHs tend to prefer the generation of (R,R)-diols, as demonstrated by the desymmetrization of cis-stilbene oxide 56. However, a recently reported variant (BD9126) exhibits the opposite enantioselectivity. This nice complement to existing methods provides good to excellent ee's, albeit at reaction rates typically two orders of magnitude less than the (R,R)-producing enzymes <04JA11156>. A new palladium-catalyzed ring opening of epoxyacrylate derivatives mediated by boric acid gives the corresponding diols 59 with net retention of configuration at both epoxide carbon centers, providing a nice complement to osmium dihydroxylation methodology. The reaction is believed to proceed through the intermediacy of cyclic boronates (e.g., 60) <04CL764>. O Ph
Ph 56
Ph
EH BD8877 (0.5 wt%)
HO
OH
phosphate buffer 5% CH3CN 22°C, 48 h
Ph
Ph
B(OH)3 Pd(PPh3)4
O CO2Et 58
83% yield 99% ee
57
HO Ph
THF 25°C 10 min
CO2Et
92% yield 98% de
OH 59
Ph
CO2Et O
O B
60
OH
Epoxides also suffer nucleophilic attack by amines, forming ethanolamine derivatives. This reaction can take place under a variety of conditions and with the influence of several catalysts. Styrene oxide 61 undergoes ring opening in the absence of catalyst under strictly thermal conditions (90°C in a sealed tube) to give predominantly the amino-alcohol 62, the product of attack at the more substituted (α) position <04SC2393>. The reaction time can be reduced by using a combination of catalytic bismuth(III) trifluoroacetate and brief microwave irradiation, as
64
A. Padwa and S. Murphree
illustrated in the reaction of 61 with p-bromoaniline, which requires only 40 sec of heating in a conventional microwave to provide 62 as the exclusive product in 90% yield <04CL304>. The reaction temperature can also be lowered (to room temperature) by the addition of 5 mol% lithium bromide as a catalyst. Under these conditions, the regioselectivity appears to be dependent upon the attacking nucleophile. Thus, p-chloroaniline engages in exclusive attack at the α-position, whereas piperidine gives an almost equimolar mixture of products 62 and 63 <04EJOC3597>. In contrast, the use of nickel(II) acetate as catalyst leads to an extremely high regioselectivity with piperidine, favoring the α-product 62 <04SL846>. Interestingly, indium bromide promotes the opposite regiochemistry. Thus, treatment of styrene oxide with p-tertbutylaniline and 1 equiv of indium tribromide gives exclusively aminoalcohol 63 in 75% yield. In this protocol, attempts to use substoichiometric amounts of catalyst led to lower yields and significant amounts of a 2:1 adduct of epoxide to amine <04TL7495>. H N R1 R2 conditions (see table)
O Ph
R1
N
R2
OH OH
Ph
N
Ph
62
61
R1
+
R2
63
amine
R1
R2
catalyst (loading)
solvent
time
temp
yield
62:63
reference
ethanolamine
HOCH2CH2-
H-
none
neat
3h
90°C*
99%
90:10
<04SC2393>
p-bromoaniline
(p-Br)Ph-
H-
Bi(TFA)3
CH3CN
40 s
MW
90%
100:0
<04CL304>
p-chloroaniline
(p-Cl)Ph-
H-
LiBr (5 mol%)
neat
5h
RT
100%
100:0
<04EJOC3597> <04EJOC3597>
piperidine
-(CH2)5-
LiBr (5 mol%)
neat
5h
RT
98%
42:58
piperidine
-(CH2)5-
Ni(OAc)2·2H2O
neat
12 h
50°C
99%
96:4
<04SL846>
InBr3 (1 eq)
CH2Cl2
12 h
RT
75%
0:100
<04TL7495>
p-t-butylaniline
(p-tBu)Ph-
H-
*sealed tube
Similar conditions have been applied to the ring-opening of meso epoxides using amines. Bismuth triflate catalyzes the reaction of cyclohexene oxide 64 with p-bromoaniline under aqueous conditions to provide the β-aminoalcohol 65 in 84% yield. In this particular case, the water solubility of the starting materials required the use of a micellar solution of sodium dodecyl sulfate (SDS); however, more soluble amines could be employed in water and bismuth triflate alone <04TL49>. A lanthanide variant has also been reported. Thus, treatment of 64 O
OH
p-bromoaniline conditions (see table)
Br
N H
64
65
conditions
time
temp
yield
reference
Bi(OTf)3 (10 mol%), SDS (40%), H2O
9h
25°C
84%
<04TL49>
SmI2(THF)2 (10 mol%), CH2Cl2
18 h
25°C
76%
<04TL7749>
with p-bromoaniline and 10% samarium iodide in methylene chloride solution provides the product 65 in 76% yield. An interesting aspect of the latter protocol is that the chiral bisbinaphthoxy iodo samarium catalyst 66 has been shown to effectively desymmetrize meso
65
Three-membered ring systems (2004)
epoxides, as illustrated by the conversion of the cyclohexadiene oxide 67 to the nonracemic aminoalcohol 68 <04TL7749>.
O
OH
o-methoxyaniline O
Sm I · (THF)2
66 (10 mol%) CH2Cl2 25°C 18 h
O 67 66
N H
OMe
68 100% conversion 60% yield 68% ee
Chromium(salen) catalysts (e.g., 69) are also useful in desymmetrizing meso epoxides. Thus, cis-stilbene oxide 70 is converted to the (S,S)-aminoalcohol 71 in the presence of catalytic quantities of 69 in methylene chloride solution open to the atmosphere. The addition of small quantities of triethylamine was found to dramatically increase enantioselectivities (by almost 25%). This catalytic system also promotes an efficient aminolytic kinetic resolution (AKR) of racemic epoxides with C2-type symmetry <04OL2173>.
O
N
N t-Bu
O
O
t-Bu
Ph
Cl t-Bu
NHPh
69 (10 mol%)
Cr Ph
Et3N (11 mol%) 25°C, 40 h
70
Ph
Ph OH 71
t-Bu 98% yield 90% ee
69
Another very useful method of introducing nitrogen during epoxide cleavage is based on the azide nucleophile. This approach was used in the regioselective ring-opening of the optically pure aryl epoxide 72, a key step in the synthesis of (-)-cytoxazone 74, a cytokine modulating natural product isolated from Streptomyces. The regioselectivity is substrate dependent: terminal epoxides are attacked preferentially at the less substituted position, whereas benzylic positions tend to be more electrophilic in the case of aryl epoxides. The regioselectivity is attributed to the potassium ions found in mesoporous 4Å molecular sieves used as a catalyst <04TL7355>. O O
N3 CO2Et
4Å sieves CH3CN 25°C, 1.6 h
MeO
72
CO2Et
NaN3 OH
MeO
73
HN
3 steps 67%
O OH
MeO
74 (-)-cytoxazone
66
A. Padwa and S. Murphree
This type of ring-opening by heteroatomic nucleophiles can also occur in an intramolecular fashion, leading to new heterocycles. For example, vinyl epoxide 75 undergoes 6-endo cyclization in the presence of a rhodium catalyst to give the trans-hydroxypiperidine derivative 76 under extremely mild conditions. The olefinic moiety is crucial, as the reaction proceeds through the initial coordination of the π-bond and nitrogen lone pair, followed by the formation of an enyl or π-allyl intermediate. This double coordination is believed to govern both the regioselectivity and stereoselectivity of the process <04TL4193>. OH [Rh(CO)2Cl]2 (2 mol%)
O
THF 25°C 30 min
CO2Et
NH Cbz
83% yield N
CO2Et
Cbz
75
76
Epoxides can serve as competent electrophiles in the alkylation of a variety of carbanions, as illustrated by the ring opening of cyclohexene oxide (64) with the dianion of phenylacetic acid (77) to produce the γ-hydroxy carboxylic acid 78. In this protocol, the dianion is generated using n-butyllithium and a substoichiometric quantity of a secondary amine; lithium chloride is also used as a Lewis acid additive to activate the secondary epoxide toward nucleophilic addition. Primary epoxides undergo addition without the use of catalyst—in these cases, the nucleophile attacks at the less substituted position <04EJOC2160>. Ph OO
64
+
LiCl (1 eq) Ph
-O
HO
CO2H 83% yield
Et2NLi (10 mol%) THF, 25°C, 3 h
77
78
A similar transformation can be carried out under milder conditions by taking advantage of silyl ketene acetals, a masked form of the carboxylate dianion. When epichlorohydrin 53 was treated with the ketene acetal 79 in the presence of titanium(IV) chloride, a regioselective epoxide ring opening occurs at the less substituted carbon. Treatment of the crude reaction mixture with catalytic p-toluenesulfonic acid promoted a lactonization to the γ-butanolide 80 in high overall yield <04T8957>. O OTMS
O
Cl
53
+ OMe 79
TiCl4 CH2Cl2 / hexane -60° --> -30°C
cat. p-TsOH O
CH2Cl2 25°C, 3 h 80
Cl
83% yield
Other carbon nucleophiles also tend to attack at the less substituted position of an unsymmetrical epoxide. This holds true for cyanide, which can be conveniently prepared in situ from methyllithium and acetone cyanohydrin 82. In a one-pot reaction, the epoxy ether 81 is
67
Three-membered ring systems (2004)
converted to hydroxy nitrile 83 in 80% yield <04TL7201>. Similarly, alkyllithium reagents attack the unsubstituted carbon of terminal epoxides, and when an excess of base is present, the intermediate alkoxides undergo elimination to form alkenes. Thus, when decyl epoxide 84 is treated with the vinyl lithium derivative 85 in the presence of lithium tetramethylpiperidine (LTMP), diene 88 is produced exclusively in the E-geometry in very good yield. The mechanism involves an initial deprotonation of the epoxide by LTMP, followed by nucleophilic attack of the carbenoid oxiranyl anion by the vinyllithium 85. The dilithio species 87 suffers elimination to provide the observed alkene <04JA12250>. OH
O
OPh
MeLi THF Δ 20 min
+ CN
81
82
O C10H21
OH NC
OPh
80% yield
83
LTMP (2 eq) +
Li
84
hexane 0° -> 25°C 2h
85
85% yield
C10H21 88
OLi 84
O
LTMP C10H21
85
Li
88
C10H21 Li 87
86
The fascinating carbenoid character of the epoxide anion is also manifested in an intramolecular cyclopropanation reaction, in which the anion adds across a tethered olefin to provide bicyclo[3.1.0]hexanols (e.g., 92). The reaction is remarkably chemo- and diastereoselective. No C-H insertion is observed, and yields are generally very good. The stereochemical outcome is rationalized on the basis of a trans-lithiation, as well as the geometric constraints imposed by the [3.1.0] bicyclic system <04JA8664>. In the absence of wellpositioned double bonds, the oxiranyl anions can undergo another well-known reaction of carbenes, namely a 1,2-hydride shift. In the case of these substrates, the rearrangement leads to the formation of an enolate anion. Treatment of the cyclohexyl alkynyl epoxide 93 with an excess of n-butyllithium leads to an oxiranyl anion at the allylic site (i.e., 94). This intermediate undergoes a formal 1,2-hydride shift to provide the enynolate 96, which undergoes double distal protonation during acidic work-up to form the allenone 98 in 64% yield <04OL3509>. O O
OH
O LTMP (2 eq)
:
80% yield 99% ee
t-BuOMe 0° -> 15°C 8h
(S)-89
90
91
(1S,2S,5R)-92
68
A. Padwa and S. Murphree
O
O
:
O n-BuLi (2.2 eq) H H
H
H
THF -78° -> -20°C
93
H
94
95 1,2-shift
H
O ·
O H
64% overall
H
O
2 ·
HCl / H2O
98
H
H
97
96
Lithiated epoxides are more commonly trapped by electrophiles, generating elaborated oxiranes. In this arena, Hodgson and co-workers <04OL4187> have optimized the lithiation of nonstabilized terminal epoxides with sec-butyllithium assisted by diamine ligands, such as dibutylbispidine (DBB, 99) or (-)-sparteine 100. The oxiranyl anions thus formed engage in smooth nucleophilic addition onto aldehydes to form epoxyalcohols (e.g., 101); the same conditions can be used for the stannylation of epoxides (e.g., 84 → 102). Similarly, epoxydisilanes 103 can be accessed through two sequences of deprotonation followed by treatment with chlorotrimethylsilane <04SL1610>. H N
Bu
Bu s-BuLi 99
PhCHO
O
99 H N
H
H
s-BuLi 99
Bu3SnCl
O C10H21
C10H21
100
Ph
75% yield
101
H
N
OH
C10H21
N
H
O
s-BuLi 100 84
SnBu3
78% yield
SiMe3
61% yield
102 Me3SiCl (two iterations)
O C10H21
SiMe3 103
Epoxides undergo a variety of interesting and synthetically useful rearrangements to provide carbonyl compounds. The siloxycyclopentyl epoxide 104 (derived from the DMD oxidation of the corresponding tetrahydropyridine) underwent Lewis acid-catalyzed ring expansion to provide spiroketone 105 as a single diastereomer, suggesting a synchronous reaction mechanism <04JOC5676>. In a similar vein, the dichlororuthenium(IV)-porphyrin catalyst 106 promotes the rearrangement of terminal epoxides (e.g., 108) to aldehydes (e.g., 109). The epoxides themselves are prepared by oxidation of terminal alkenes (e.g., 107) with 106 in the presence of the stoichiometric oxidant 2,6-dichloropyridine N-oxide (Cl2pyNO), thereby representing a novel
69
Three-membered ring systems (2004)
conversion of terminal alkenes to aldehydes <04AGE4950>. Ruthenium catalysts also promote other unusual cyclizations of epoxides, such as the rearrangement of enynyl epoxide 110 to the cyclohexa-2,4-dienone 111 <04JOC7700>, and the cyclization of o-ethynylphenyl epoxide 112 to the alkylidene indanone 113 <04JA6895>. Both processes are thought to proceed through a ruthenium-ketene intermediate. TBSO
OH O
TBSO O
TiCl4 (1.1 eq)
OTMS
96% yield
CH2Cl2 -78°C 30 min
N Ts
N Ts
104
105
Cl
Cl N
Cl
Cl
Cl Ru
N
Cl
N
N
Cl
Cl
Cl
Cl 106
O
O
106 (2 mol%) Cl2pyNO (1 eq) CDCl3 25°C / 30 min
MeO 107
106
99% yield MeO
MeO 108
O
109
Me Ph
Me
TpRuPPh3(CH3CN)2PF6 (10 mol%)
Ph
toluene 100°C 12 h
92% yield
O
110
111 O TpRuPPh3(CH3CN)2PF6 (10 mol%)
F
F O
toluene 100°C 12 h 112
3.1.3
91% yield
113
AZIRIDINES
3.1.3.1 Preparation of Aziridines One method widely used for the synthesis of aziridines is the addition of nitrenes to olefins. Along these lines, sulfonamides serve as convenient nitrene precursors, which can be converted
70
A. Padwa and S. Murphree
using commercially available iodobenzene diacetate in the presence of various transition-metal catalysts. A copper(I) catalyst derived from the Evans chiral bis(oxazoline) ligand 114 was found to promote the high-yielding aziridination of styrene 4 with good enantioselectivity <04TL3965>. Chang and co-workers have developed a copper-catalyzed variant that requires no external ligand. Instead, a pyridyl nitrogen onboard the sulfonamide moiety serves as an internal ligand (i.e., 118), which in turn increases the efficiency of the aziridination <04OL4109>. Several unsaturated sulfonamides (e.g., 120) were shown to undergo a very facile intramolecular aziridination in the presence of a rhodium catalyst to provide tricyclic aziridines (e.g., 121) <04 JOC6377>. SO2NH2 +
114 (6 mol%) [Cu(CH3CN)4]ClO4 (5 mol%)
NO2
115
116 94% yield 75% ee O
O N
t-Bu
N t-Bu
114
PhI(OAc)2 Cu(tfac)2(3 mol%) N
CH3CN 25°C, 12 h
SO2NH2
4 N
N
SO2
118
SO2NH2
N
O2 S
[Cu] N
117
PhI(OAc)2
119 84% yield
O2 S
N 91% yield
Rh2(OAc)4 MgO, CH2Cl2 120
O2 S
PhI(OAc)2 benzene
O2N 4
N
121
Other interesting catalyst systems include copper(II) acetylacetonate (acac) immobilized in ionic liquids such as 1-n-butyl-3-methylimidazolium tetrafluoroborate (bmimBF4), which facilitates catalyst recycling and also appears to accelerate the reaction. Thus, transmethylstyrene 122 was converted to the corresponding tosyl aziridine 123 within 10 min using (tosylimino)phenyliodinane as the nitrogen donor <04SL525>. Bromamine T 125 is also a convenient, stable, and commercially available nitrene precursor. The perfluoroaryl iron porphyrin catalyst 124 is effective in promoting aziridination of a wide spectrum of alkenes in fair to good yields, as illustrated by the conversion of styrene 4 to the corresponding N-tosyl aziridine 126, which is believed to proceed through a mechanism involving an iron-nitrene intermediate <04OL1907>. A fluorinated aryl ligand is also at the heart of a chiral ruthenium(salen) catalyst 127 designed for the purpose of effecting enantioselective aziridination
71
Three-membered ring systems (2004)
Ts PhI=NTs Cu(acac)2 bmimBF4 25°C 10 min
122 F
F
F F
N
87% yield
Ph
Me 123
F
F
F
F N
F N
F
Fe N
O2 S
F N
Cl
+
F F
F F F
F
Br
N Na
4
125
NTs 124 (5 mol%) CH3CN 5A mol sieves 25°C, 12 h
F F
124
126 80% yield
F
F Ar = N
N Ru
O O Ar Ar
Me NTs
TsN3
F
127 (9 mol%) 4A mol sieves CH2Cl2 25°C, 24 h
Br
128
79% yield 90% ee
Br
129
CO 127
of olefins using sulfonyl azides as nitrene precursors. Thus, p-bromostyrene 128 provides the corresponding aziridine 129 in the presence of tosyl azide and catalyst 127. Enantioselectivities can reach as high as 99%, and the protocol also works well when tosyl azide is substituted with nosyl azide <04CC2060>. In the case of electron-deficient olefins, other methodologies are also available. For example, the dicyanoalkene 130 (derived from the Knoevenagel condensation of malononitrile with acetaldehyde) undergoes a facile aza-Michael addition of ethyl nosyloxycarbamate in the presence of calcium oxide to give a β-aminocarbanion intermediate 131, which quickly cyclizes to the corresponding dicyanoaziridine 132 in excellent yield <04SL1083>. When trifluoromethylacrylates are used as substrates, the intermediate Michael adducts can be isolated in >95% yield <04OL197>. Some degree of enantioselectivity has been observed when Cinchona alkaloids are used as catalysts in the reaction <04T8073>. An electrophilic variant is represented by the copper-catalyzed addition of N,N-dichloroarylsulfonamide across electrondeficient olefins such as methyl acrylate 133. The resulting β-chloroamines, which exhibit stereochemistry resulting from net anti addition, can be cyclized by treatment with sodium hydroxide to provide tosyl aziridines (e.g., 135) in good overall yield <04SC1337>.
72
A. Padwa and S. Murphree
An intriguing electrochemical aziridination is based on the selective anodic oxidation of Naminophthalimide (136, oxidation potential +1.60 V) in the presence of olefins. Thus, trans-hex4-en-3-one 137 is converted to the corresponding aziridine 138 in acetonitrile solution using a platinum electrode at a constant potential of +1.80 volts. The reaction mixture is buffered using triethylammonium acetate, since the cathodic process reduces proton to hydrogen gas. The use of platinum at the anode is critical, as graphite electrodes yielded no aziridination products <04PAC603>. NC
EtO2C NC N ONs
NsONHCO2Et
NC
CaO CH2Cl2 25°C, 2 h
Me
NC
Me
130
98% yield
NC
Me
131 TsNCl2 Cu(acac)2 (8 mol%)
CO2Me
CO2Et NC N
132 Ts NHTs
aq Na2SO3
CH3CN 25°C, 24 h
Cl
133
CO2Me
N
aq NaOH
CO2Me
134 O
135 O
O O
N NH2
+ 1.80 V (vs Ag)
+
Et3N·HOAc CH3CN 25°C, 4 h
O 136
80% yield
THF
N N
93% yield
O
137
138
Just as epoxides can be prepared from carbonyl compounds, aziridines can be accessed through the addition of amphophilic carbon centers onto imines, and sulfur ylides are frequently used as carbon donors in this regard. Thus, S-allyl tetrahydrothiophenium bromide 139 is smoothly deprotonated with strong base to provide an ylide which adds to a variety of Nprotected imines. For the N-tosyl aldimine 140 derived from isovaleraldehyde, the corresponding vinyl aziridine 141 is formed in fair yield as a mixture of stereoisomers <04TL1589>.
NTs
S Br
139
140
139 n-BuLi THF -78°C
Ts N 58% yield cis/trans 1:2 141
When chiral t-butylsulfinylimines (e.g., 142) are used as substrates, a highly stereoselective aziridination ensues, providing the heterocycles in good yield and good to excellent diastereomeric excess <04OL2377>. This approach of leveraging chirality at the imine nitrogen to impart enantioselectivity has also been used to advantage in the preparation of chiral heterosubstituted aziridines. Thus, when 2-(1-chloroethyl)-4-methyl-thiazole 145 is
73
Three-membered ring systems (2004)
deprotonated with LDA and treated with the chiral aldimine 144, the aziridinyl thiazole derivative 146 is produced in excellent yield and diastereoselectivity <04T1175>. O S
S
139 t-BuOLi
N
O
N
78% yield cis/trans 17:83
THF 25°C 142
143
Ph
OMe Me
N
Cl
+
N
Ph
S Me
Ph
LDA THF -78°C
Me S
OMe N
90% yield > 96% de
H Ph
N
144
Me
145
146
Chiral induction can also be quite effective when the locus of asymmetry is attached to the sulfur ylide itself. The sulfonium salt 147 derived from Eliel's oxathiane can be used to deliver a benzylic center to tosylimines (e.g., 148) and efficiently produces phenylaziridines with a very high degree of asymmetric induction. The method is amenable to gram-quantity synthesis, and the chiral auxiliary can be easily recovered. In general, cis/trans mixtures are obtained, depending upon the steric bulk of the imine substituent <04JOC1409>.
NTs O
S
147
Ts N
CH2Cl2 -78° 30 min
Ph
OTf
147 phosphazene base
Ph
148
149 80% yield 98.7% ee
As a complement to the base-catalyzed ylide approach, the Johnston group has developed a Bronsted acid-catalyzed direct aza-Darzens protocol for the synthesis of N-alkylaziridines. Ethyl diazoacetate 151 serves as an acetate enolate synthon under acidic conditions, engaging in [2+1] annulation with N-alkyl aldimines (e.g., 150) to provide the corresponding aziridine 152 with very high cis-selectivity. The conditions are mild enough that acid-catalyzed ring-opening of the products is not observed <04JA1612>. Ph N
N2
Ph +
MeO2C 150
TfOH (25 mol%) CO2Et
151
CH3CH2CN -78°C
86% yield cis/trans > 95:5
N MeO2C
CO2Et 152
74
A. Padwa and S. Murphree
3.1.3.2 Reactions of Aziridines One of the most widely encountered reactions of aziridines is the nucleophilic ring-opening of the heterocyclic ring. This has been the subject of a recent thoroughgoing and excellent review, to which the reader is directed <04T2701>. The interesting highlights of the previous year can be divided into the two categories of carbon-based nucleophiles and heteroatomic nucleophilic centers. Alkynylation of aziridines can be effected through the copper-catalyzed ring opening with acetylides. For example, lithium phenylacetylide engages in smooth nucleophilic attack of N-tosyl-7-azabicyclo[4.1.0]heptane 153 in the presence of copper(I) triflate to provide the cyclohexyl alkyne 154 in excellent yield <04SL1691>. Similarly, the lithium dimethyl cyanocuprate engaged in nucleophilic attack of the less substituted carbon on 1-pentyl-Ntosylaziridine 155 to give N-tosyl-octane-3-amine 156. In this system, the use of alkyllithium reagents led to eliminative pathways <04T3637>. However, there are other reports of productive ring-opening by lithiates. Treatment of 6-aza-3-oxabicyclo[3.1.0]hexane 157 with (trimethylsilyl)methyllithium led to the formation of an intermediate ring-opened dianion 158 which subsequently underwent elimination to form the functionalized allylic amine 159 <04CC2234>. Key to the success of this protocol is the formation of the aziridinyl anion, which has considerable carbenoid character. A fascinating example of this property is seen in the desymmetrization of the bicyclic tosyl aziridine 160 mediated by sec-butyllithium and (-)sparteine 100. The initially formed anion 161 behaves much like an amino carbene (i.e., 162) which engages in a transannular C-H insertion to give the bicyclo[3.3.0]octane derivative 163. Interestingly, the absolute configuration of 163 is the opposite of the alcohol formed from the corresponding rearrangement of the analogous alcohol <04HCA227>. NHTs Ph
NTs
Li
96% yield CuOTf (10 mol%) Et2O, 25°C, 45 h
Ts N
Li2CuCN(Me)2 Et2O -78°C 25°C 12 h
155
NTs
O
157
Me3SiCH2Li THF -78° -> 0°C
Ph 154
153
NHTs 63% yield 156
NTs
HO
NHTs
O
SIMe3
SIMe3 158
159
92% yield
75
Three-membered ring systems (2004)
NTs
C-H insertion
NTs
s-BuLi
NTs
100
H
NHTs
:
69% yield 75% ee
H 160
162
161
163
Aziridines can be opened with a variety of heteroatomic nucleophiles. Silica-supported phosphomolybdic acid (PMA-SiO2) is effective in promoting the ring-cleavage of tosyl aziridines by a variety of nucleophiles. Thus, the azide anion preferentially attacked at the benzylic position to provide the azidoaminoalcohol 165, whereby the regioselectivity can be rationalized in terms of partial positive charge stabilization <04SL1719>. A different type of selectivity is observed in the magnesium bromide mediated opening of hydroxymethyl aziridines. In these systems, the delivery of the nucleophile (i.e., bromide) is under chelation control, as demonstrated in the conversion of aziridine 166 to the bromo aminoalcohol 167 <04SC85>. In the absence of Lewis acid catalysts, heteroatomic nucleophiles tend to attack at the sterically least hindered center. Such is the case when the the butylaziridine 168 is treated with tributylphosphine, a strong nonbasic nucleophile which smoothly opens the heterocyclic ring. The initial adduct undergoes rapid proton transfer to provide a betaine 169 which can serve as a Wittig reagent. The addition of benzaldehyde leads to an olefination/elimination sequence to afford the diene 170 as a mixture of E/Z isomers <04JOC689>. N3
NTs Ph
NaN3 OH
Ph
PMA-SiO2 CH3CN / H2O (9:1) 25°C, 1 h
164
OH NHTs 165
Boc
NHBoc
N BnO
MgBr2 OH
BnO
168
PBu3 (1.2 eq) benzaldehyde t-BuOH reflux
OH
Et2O 25°C
95% yield
Br 167
166 Ts N
93% yield
NHTs PBu3 169
PhCHO Ph 170 74% yield (E,E):(E,Z) 84:15
Another interesting and synthetically useful behavior of aziridines is their tendency to open thermally to azomethine ylides, a process which can also be facilitated by Lewis acid catalysts. These reactive intermediates can be trapped by a variety of dipolarophiles to give new heterocyclic species. Methyl vinyl ethers convert aziridines such as 172 into a pyrrolidine derivative (i.e., 174) in the presence of a zinc(salen) Lewis acid catalyst 171 <04JA2294>. Similarly, nitriles (e.g., 175) lead to the formation of 2,4-disubstituted 1H-imidazolines (e.g., 176) under the catalysis of boron triethyloxonium tetrafluoroborate <04TL1137>. Under almost
76
A. Padwa and S. Murphree
identical conditions, the aziridine-Lewis acid complex can be trapped with π-nucleophiles, such as a tethered olefin, to provide fused bicyclic pyrrolidines (e.g., 178) <04TL5011>. Ph N Ph
CO2Et
171 (20 mol%)
Ph
N
toluene 45°C 76 h
CO2Et
Ph
OMe
Ph
Me
CO2Et
N
Ph
CO2Et
CO2Et
172
CO2Et
Me
173
OMe
174 76% yield dr = 1.3:1
N Ph
N Zn Cl Cl
Ph
171
NTs Et3OBF4
+ 126
CN
Ph
N 67% yield
CH2Cl2 25°C
NTs
175
176
Me Me Me
H
N H Ts 177
Et3OBF4
Me NTs
CH2Cl2 0°C
75% yield
178
The (salen)chromium complex 179 was shown to promote the insertion of carbon dioxide into aziridines (e.g., 180) to yield the corresponding oxazolidinones (e.g., 181), whereby the substrate is treated with CO2 under high pressure (Parr reactor) in the presence of catalytic quantities of 179 and dimethylaminopyridine (DMAP) <04OL2301>. Considerably milder conditions have been reported independently, in which lithium bromide serves as catalyst in a medium of Nmethylpyrrolidone (NMP). For example, aryl aziridine 182 was converted to oxazolidinone 183 in 79% yield over 24 hours. Use of the more polar and higher boiling solvent allows for delivery of CO2 using a balloon at atmospheric pressure. Electron-donating substituents tend to accelerate the reaction <04TL1363>.
77
Three-membered ring systems (2004)
N
N
N Pr
Cr t-Bu
O
O
t-Bu
Cl t-Bu
N
DMAP (2 mol%) CH2Cl2 100°C, 2 h
O
180
t-Bu
NTs
Ts N
LiBr (20 mol%)
MeO
CO2 (1 atm) NMP 100°C, 24 h
182
Ph Ph
P
(CO)2Cl Rh Ph P Ph
Ph
Ph Ph
O
79% yield
P
(CO)2Cl Rh Ph P Ph
O
HN
N
O
N O
Ph
181
183
N
Ph P Cl(OC)2Rh
O
75% yield
179
MeO
Pr
179 (5 mol%) CO2 (400 psi)
NH
N
P
P Ph
Ph O
Ph P Ph Rh(CO)2Cl Ph
NH
O
184
t-Bu N
CO (400 psi)
Ph
t-Bu N
benzene
Ph 185
O 186 99% yield
In a similar vein, a resin-supported rhodium-complexed dendrimer 184 has been shown to promote the carbonylative ring expansion of aziridines to β-lactams, as illustrated by the conversion of the N-t-butyl aziridine 185 to the corresponding lactam 186 in almost quantitative yield. The supported catalyst, which shows reactivity comparable to the solution-phase variety, is easily recovered by filtration and exhibits no significant loss of activity upon recycling.
78 3.1.4
A. Padwa and S. Murphree
REFERENCES
04ACR488 04ACR497 04ACR611 04ACR645 04AGE84 04AGE615 04AGE1460 04AGE3952 04AGE4950 04CC554 04CC582 04CC608 04CC1076 04CC2060 04CC2234 04CL304 04CL764 04COC149 04H(62)635 04HCA227 04JA18 04JA1360 04JA1612 04JA2294 04JA5086 04JA6844 04JA6870 04JA6895 04JA8664 04JA11156 04JA12250 04JA13608 04JOC689 04JOC1409 04EJOC1464 04JOC2099 04EJOC2151 04EJOC2160 04EJOC3597 04EJOC3820 04JOC3453 04JOC3558 04JOC3595 04JOC5676 04JOC5974
Y. Shi, Acc. Chem. Res. 2004, 37, 488. D. Yang, Acc. Chem. Res. 2004, 37, 497. V. K. Aggarwal, C. L. Winn, Acc. Chem. Res. 2004, 37, 611. D. V. Deubel, G. Frenking, P. Gisdakis, W. A. Herrmann, N. Rösch, J. Sundermeyer, Acc. Chem. Res. 2004, 37, 645. M. Bandini, P. G. Cozzi, P. Melchiorre, A. Umani-Ronchi, Angew. Chem. Int. Ed. 2004, 43, 84. C. Rameshkumar, R. P. Hsung, Angew. Chem. Int. Ed. 2004, 43, 615. A. Armstrong, Angew. Chem. Int. Ed. 2004, 43, 1460. S. K. Kim, E. N. Jacobsen, Angew. Chem. Int. Ed. 2004, 43, 3952. J. Chen, C. -M. Che, Angew. Chem. Int. Ed. 2004, 43, 4950. S. Bhattacharjee, J. A. Anderson, J. Chem. Soc., Chem. Commun. 2004, 554. Y. Liu, K. Murata, M. Inaba, J. Chem. Soc., Chem. Commun. 2004, 582. S. L. H. Rebelo, M. M. Q. Simões, M. Graça P. M. S. Neves, A. M. S. Silva, J. A. S. Cavaleiro, J. Chem. Soc., Chem. Commun. 2004, 608. B. R. Bellenie, J. M. Goodman, J. Chem. Soc., Chem. Commun. 2004, 1076. K. Omura, T. Uchida, R. Irie, T. Katsuki, J. Chem. Soc., Chem. Commun. 2004, 2060. D. M. Hodgson, B. Stefane, T. J. Miles, J. Witherington, J. Chem. Soc., Chem. Commun. 2004, 2234. A. R. Khosropour, M. M. Khodaei, K. Ghozati, Chem. Lett. 2004, 33, 304. X. -Q. Yu, A. Hirai, M. Miyashita, Chem. Lett. 2004, 33, 764. D. J. Ramón, M. Yus, Curr. Org. Chem. 2004, 8, 149. A. C. Schmitt, C. M. Smith, E. A. Voight, G. A. O'Doherty, Heterocycles 2004, 62, 635. P. Müller, D. Riegert, G. Bernardinelli, Helv. Chim. Acta 2004, 87, 227. S. H. Wang, B. S. Mandimutsira, R. Todd, B. Ramdhanie, J. P. Fox, D. P. Goldberg, J. Am. Chem. Soc. 2004, 126, 18. L. P. C. Nielsen, C. P. Stevenson, D. G. Blackmond, E. N. Jacobsen, J. Am. Chem. Soc., 2004, 126, 1360. A.L. Williams, J.N. Johnston, J. Am. Chem. Soc. 2004, 126, 1612. P. D. Pohlhaus, R. K. Bowman, J. S. Johnson, J. Am. Chem. Soc. 2004, 126, 2294. I. D. G. Watson, S. A. Styler, A. K. Yudin, J. Am. Chem. Soc. 2004, 126, 5086. T. Ooi, D. Ohara, M. Tamura, K. Maruoka, J. Am. Chem. Soc. 2004, 126, 6844. D. M. Hodgson, C. D. Bray, N. D. Kindon, J. Am. Chem. Soc., 2004, 126, 6870. R. J. Madhushaw, M. -Y. Lin, S. Md. Abu Sohel, R. -S. Liu, J. Am. Chem. Soc. 2004, 126, 6895. D. M. Hodgson, Y. K. Chung, J. -M. Paris, J. Am. Chem. Soc. 2004, 126, 8664. L. Zhao, B. Han, Z. Huang, M. Miller, H. Huang, D. S. Malashock, Z. Zhu, A. Milan, D. E. Robertson, D. P. Weiner, M. J. Burk, J. Am. Chem. Soc. 2004, 126, 11156. D. M. Hodgson, M. J. Fleming, S. J. Stanway, J. Am. Chem. Soc., 2004, 126, 12250. A. E. Lurain, A. Maestri, A. R. Kelly, P. J. Carroll, P. J. Walsh, J. Am. Chem. Soc. 2004, 126, 13608. R. -H. Fan, X. -L. Hou, L. -X. Dai, J. Org. Chem. 2004, 69, 689. A. Solladié-Cavallo, M. Roje, R. Welter, V. Sunjic, J. Org. Chem. 2004, 69, 1409. H. -J. Gais, G. S. Babu, M. Günter, P. Das, Eur. J. Org. Chem. 2004, 1464. M. Pineschi, F. Del Moro, P. Crotti, V. Di Bussolo, F. Macchia, J. Org. Chem. 2004, 69, 2099. O. Equey, E. Vrancken, A. Alexakis, Eur. J. Org. Chem. 2004, 2151. S. Gil, M. Torres, N. Ortúzar, R. Wincewicz, M. Parra, Eur. J. Org. Chem. 2004, 2160. A. K. Chakraborti, S. Rudrawar, A. Kondaskar, Eur. J. Org. Chem. 2004, 3597. S. Stamm, H. Heimgartner, Eur. J. Org. Chem. 2004, 3820. B. B. Wentzel, P. L. Alsters, M. C. Feiters, R. J. M. Nolte, J. Org. Chem. 2004, 69, 3453. S. -M. Lu, H. Alper, J. Org. Chem. 2004, 69, 3558. P. C. Bulman Page, D. Barros, B. R. Buckley, A. Ardakani, B. A. Marples, J. Org. Chem. 2004, 69, 3595. G. R. Dake, M. D. B. Fenster, M. Fleury, B. O. Patrick, J. Org. Chem. 2004, 69, 5676. Y. Dajaegher, N. De Kimpe, J. Org. Chem. 2004, 69, 5974.
Three-membered ring systems (2004) 04JOC6377 04JOC7700 04OL59 04OL197 04OL1543 04OL1597 04OL1907 04OL2173 04OL2301 04OL2377 04OL3119 04OL3509 04OL3573 04OL4109 04OL4187 04OL4367 04PAC557 04PAC603 04SC85 04SC1337 04SC2393 04SL271 04SL525 04SL639 04SL846 04SL983 04SL1011 04SL1083 04SL1610 04SL1691 04SL1719 04T525 04T1175 04T2701 04T3611 04T3637 04T8073 04T8957 04TL49 04TL747 04TL1137 04TL1211 04TL1283 04TL1363 04TL1589 04TL1845 04TL3965
79
A. Padwa, A. C. Flick, C. A. Leverett, T. Stengel, J. Org. Chem. 2004, 69, 6377. L. Ming-Yuan, R. J. Madhushaw, R. -S. Liu, J. Org. Chem. 2004, 69, 7700. Y. G. Abashkin, S. K. Burt, Org. Lett. 2004, 6, 59. D. Colantoni, S. Fioravanti, L. Pellacani, P. A. Tardella, Org. Lett. 2004, 6, 197. P. C. Bulman Page, B. R. Buckley, A. J. Blacker, Org. Lett. 2004, 6, 1543. W. -K. Chan, P. Liu, W. -Y. Yu, M. -K. Wong, C. -M. Che, Org. Lett. 2004, 6, 1597. R. Vyas, G. -Y. Gao, J. D. Harden, X. P. Zhang, Org. Lett. 2004, 6, 1907. G. Bartoli, M. Bosco, A. Carlone, M. Locatelli, M. Massaccesi, P. Melchiorre, L. Sambri, Org. Lett. 2004, 6, 2173. A. W. Miller, S. T. Nguyen, Org. Lett. 2004, 6, 2301. D. Morton, D. Pearson, R. A. Field, R. A. Stockman, Org. Lett. 2004, 6, 2377. A. Murphy, A. Pace, T. D. P. Stack, Org. Lett. 2004, 6, 3119. A. Denichoux, F. Ferreira, F. Chemla, Org. Lett. 2004, 6, 3509. D. Leca, A. Toussaint, C. Mareau, L. Fensterbank, E. Lacôte, M. Malacria, Org. Lett. 2004, 6, 3573. H. Han, I. Bae, E. J. Yoo, J. Lee, Y. Do, S. Chang, Org. Lett. 2004, 6, 4109. D. M. Hodgson, N. J. Reynolds, S. J. Coote, Org. Lett. 2004, 6, 4187. T. Matsumoto, H. Masu, K. Yamaguchi, K. Takeda, Org. Lett. 2004, 6, 4367. Y. D. Y. L. Getzler, V. Mahadevan, E. B. Lobkovsky, G. W. Coates, Pure Appl. Chem. 2004, 76, 557. A. Caiazzo, S. Dalili, C. Picard, M. Sasaki, T. Siu, A. K. Yudin, Pure Appl. Chem. 2004, 76, 603. G. Righi, S. Catullo, Synth. Commun. 2004, 34, 85. U. K. Nadir, A. Singh, Synth. Commun. 2004, 34, 1337. G. Huerta, G. Contreras-Ordoñez, C. Alvarez-Toledano, V. Santes, E. Gómez, R. A. Toscano, Synth. Commun. 2004, 34, 2393. M. D'hooghe, N. De Kimpe, Synlett 2004, 271. M. L. Kantam, V. Neeraja, B. Kavita, Y. Haritha, Synlett 2004, 525. S. Muthusamy, C. Gunanathan, M. Nethaji, Synlett, 2004, 639. P. -Q. Zhao, L. -W. Xu, C. -G. Xia, Synlett 2004, 846. F. Chemla, F. Ferreira, Synlett 2004, 983. A. Fernández-Mateos, L. M. B. R. Rabanedo Clemente, A. I. R. Silvo, R. R. González, Synlett 2004, 1011. S. Fioravanti, A. Morreale, L. Pellacani, P. A. Tardella, Synlett 2004, 1083. D. M. Hodgson, E. H. M. Kirton, Synlett 2004, 1610. C. -H. Ding, L. -X. Dai, X. -L. Hou, Synlett 2004, 1691. G. D. Kishore Kumar, S. Baskaran, Synlett 2004, 1719. E. T. Farinas, M. Alcalde, F. Arnold, Tetrahedron, 2004, 60, 525. L. De Vitis, S. Florio, C. Granito, L. Ronzini, L. Troisi, V. Capriati, R. Luisi, T. Pilati, Tetrahedron 2004, 60, 1175. X. E. Hu, Tetrahedron 2004, 60, 2701. D. M. Hodgson, C. R. Maxwell, T. J. Miles, E. Paruch, I. R. Matthews, J. Witherington, Tetrahedron, 2004, 60, 3611. M. D'hooghe, I. Kerkaert, M. Rottiers, N. De Kimpe, Tetrahedron 2004, 60, 3637. S. Fioravanti, M. Gabriella Mascia, L. Pellacani, P. A. Tardella, Tetrahedron 2004, 60, 8073. V. Maslak, R. Matovic, R. N. Saicic, Tetrahedron, 2004, 60, 8957. T. Ollevier, G. Lavie-Coupin, Tetrahedron Lett. 2004, 45, 49. L. Bohé, M. Kammoun, Tetrahedron Lett. 2004, 45, 747. B. A. Bhanu Prasad, G. Pandey, V. K. Singh, Tetrahedron Lett. 2004, 45, 1137. W. Medjahed, A. T. Zatla, J. K. Mulengi, F. Z. Baba Ahmed, H. Merzouk, Tetrahedron Lett. 2004, 45, 1211. B. Kaboudin, H. Norouzi, Tetrahedron Lett. 2004, 45, 1283. A. Sudo, Y. Morioka, F. Sanda, T. Endo, Tetrahedron Lett. 2004, 45, 1363. L. G. Arini, A. Sinclair, P. Szeto, R. A. Stockman, Tetrahedron Lett. 2004, 45, 1589. S. Arai, K. Tokumaru, T. Aoyama, Tetrahedron Lett. 2004, 45, 1845. H. -L. Kwong, D. Liu, K. -Y. Chan, C. -S. Lee, K. -H. Huang, C. -M. Che, Tetrahedron Lett. 2004, 45, 3965.
80 04TL4193 04TL4405 04TL5011 04TL5069 04TL5073 04TL5347 04TL5359 04TL5991 04TL6003 04TL6357 04TL7201 04TL7355 04TL7495 04TL7749
A. Padwa and S. Murphree J. D. Ha, E. Y. Shin, S. K. Kang, J. H. Ahn, J. -K. Choi, Tetrahedron Lett. 2004, 45, 4193. Y. Cai, H. -S. Dang, B. P. Roberts, Tetrahedron Lett. 2004, 45, 4405. S. C. Bergmeier, S. J. Katz, J. Huang, H. McPherson, P. J. Donoghue, D. D. Reed, Tetrahedron Lett. 2004, 45, 5011. T. Geller, C. M. Krüger, H. -C. Militzer, Tetrahedron Lett. 2004, 45, 5069. J. -M. Lopez-Pedrosa, M. R. Pitts, S. M. Roberts, S. Saminathan, J. Whittall, Tetrahedron Lett. 2004, 45, 5073. G. J. Rowlands, W. K. Barnes, Tetrahedron Lett. 2004, 45, 5347. S. Rodríguez, A. Vidal, J. J. Monroig, F. V. González, Tetrahedron Lett. 2004, 45, 5359. A. Padwa, T. Stengel, Tetrahedron Lett. 2004, 45, 5991. A. F. Khlebnikov, M. S. Novikov, A. A. Amer, Tetrahedron Lett. 2004, 45, 6003. J. T. W. Kan, P. H. Toy, Tetrahedron Lett. 2004, 45, 6357. J. A. Ciaccio, M. Smrtka, W. A. Maio, D. Rucando, Tetrahedron Lett. 2004, 45, 7201. J. Boruwa, J. C. Borah, B. Kalita, N. C. Barua, Tetrahedron Lett. 2004, 45, 7355. J. R. Rodríguez, A. Navarro, Tetrahedron Lett. 2004, 45, 7495. F. Carrée, R. Gil, J. Collin, Tetrahedron Lett. 2004, 45, 7749.
81
Chapter 3.2
Three-membered ring systems (2005) Stephen C. Bergmeier and Damon D. Reed Department of Chemistry & Biochemistry, Ohio University, Athens, OH, USA
[email protected] and
[email protected]
3.2.1 INTRODUCTION Three-membered heterocyclic ring systems continue to receive attention from organic chemists. These heterocyclic ring systems provide a useful combination of reactivity, utility and stability. This review is not a comprehensive review but rather covers a selection of interesting and synthetically useful transformations. Some themes that have emerged in the past year include the use of supported reagents, aqueous reactions and solvent free reactions. The organization of this chapter follows that of previous years. Several reviews on specific topics in aziridine or epoxide chemistry have been published in the past year. Two recent reviews have focused on advances in the metal catalyzed asymmetric epoxidation. One review focuses on Cr and Mn(salen) complexes <05CRV1563>. The other review focuses on the broader topic of homogenous and heterogeneous asymmetric epoxidation reactions <05CRV1603>. The coverage of these reviews is roughly to the end of 2004. A review on the use of chiral auxiliaries in epoxidation reactions has been published <05SL1047>. The review focuses on the epoxidation of several select substrates. The use of enzymatic transformations including the opening of epoxides has been reviewed <05MI181>. A recent review has covered asymmetric ring opening reactions of epoxides <05MI1>. The synthesis and reactions of lithiated epoxides has been the subject of a recent review <05SL1359>. A review on the synthesis of α,β-diamino acids that covers some syntheses from aziridines has been published <05CRV3167>. 3.2.2 EPOXIDES 3.2.2.1 Preparation of Epoxides The development of methods for metal-catalyzed epoxidations continues at a rapid pace. Mechanistic studies of the Jacobsen-Katsuki epoxidation have rationalized the enantioselectivity as arising from a competition of approach vectors <05JA13672>. The development of Mn-catalyzed epoxidation methods have provided useful methods for the stereocontrolled epoxidation of olefins. Evidence for a peroxy-Mn complex as a key intermediate in high valent manganese catalyzed epoxidations has been proposed <05JA17170>. From a synthetic perspective, a Mn-porphyrin catalyst has been developed for erythroselective epoxidations <05JOC4226>. This epoxidation catalyzed by Mn-porphyrin is highly
82
S.C. Bergmeier and D.D. Reed
substrate dependent. As shown below, reaction of 1 with Mn(2,6-Cl2TPP)Cl and oxone provides a reasonable yield of erythro-2 when R = COOMe. However, when R = OTBS or OAc the yields drop precipitously. R Mn(2,6-Cl2TPP)Cl, oxone, NH4OAc Ph
O
CH3
1
Ph
R
O CH3
R
Ph
erythro-2 6 R = CO2Me, 70% yield R = OTBS, <5% yield 1 R = OAc, 35% yield
CH3 threo-2 1 1
The use of Ru catalysts for selective epoxidations has also been explored. The Ru(2,6Cl2TPP)CO catalyst with dichloropyridine N-oxide as the stoichiometric oxidant provides good levels of stereocontrol for the synthesis of threo-amino epoxides, 4 <05MI29>. The use of the manganese system, Mn(2,6-Cl2TPP)Cl, on amine 3 provides a 1.4:1 mixture of the 4erythro: 4-threo isomers in 88% yield after 1 hour <05JOC4226>. BocHN Ph
O
BocHN
Cl2PyNO, Ru(2,6-Cl2TPP)CO
Ph
3
32% yield >99% threo 4
The epoxidation of olefins has been reported using an interesting tri-pyridyl catalyst 7 <05OL987>. Yields of the corresponding epoxides are generally quite high. An advantage of this epoxidation system is the use of hydrogen peroxide as oxidant. Chiral Ru analogs of 7 were used to carry out asymmetric epoxidations in which the ee reached only 54%.
N O 5
30% H2O2 t-AMOH 7, 0.005 eq.
N
O
O
O
N
N
N Ru
O
O
O 6 81% yield
O
O 7
Methyltrioxorhenium (MTO) has proven to be a useful oxidant for a number of reactions. A problem with the use of MTO in epoxidation is the acidity of the reagent, which leads to diol formation. Several different methods have previously been reported in an attempt to solve this problem. The use of microencapsulated Lewis base adducts of MTO appears to be a good solution <05T1069>. Another modification of MTO is (PPh3)2[Re(NCS)6] with H2O2 as an oxidant <05TL339>. Janda and co-workers have found that the enantioselectivity of the Sharpless epoxidation reaction can be reversed when utilizing a tartrate ester of polyethylene glycol <05JOC1728>. The work described here is based on earlier reports <02CC118, 04JOC2042> in which conflicting results were obtained with PEG-tartrate esters. In the current study, the molecular weight of the polyethylene glycol used has a significant effect on which epoxide enantiomer is produced. Using the usual Sharpless epoxidation conditions on alcohol 8, the (2S,3S)
83
Three-membered ring systems (2005)
enantiomer, 9, was obtained in 96% ee. A number of polyethylene glycol esters of tartaric acid were then prepared and used in the epoxidation reaction. Polyethylene glycol up to a MW of 350 all gave the expected epoxide, 9. A polyethylene glycol of MW 550 gave an epoxide with an ee of only 5%, while the next higher MW polyethylene glycol, MW 750, gave epoxide 10 with an ee of 67%. Increasing the size of the polyethylene glycol to MW 2000 gave 10 in 75% ee. The rationale for this change in the preferred enantiomer is not clear but the authors have hypothesized that it may be due to a change in aggregation of the ligand to the metal. O
O
L-DIPT, 96% ee OH
OH 9
PEG-DIPT, MW 350 75% ee
OH
8
10 PEG-DIPT, MW 2000 75% ee
A method for the polymer supported epoxidation of olefins has been reported <05TL1643>. The resin supported phthalate, 11, was oxidized to peracid 12 through oxidation with H2O2 or a urea-H2O2 complex. The reaction was most conveniently carried out by mixing 11, the urea-H2O2 complex and the olefinic substrate. Simple filtration then provides a wide variety of epoxides in excellent yield. This reagent system provides all of the typical advantages of supported reagents as well as an improved safety profile of the supported peracid. O O
nO
11
R2
R1 13
O
O
30% H2O2 or O urea-H2O2 complex O
O 1) 11, urea-H2O2 complex 2) filtration R1 14
O n
O
CO2H O
12
OH
O
R2
R1 n-C6H13 Ph Ph CH2OH
Yields(%) R2 95 H 75 H 80 CH2OH 90 H
Walsh and co-workers have developed a one-pot method for the synthesis of hydroxyepoxides via an initial synthesis of an allylic alcohol followed by an asymmetric epoxidation <05JOC1262, 05JA14668, 05JA16416>. This reaction provides an improvement in overall yields over the typical kinetic resolution reaction. The method involves an initial asymmetric addition to the aldehyde followed by a diastereoselective epoxidation reaction. O O H 15
O
OH
ZnEt2, Ti(OiPr)4, O2, 17 16
90% yield 99% ee 20:1 dr (erythro:threo)
N OH 17
Several methods for the epoxidation of α,β-unsaturated carbonyl compounds have been reported. The use of amino acid derivatives or peptides as chiral ligands for epoxidation continues to be an active area of investigation. The use of silica bound poly-L-leucine, 21, with sodium percarbonate appears to be an excellent route to enantiomerically pure keto
84
S.C. Bergmeier and D.D. Reed
epoxides, 19 <05TL5665>. Interestingly, the diphenylprolinol/t-BuOOH system 22, provides enantioenriched ketoepoxides of opposite configuration, 20, albeit with lower enantiomeric excess <05OL2579>. The use of the related 3,5-(CF3)2Ph prolinol catalyst 23 with H2O2 as oxidant provides epoxy aldehyde 19 (R1 = Ph, R2 = H) in excellent yield and enantiomeric excess <05JA6964>. Significantly this is one of the few routes to epoxy aldehydes. O
O Catalyst
R1
R2 19 (2S,3R)
O R1
or
R2 18
O
Yields R1 = R2 = Ph, 94% yield, 93% ee (2S,3R) R1 = R2 = Ph, 72% yield, 75% ee (2R,3S) R1 = Ph, R2 = H, 80% yield, 96% ee (2S,3R) R1 = R2 = Ph, 95% yield, 99% ee (2S,3R) R1 = R2 = Ph, 99% yield, 97.6% ee (2R,3S)
21 22 23 24 25
O
R1
R2 20 (2R,3S)
CF3 Si-AMP-(L-Leu)n, Na2CO4 21
HN HO
OCH3 Br
N
N
HN
t-BuOOH 2
Ph
TMSO 22
F
O H
N
2
23
Br
O H
H2O2 CF3
OCH3
N
H2O2 24
HO HO
OH OH La(Oi-Pr)3, Ph3PO 25
The use of a variety of chiral catalysts for the asymmetric epoxidation of α,β-unsaturated ketones has produced some interesting results. The use of a bis-quinoline catalyst, 24, and H2O2 as oxidant provides the desired epoxide 19 <05AG(I)1383>. A heterogeneous version of Shibasaki’s BINOL catalyst provides a very nice method to overcome some of the disadvantages inherent in the use of polymer supported version of the BINOL catalysts <05AG(I)6362>. The heterogeneous catalyst 25 provided (2R,3S)-epoxide 20 in excellent yield and with high enantioselectivity. The use of polyethylene glycol supported BINOL catalyst for example, provides the expected epoxide in good yield but with only 45% ee <05MI59>. The Baylis-Hillman reaction is a highly useful and general method for the synthesis of allylic alcohols. A method to convert the product of a Baylis-Hillman reaction to an epoxidized α,β-unsaturated ketone has been reported <05TL8895>. Iodosobenzene and KBr
Three-membered ring systems (2005)
85
initiate the reaction through the oxidation of the allylic alcohol to ketone 27. The resulting α,β-unsaturated ketone is then epoxidized with PhIO. OH CO2Me
Ph
O
PhIO, KBr
CO2Me
Ph
26
O
PhIO
CO2Me O
Ph
27
85% yield
28
The epoxidation of gem-deactivated olefins is a vexing problem in organic chemistry. While the epoxidation of α,β-unsaturated carbonyl compounds is well studied, the inclusion of an additional electron stabilizing group makes epoxidation much more difficult. The use of m-CPBA/K2CO3 provides an excellent solution to this problem in the epoxidation of the sulfone ester 29 <05JOC4300>. O
O TolO2S
m-CPBA, K2CO3
O 29
TolO2S
OEt
O
O
30
OEt
77% yield
A report on selective epoxidations of α,β-unsaturated carboxylates that uses the hydrophobicity of the substrate and reagent to provide largely a single product <05JA10812>. Reaction of a mixture of two carboxylates, 31 and 32, with oxaziridine 33 provides 34 as the major product. While this is a mechanistic study and reactions were carried out to only 5% completion, it does suggest that high levels of chemoselectivity can be accomplished through hydrophobic interactions between reagent and substrate. BF4 O
O Ph
O
+ H3C
31
O 32
33 oxone D2O
N CH3 O
O
O
O
Ph
O
H3C
98.1 34
O O
1.9 35
The selective capture of one isomer of interconverting allylic azides by epoxidation has been investigated <05JA13444>. Allylic azides 36 and 37 exist as a 70:30 equilibrium mixture. Upon treatment with m-CPBA, one isomer, 36, can be captured as the epoxide 38. As might be expected, the more substituted double bond of the mixture is epoxidized. N3
N3
m-CPBA, K2CO3, H2O
O N3
(70:30) 36
37
85% yield
38
A very interesting sulfur ylide approach to epoxides has been reported <05JOC4166>. In this method, a catalytic amount (10 – 20 mol%) of a C2 symmetric thiolane, 40, with a controlled topology is used to generate ylide 41. Reaction with an aryl aldehyde provides epoxide 42 via a catalytic transfer of benzylidene in generally excellent yields with good ee.
86
S.C. Bergmeier and D.D. Reed
A Darzens reaction has been used to generate trans-epoxides <05SL842>. Reaction of electron deficient p-substituted benzylammonium chlorides with benzaldehyde provides the trans-epoxide 46 in excellent to moderate yield as a 99:1 mixture of trans:cis epoxides.
O
O CHO
O
O
O
200 mol% BnBr NaOH
Ph
S 42
S 39
66% yield trans/cis 90:10 R,R/S,S 97.5:2.5
40 41
N
Cl
O
N
KOt-Bu, PhCHO
N
Ph
N
F3C
46 F3C
43
100% yield
CF3
44 45
The ring closure of halohydrins to form epoxides is a well known reaction. The ability to generate enantiopure halohydridns has been addressed through a biocatalytic approach <05MI1827>. The biocatalytic hydrogen-transfer reduction of prochiral α-chloroketones has been reported using lyophilized cells of Rhodococcus ruber DSM 44541 to provide chlorohydrin 48 in 99% conversion and with 99% ee. A subsequent cyclization reaction then provides epoxide 49. A strategy that uses whole cells of R. ruber as a base stable biocatalyst at pH >12 yields the epoxide in a single step, again with 99% conversion and 99% ee. O Cl
OH C6H13
47
R. ruber lyophilized cells pH 7.5, 30 ˚C
Cl
C6H13 48
KOH pellets pH > 12 30 ˚C
O
H C6H13 49
R. ruber lyophilized cells KOH pellets, pH ~13 30 ˚C
Enzymatic approaches to epoxidation are potentially quite powerful in that they avoid harsh reaction conditions and can provide high levels of enantioselectivity. Monooxygenases catalyze the activation of molecular oxygen and its addition to a variety of substrates. Monooxygenases are cofactor-dependent enzymes which restrict their use in epoxidation reactions. The use of direct electrochemical regeneration of monooxygenases appears to be a solution to the use of these enzymes in epoxidation reactions <05JA6540>. This approach uses the FADH2-dependent oxygenase component (StyA) of styrene monooxygenase (StyAB) from Pseudomonas sp. VLB120 coupled with cathodic reoxidation to epoxidize a series of styrene derivatives with excellent enantioselectivities.
87
Three-membered ring systems (2005)
A problem with enzymatic reaction systems is the inherent substrate specificity of the enzyme. An interesting approach to enzymatic epoxidation has been reported that overcomes this limitation <05T6009>. This approach combines the in situ enzymatic generation of H2O2 with the broad substrate specificity of a catalytic chemical system. Glucose oxidase catalyzes the conversion of β-D-glucose to gluconolactone and H2O2. Reaction of an olefin with glucose oxidase provides the epoxide through reaction with the generated H2O2. Both water soluble olefins as well as hydrophobic olefins such as 50 can be epoxidized. Hydrophobic olefins require the use of an additive such as t-BuOH or SDS to solubilize the olefin in the reaction medium. The enzyme has been immobilized on silica gel as well. glucose oxidase 0.2 M glucose, O2 pH 7.0 phosphate 50 Additive 10% t-BuOH 5 mM SDS
O
51 % Conversion 45 65
3.2.2.2 Reactions of Epoxides The reactions of epoxides are largely exemplified by nucleophilic attack on the epoxide ring. Both carbon and heteroatom nucleophiles are widely used. The use of carbon nucleophiles provides an excellent route for the preparation of highly substituted alcohols. The literature is replete with examples of organolithium and Grignard reagents used to open epoxides. In recent years the use of additional metals (e.g. B, Al, Ti, Pd) to modulate the ring opening in interesting and useful ways has been reported. The reaction of cyclohexene oxide with aryllithium reagents in the presence of both a Lewis acid (BF3•OEt2) and a Lewis base (sparteine) provides the ring opened product in excellent yields with moderate enantioselectivity <05EJO1354>. Reaction always occurs at the (S)-carbon of the oxirane. Other meso-epoxides gave excellent yields but with a lower enantioselectivity. H N O
N OH H
ArLi, BF3•OEt2 52
Ar = 2-Me-Phenyl, 91% yield, 65% ee Ar = 4-OMe-Phenyl, 95% yield, 40% ee Ar = 3-CF3-Phenyl, 90% yield, 60% ee
Ar 53
Regiocontrol in the ring opening of unsymmetrical epoxides is synthetically important. The ring opening of epoxides at the more substituted carbon is generally difficult yet potentially valuable synthetic transformation. The use of titanium reagents provides one solution to this problem.
88
S.C. Bergmeier and D.D. Reed
OMOM
ClTi(OPh)3
O
HO OMOM
MgCl 54
55 O
ClTi(OPh)3 MgCl
t-BuO2C
46% yield
49% yield OH
t-BuO2C
56
57
The reaction of a wide variety of functionalized epoxides containing esters, amides and acetals with chlorotitanium triphenoxide and allylmagnesium chloride provides exclusive reaction at the more substituted carbon <05T6726>. The use of protected chiral epoxides, 54 and 56, with the same reagent system provides a facile route into chiral quaternary centers, 55 and 57. The use of organoaluminum reagents also provides a useful solution to the regioselective ring opening of epoxides <05TL797>. The use of diethylpropynylalane with diastereomeric epoxides will provide different ring-opened products depending on the relative stereochemistry of the alcohol and epoxide. The anti-hydroxy epoxide, 58, leads to nucleophilic ring-opening at the carbon distal to the alcohol to provide 59. The syn-hydroxy epoxide, 60, provides the product of nucleophilic ring opening at the proximal carbon of the epoxide providing 61 in 39% yield.
AlEt2 TIPSO OH
78% yield 89:11
TIPSO
O
OH
OH
59
58
OH AlEt2
TIPSO OH
O
39% yield 15:85
TIPSO OH
60
61
Epoxides of α,β-unsaturated ketones can undergo a ring opening/arylation reaction under Heck conditions <05JOC4720>. Epoxide 62 undergoes an initial Pd-catalyzed rearrangement to a 1,2-cyclohexanedione which then undergoes a Heck arylation reaction to form 63. O
O O
62
Pd(OAc)2, PPh3, i-Pr2NEt Δ or MW Ar Br
OH Ar
Ar = 3-(NMe2)-Ph, 71% yield Ar = 4-(CF3)-Ph, 33% yield Ar = 4-(acetyl)-Ph, 40% yield Ar = Ph, 72% yield
63
Epoxides derived from 1,6-anhydro-β-D-glucopyranose undergo a quite interesting rearrangement to generate substituted allylic alcohols <05EJO2841, 05EJO4557>. Treatment of epoxide 64 with MeLi and CuCN initiates an epoxide to allylic alcohol rearrangement to
89
Three-membered ring systems (2005)
generate intermediate 65. Intramolecular delivery of the methyl group provides the final product 66 in 92% yield.
O
O
O H
B
O
MeLi CuCN
64
O 92% yield
O OTs Li Cu Me Me 65
OTs
O
O
HO
Me 66
Control of SN2 versus SN2’ additions to vinyl epoxides continues to be of interest. The usual group of alkynyl lithium reagents generally provided a mixture of the SN2 and SN2’ products <05EJO3946>. However when lithio-ethoxyacetylene was used, the SN2 product 68 was the major product (98:2). Changing the metal to aluminum provided a shift to the SN2’ product 69 in a similar 98:2 ratio as a mixture of E and Z-isomers. OH EtO Li BF3•OEt2
OTBS
62% yield SN2/SN2' 98:2
68 OEt
OTBS
O 67
EtO
AlEt2
EtO
OH OTBS
55% yield SN2'/SN2 98:2 E/Z 70:30
69
An alternate approach to regiocontrol in the ring opening of unsaturated epoxides is found in the initial ring opening of unsaturated epoxides with a transition metal prior to a coupling reaction <05MI5260, 05TL6705>. The reaction of vinylepoxide 70 with pincer catalyst 73 and an arylboronic acid provides the SN2’ product 71 in an 11:1 ratio.
73, PhB(OH)2
O 70
Ph HO
Ph
HO
PhSe 72
71 94% yield
Pd Cl 73
SePh
Propargylic oxiranes can undergo a similar SN2’ type reaction <05TL6705>. Ring opening of oxirane 74 with palladium followed by coupling to an aryl boronic acid provides the allenic alcohol 75 as a single stereoisomer.
90
S.C. Bergmeier and D.D. Reed
Pd(PPh3)4
CH3
OH
B(OH)2
•
O
75
CH3
Ph
O
74
92% yield
Ph
Ph
Pd2(dba)3•CHCl3, dppb
54% yield O
HO
CH3
76 CH3
The reaction of the same propargylic oxirane with a different catalyst and nucleophile provides radically different product <05TL3669>. Treatment of 74 with a phenol in the presence of a Pd2(dba)3 provides 76, the product of simple addition across the triple bond. It is interesting to note that no reaction of the epoxide ring occurs. The intramolecular ring opening of oxiranes with carbon nucleophiles is an excellent method for the construction of a number of novel molecules. A tandem base-promoted ringopening/Brook rearrangement/allylic alkylation of silyl epoxides provides the silyl enol ether 81 in very good yield <05JOC10515>. Reactions in which the cyclopropane derivatives are formed have also been reported <05T3349>. O
NaHMDS
CN
t-BuMe2Si
O t-BuMe2Si
77
O t-BuMe2Si
CN
78
t-BuMe2SiO CN
79
t-BuMe2SiO
R X
R = H, 73% yield R = Me, 63% yield
CN
80
CN
81 R
The acid catalyzed rearrangement of epoxides to form an aldehyde or ketone is a useful and commonly used reaction <05TL1269, 05T2541, 05JOC10747, 05TL89, 05JOC6537>. An interesting application of this reaction involves the in situ rearrangement of an epoxide to an aldehyde followed by reaction with an allenylstannane, 84, to generate alkyne 85 <05JOC6541>. None of the products that might arise from reaction of the allenylstannane with the epoxide were observed. Fused ring epoxides (e.g. cyclohexene oxide) were unreactive. OH O O
BF3•OEt2
Ph
CHO
Bu3Sn TMS
Ph 82
83
•
N
O
O
Ph 84
Ph
TMS
Ph
85
N
Ph
79% yield syn/anti >95:5
O Ph
Another interesting variation on this common rearrangement involves trapping the intermediate oxonium ion with an external nucleophile <05TL2311>. Treatment of epoxide 86 with ZrCl4 and a homoallylic alcohol generates intermediate 87. Cyclization and trapping
91
Three-membered ring systems (2005)
of the carbocation with chloride provides the isolated product 89. A number of homoallylic alcohols and epoxides were examined to provide a number of examples of 89 in excellent yields.
O
ZrCl4
O
Ph
Ph
Ph
Ph
Ph
Ph ZrCl3
O
Ph
O
Ph
87% yield
87 86
Cl 88
HO
89
The ruthenium-catalyzed cyclization of epoxy iodoalkynes shows a very intriguing solvent dependence <05OL1745>. The authors rationalize this solvent dependence as a result of two different ruthenium intermediates. In a polar solvent such as DMF an iodovinylidene species is formed followed by attack of the epoxide oxygen to eventually lead to naphthalene 91 in 88% yield. A nonpolar solvent such as benzene favors the formation of a p-iodoalkyne ruthenium species. Attack of this species by the epoxide oxygen leads to formation of oxepin derivative 92 in 78% yield. O TpRuPPh3(CH3CN)2PF6
O OH
90
I DMF (yields) Benzene (yields)
I 91 88% 12%
I 92 1% 78%
Radical cyclizations of epoxides initiated by Ti are versatile reactions for the formation of carbocycles and heterocycles <05JA14911>. While not truly a nucleophilic ring opening, these reactions provide similar products as a typical nucleophile ring opening reaction. The titanium-catalyzed intramolecular cyclization of 93 was studied <05S1405>. The use of sulfoximines and phosphine oxides as the leaving group (LG) were examined. The sulfoximines proved to be more difficult to prepare and gave poorer yields in the cyclization reaction than the corresponding phosphine oxides. Ts N
O
R2
LG 93
R
1
O LG = R1 = R2 = Me 40% yield S TsN p-Tol
Ts N
Cp2TiCl2, Mn HO 94
R1
R2
O P LG = Ph Ph
R1 = R2 = Me 80% yield
The metal catalyzed ring opening of epoxides followed by reaction with CO or CO2 to form β-lactones and carbonates is a useful reaction that continues to attract attention. In an expansion of previous work, Coates and co-workers have developed an improved catalyst, 99, for the carbonylation of epoxides <05JA11426>. These reaction conditions are compatible with a wide variety of side chains, including those bearing Lewis basic functionality. Interestingly, the cyclopentene oxide 97 was readily converted to the β-lactone 98 in excellent yield.
92
S.C. Bergmeier and D.D. Reed
O O
O
99, 900 psi CO
O
R R
95
96 R = Et, 99% yield R = t-Bu, 99% yield R = CH2OTBS, 99% yield R = CH2OCH2CHCH2, 88% yield R = CH2OAc, 99% yield
N
N Cr N
N
O
O
99, 900 psi CO 99% yield
O
O 98
97
Co(CO)4
99, [(OEP)Cr(THF)2][Co(CO)4]
An interesting reaction for the synthesis of cyclopropanes makes use of a tungsten carbonyl compound as the electrophile <05JOC5852>. An initial conjugate addition of lithiated epoxide 101 onto tungsten carbonyl 102 leads to intermediate 103, which then does an intramolecular ring opening of the epoxide to provide cyclopropane 104. H3CO
O
W(CO)5 O
Ph 100
s-BuLi, TMEDA
73% yield
O
Ph Li 101
HO Ph Ph 104
Ph
Ph
OCH3
Ph
102
103
W(CO)5
pyridine N-oxide
OCH3
HO Ph Ph 105
O
W(CO)5 Li
83% yield
OCH3
α-Lithiated epoxides constitute an alternative to carbenes for a variety of reactions. The homo-dimerization of α-lithiated epoxides has been found to provide an excellent route to 1,4-diols <05OL2305>. R
O
OH LTMP
R
R 106
107
OH
R = t-Bu, 86% yield R = CH2OTr, 51% yield R = cC6H11, 51% yield (+ 26% of the cis isomer) R = n-C5H11, 43% yield (+ 19% of the cis isomer)
Vicinal amino alcohols are highly useful molecules. Vicinal amino alcohols find use as synthetic intermediates, ligands for metal catalyzed reactions, and as biologically interesting molecules. It is not surprising that considerable effort has gone into the synthesis of useful vicinal amino alcohols as well as the development of new and improved methods for their synthesis. Pericàs and coworkers have elucidated a facile and inexpensive route to determining the enantiomeric excess of primary amines. A regioselective and enantioselective epoxide ring opening of 108 with BF3 followed by lithium tert-butoxide catalyzed epoxide closure yielded 109, which was utilized as a resolution reagent. Through the use of 20 mol% of 109 relative to an amine, an ee determination could be performed on 110 via NMR without further purification <05OL3829>.
93
Three-membered ring systems (2005)
O OTs
Ph
NH2
1. BF3•OEt2 70% yield 2. t-BuOLi, THF 90-100% yield
F Ph
108
O
R1
F
R1 R2 LiClO4, THF MW, 75 °C
Ph OH 110
109
N H
R2
The microenvironment created by cyclodextrins can be used to overcome the low reactivity of epoxides. Rao and coworkers have shown that in situ formation of an epoxide/β-cyclodextrin complex in water, followed by amine addition yields regioselective epoxide openings <05SL506>. Several substituted epoxides and aromatic amines were examined with isolated yields in the range of 80-90%. NH2
O OH
Ph HN
β-CD, H2O, rt,
OH
92% yield
OH 111
112
Most methods for the ring-opening of epoxides require some type of acid catalyst. A potentially very useful ring-opening process has been reported that takes place in water and requires no catalyst <05OL3649>. In this reaction, the epoxide and amine are simply mixed in water for 5 – 24 hours and the resulting β-amino alcohol, 114, is then isolated in excellent yields. It is worth noting that aliphatic amines will preferentially react in the presence of aryl amines in this reaction system. O H2O, rt, R2
113
H N
R1
HO
R1 N R2
114
R1 R2 Yield(%) -(CH2)492 -(CH2)593 H n-Bu 84 Et Et 86
The search for improved catalytic systems for epoxide opening reactions has yielded a number of methods to improve this reaction. The use of 10 mol% of Cu(BF4)2 has been found to catalyze the ring-opening of epoxides with amines under solvent free conditions <05TL2675>. Both aliphatic and aromatic amines provide excellent yields of the β-amino alcohols. Scandium triflate has also been found to catalyze the ring-opening of epoxides with both aromatic and aliphatic amines in the absence of solvent <05TL9029>.
94
S.C. Bergmeier and D.D. Reed
O
PhNH2
R1
PhHN
R2
OH
R1
R2
O
116
115
Sm I
O 117
R1, R2 (CH2)4 (CH2)4 (CH2)4 (CH2)4 (CH2)4 Ph, Ph
Reference <05TL2675> <05TL9029> <05TL8229> <05MI93> <05OL1023> <05OL4593>
Catalyst %Yield (ee) Cu(BF4)2 97 Sc(OTf)3 92 BiCl3 89 Ce-W10O36 100 117 79 (91) 118 89 (91)
N
N
OH
HO
Sc(OSO3C12H25)3
118
The use of BiCl3 is an interesting catalyst for the opening of epoxides with aryl amines <05TL8299>. When the ring opening reaction is carried out in acetonitrile, a chlorohydrin is the primary product. Changing the solvent to cyclohexane provides excellent yields of the βamino alcohol 116. Ammonium decatungstocerate (IV) polyoxometalate has been shown to be an effective heterogeneous catalyst for the ring opening of epoxides with arylamines <05MI93>. The conversion of meso epoxides to β-amino alcohols in high enantiomeric excess continues to be a rich area of research. The samarium binol catalyst 117, generates β-amino alcohols in excellent yield with good asymmetric induction (91%) <05OL1023>. The combination of a chiral bipyridal ligand and scandium tris(dodecylsulfate), 118, provides a method to open meso epoxides in water <05OL4593>. This catalytic system provides the amino alcohols in excellent yield and with good enantioselectivity. A one-pot epoxidation/azide-opening sequence has been developed <05JA2147>. A samarium-BINOL-Ph3AsO complex is used as a catalyst for enantioselective epoxidations of α,β-unsaturated amides. Upon addition of TMSN3 a new samarium azide complex is generated which regioselectively opens the epoxide to form 120. This method has also been extended to thiols and cyanide. O
N3 Sm(O-i-Pr)3, (S)-BINOL, Ph3As=O (1:1:1) Me3SiN3, TBHP in decane, THF, MS 4A, rt
N
O N
99% yield 99% ee
OH
119
120
The syn-opening of epoxides is a challenging reaction pathway to access. The use of arylborates, 122, may provide a general non-catalyzed route to such a reaction manifold <05CC1426>. Treatment of epoxide 121 with borate 122 provides 123 in 63% yield. The reaction occurs through an initial activation of the epoxide with the boron followed by synnucleophilic attack of the phenolic oxygen. This reaction occurs with some N-Boc aziridines as well although both syn and anti-opened products are obtained. OH O O
63% yield
O BOn-Bu
OH
O 121
122
123
Three-membered ring systems (2005)
95
Carboxylic acids are well known nucleophiles for opening epoxides and aziridines. Recently the stereoselective epoxide ring opening has also been achieved via palladium catalyzed formal 1,4 addition <05TL7243>. OH
O AcOH, Pd(Ph3)4
AcO OTES
OTES Ph
Ph
Ph
67% yield 94% ds
Ph 125
124
A tandem aldol/intramolecular enol cyclization of epoxyaldehydes to form α-furyl carbinols, 127, has been reported <05TL5467>. Only isopropyl methyl ketones or t-butyl methyl ketones have been shown to work in this reaction. The corresponding N-Boc aziridine aldehyde 127 (X = N-Boc) has also been used to generate an α-amino furan in excellent yield. H
X Bu2BOTf/DIPEA, DCM, 0 °C to 25 °C
X n-Pr
CHO
O
126
n-Pr
O
X Yield (%) O 71 N-Boc 72
127
3.2.3 AZIRIDINES 3.2.3.1 Preparation of Aziridines A general solution for the formation of aziridines by addition of nitrogen across an olefin has yet to be firmly established. Several examples of the transition metal mediated aziridination of olefins have been reported in the past year. The use of the rhodium catalyst, Rh2(cap)4, TsNH2 and NBS provides a number of aziridines in good to excellent yields <05OL2787>. Another rhodium catalyst, Rh2(pfm)4, (pfm = perfluorobutyramide) has been shown to catalyze the aziridination of olefins using TsNH2 and PhI(OAc)2 <05TL4031>. An advantage of the Rh2(pfm)4 catalyst system is the reported ability to use a variety of sulfonamides (e.g. nosyl, trichloroethoxysulfonyl) in the aziridination reaction. A cobalt porphyrin catalyst system that uses bromamineT as the nitrogen source provides excellent yields of aziridines <05OL3191>. A simple copper complex has been shown to catalyze aziridination as well <05JOC4833>. This reaction system uses PhINTs as the nitrogen F source and requires a borate, NaBAr 4, to remove the anionic ligands creating a coordinatively unsaturated cationic copper species. A key feature of all of these methods is that the olefinic substrate is the limiting reagent. This is an important feature of being able to use these methods in synthetically significant settings.
96
S.C. Bergmeier and D.D. Reed Ts N
R2
R1
R1
128 Catalyst
129
R2
Yield (%)
1 mol% Rh2(cap)4, NBS, TsNH2
R1 1 mol% Rh2(pfm)4, PhI(OAc)2, TsNH2
N Rh
R1 = Ph, R2 = H, 77% = n-C4H9,
R2
= H, 77%
R1 = Ph, R2 = H, 73%
Rh2(cap)4
R1 = n-C3H7, R2 = CH3, 44% 5 mol% Co(TDClPP), bromamine T
R1 = Ph, R2 = H, 83%
5 mol% (py)2CuCl2, NaBArF4, PhINTs
R1 = Ph, R2 = H, 97%
O Rh
R1 = n-C7H15, R2 = H, 56% R1 = n-C4H9, R2 = H, 49%
A rhodium-catalyzed route to bicyclic aziridines 131 from N-tosyloxycarbamates has been reported <05JA14198>. Several olefins were tested in this intramolecular process with yields ranging between 62-79%. O O O
N H
OTs
K2CO3, Rh2(OAc)4, Acetone, 25 °C
H
O
N
79% yield 131
130
The use of N-aminophthalimide as a nitrogen source in aziridination reactions has been examined. One of the problems associated with N-aminophthalimide as a nitrogen source is the need for a strong oxidant. The use of electrochemical catalysis with N-amino phthalimide has proved to be an effective and mild route for aziridination <05JOC932>. Both electronrich and electron-poor substrates worked well in this reaction.
MeO2C O
N
+ 1.80 V (vs Ag), MeCN, rt, NEt3H+ OAcCO2Me
NH2 132
O
O
133
N
O
92% yield trans
N MeO2C
134
CO2Me
The synthesis of aziridines from imines and sulfur ylides has been reviewed in previous editions of PHC and is a well-known reaction. A current study reveals that telluronium ylides add to α,β-unsaturated imines through a Michael addition-elimination to the olefin followed by a second equivalent of telluronium ylide addition to the imine, which subsequently eliminates to form aziridines 137 and 138 in a ratio of 13:1 <05JA12222>.
97
Three-membered ring systems (2005) Ph 1. NaHMDS
Te TMS
2. Ph
N
135
Ph Ph N
Ph
Ph N
TMS
TMS
TMS
136
137
TMS
138
82% yield 137/138 13:1
A new example of the aza-Payne rearrangement has been used to prepare βhydroxyaziridines <05OL3267>. The epoxy imine 139, is prepared by a sequential epoxidation and imination. Reaction of 139 with a series of alkyl lithium reagents initially adds to the imine which then does an aza-Payne rearrangement to form the hydroxyaziridine 140. While the method generally suffers from poor yields, the one step nature of the transformation lends greatly to its appeal. OH O N
t-Bu
R-Li N
139
140
R t-Bu
R = Me, 35% yield R = n-Bu, 47% yield R = Ph, 65% yield R = PhC≡C, 33% yield
3.2.3.2 Reactions of Aziridines In the synthesis of poison-frog alkaloid (-)-205B, a three-component Linchpin coupling was used to form a complex intermediate, 144, in a single step <05OL3247>. Lithiation of 141 followed by addition of epoxide 142, warming the reaction and then addition of aziridine in THF and DME to trigger the Brook rearrangement leads to 144. 1. t-BuLi, Et2O, -78 °C → -45 °C 2. Et2O, -78 °C → -20 °C S
S
3. THF/DME, -78 °C → 0 °C
OBPS
S
N Ts O
TBS O
O
O
142
141
O
OBPS
S OTBS NHTs
53% yield 144
143
The homologation of aziridines to allylic amines is an attractive process to a very useful class of molecules. Reaction of N-protected aziridines with excess dimethylsulfonium methylide provides the homologated allylic amines in excellent yields <05OL3295>. H 3C SO2t-Bu N R
145
S CH2 (300 mol%)
NHSO2t-Bu
H 3C R
146
R = CH2OTr, 90% yield R = (CH2)2CHCH2, 99% yield R = (CH2)4Cl, 98% yield R = CH2Ph, 99% yield
98
S.C. Bergmeier and D.D. Reed
The gadolinium•149 complex was used to catalyze the enantioselective desymmetrization of an assortment of aziridines <05JA11252>. The substitution on the nitrogen was critical to obtaining optimal yields and enantioselectivity. The use of N-tosyl aziridine gave 148 in only 24% ee while changing to the p-nitrobenzoyl gave 148 with an 87% ee. Aziridines have also been opened through the use of nucleophilic catalysis <05OL3509>. Several nucleophilic catalysts were examined for the preparation of cyanoamides, 148, and the optimal choice was TMEDA (20 mol%). This represents a significant departure from the more typical acid catalysis used for aziridine ring opening.
N R 147
H N
Gd(Oi-Pr), TMSCN, 149 R = Ts, 58% yield, 24% ee R = 4-NO2-PhCO, 94% yield 87% ee or
Ph R
Ph
CN 148
P O HO
O
O
F
HO
F
149
TMEDA, KCN, R = Ts, 57% yield
1,2-Diamines are another highly useful class of molecules with potent biological activity and use as synthetic intermediates and metal ligands. The ring-opening reactions of aziridines with amines and azide provides a facile route for the synthesis of 1,2-diamines. The use of microwave induced Montmorillonite K-10 clay catalyzed opening of tosylaziridines provides an environmentally friendly route to 1,2-diamines 151 and 152 <05TL2083>. In general, these ring-opening reactions are regioselective with both arylamines and aliphatic amines participating equally well. Particularly interesting is the opening of aziridine 150 (R1 = Me, R2 = CO2Me) at the most substituted carbon to provide diamino ester 151. Ts R1 R3 Yield (%) R2 3HN 3 TsHN R NHTs NHR 97 N MW, K-10 H Me Ph R1 93 H Me PhCH R3-NH2 2 R1 R2 R1 R2 R2 PhCH2 92 H Ph 150 85 151 152 Ph Me CO2Me
Ratio (151:152) only 152 10:90 90.10 only 151
A dynamic kinetic asymmetric transformation (DYKAT) of racemic vinyl aziridine 153 yielded the enantiopure imidazolidinone 154 <05OL823>. This transformation was the initial step in a total synthesis of (+)-pseudodistomin D. (η3-C3H5PdCl)2, 155 DMB N AcOH, DCM
DMB N
O N DMB
O
O NH HN
O 153
154 O OCN
88% yield 94% ee
PPh2 Ph2P 155
The ring opening of unactivated aziridines is difficult due to the inertness of these ring systems. The use of AlCl3 to catalyze the ring opening of aziridine 156 by NaN3 has proven
99
Three-membered ring systems (2005)
surprisingly effective <05TL4407>. The authors report complete inversion at the carbon bearing the azide. Given the acidic reaction conditions, it is also interesting to note that the reaction was carried out on a several hundred gram scale without any difficulties! Me
Ph N
Ph
H
AlCl3 (cat.), NaN3, EtOH:H2O (50:50), pH 4
Me
CO2Et
N H
86% yield N3
CO2Et 156
157
The silicon β-effect has been exploited to convert aziridines to 2-imidazolines and oxazolidines <05JA16366>. This reaction presumably goes through siliranium ion 159, which can then react with an electrophile to form 160 or 161. It has also been shown that zinc dihalides are effective in catalyzing the formation of 160, but require elevated temperatures <05TL4103>. SiPh2t-Bu N Me
MeCN Ts N
SiPh2t-Bu
BF3•Et2O DCM, rt
F3B
O O S N
p-Tol
158
N Ts 160, 90% yield
SiPh2t-Bu
SiPh2t-Bu R 159
O
EtCHO
Et N Ts 161, 90% yield cis/trans 67:33
An interesting copper catalyzed phenol opening of aziridine 163 yielded an intermediate, 164, for the synthesis of ustiloxin D <05OL5325>. This reaction is quite unique in that the phenol is reacting at a highly congested carbon and that none of the SN2’ addition is observed. OBn
CO2Bn
HO Boc
N Ns
N 162
O
O
OH
OBn N H
CO2t-Bu
CuOAc DBU Toluene
O Ns
CO2Bn
HO 163
Boc
NH
N
N H
CO2t-Bu
90% yield
164
In a very neat reaction sequence, N-methylaziridines have been shown to be useful directing groups for ortho-metallation <05OL3749>. Reaction of 165 with s-BuLi followed by trapping with a carbonyl compound provides alcohol 167. Subsequent intramolecular aziridine ring opening provides isobenzofuran derivative 168.
100
S.C. Bergmeier and D.D. Reed
CH3 N
OH
CH3
Li
N
s-BuLi, -78 °C
acetone
165
167
166 O
NHCH3
TFA
CH3 N
95% yield
168
Ring-opening reactions of aziridines (and epoxides) typically require the use of a Lewis acid to catalyze the reaction. β-Cyclodextrins (β-CD) are very useful in creating microenvironments in which aziridines can be opened using mild conditions. The reaction of aziridines with β-CD and sulfur nucleophiles such as thiocyanate <05SL489> or thiophenols <05TL6437> provides a mild route to such ring-opened compounds. TsHN
Ts N
SPh
β-CD, H2O, PhSH, 50 °C
β-CD, H2O, KSCN, rt
TsHN
SCN
78% yield
90% yield 169
170
171
Several thiazolidines were synthesized via titanium tetrachloride catalytic cyclization <05JOC227>. The reaction proceeds via an intramolecular attack on the nitrile by the aziridine nitrogen to provide bicyclic aziridinium intermediate 173. Subsequent ring opening by chloride yields thiazolidine 174. O Cl
N 172
N
Cl 1. TiCl4, MeCOCl, DCM, rt 2. NaHCO3, rt
N
NH
SCN Ar
Cl N
Me 96% yield
S 174
S
Cl 173
An interesting SN2/formal [3+2] cycloaddition route for the synthesis of substituted indolizidines has been reported <05OL5545>. This reaction requires both an electron withdrawing group on the alkyne and an aromatic ring on the aziridine. The reaction goes through an initial N-alkylation of the aziridine with iodide 175 followed by a Michael addition/rearrangement to generate indolizidines 179 - 181.
101
Three-membered ring systems (2005) H N
176
Ph racemic K2CO3, MeCN, 60°C, 24hr
95% yield racemic
179 Ph
EtO2C
>99% ee Ph K2CO3, MeCN, 50°C, 16hr
I
OBn N
H N
177
CO2Et
Ph
EtO2C
BnO
92% yield >99% ee N 180
175
Cl K2CO3, MeCN, 65°C, 24hr H N
178
83% yield 94% ee
EtO2C
95% ee
181
N Cl
The regioselective oxidation of aziridines to α-tosylamino ketones has been accomplished via N-Bromosuccinimide (NBS) and cerium(IV) ammonium nitrate <05TL4111>. Both styryl aziridines, 182, and aliphatic aziridines, 184, have been oxidized. A related report uses β-cyclodextrins in addition to NBS to catalyze the same transformation <05TL1299>. These reaction conditions also work well for epoxides to provide the corresponding α-hydroxy ketones. Ts N Ph
O
CH3CN:H2O (9:1), CAN, NBS
NHTs
Ph 182
92% yield
183
184
O
CH3CN:H2O (9:1), CAN, NBS
N Ts
185
H NHTs
84% yield
The transformation of aziridines that do not involve ring opening are rare due to the reactivity of the aziridine ring. Considering the somewhat more difficult synthesis of aziridines (relative to epoxides), the ability to convert one aziridine into another represents a significant expansion of the scope of any aziridine synthesis. The deprotection of N-protected aziridines continues to be a problematic process. Many methods used to deprotect N-protected aziridines results in cleavage of the aziridine ring. The use of ozone to deprotect N-benzhydryl aziridines, 186, has been reported <05OL2201>. While the yields of this method were modest, this is an important new method for such deprotections. Ph
Ph N
Ph
CO2Et 186
1. O3, DCM, -78 °C 2. NaBH4, MeOH
H N Ph
60% yield CO2Et
187
102
S.C. Bergmeier and D.D. Reed
The Darzens reaction of the oxazoline 188 with a series of aldimines has been shown to form aziridine 190 in good yields and diastereoselectivity <05T3251>. Deprotonation of the aziridine to form the aziridinyl anion and subsequent reaction with an electrophile provides the highly substituted aziridines 191 in moderate yields. The diphenylphosphinyl group on the nitrogen provides optimal yields in the lithiation reaction.
1. LDA, -98 °C, THF
N Cl
O
2.
188
Ph
Me
Me
191
E
Electrophile Yield (%) 50 MeI 58 BnBr 24 PHCHO
H
66% yield dr 90:10
189
s-BuLi, -98 °C TMEDA Electrophile
N POPh2 N Ph O
O P Ph Ph N
N POPh2 N Ph O
190
Terminal aziridines were deprotonated with LTMP and directly treated with a variety of electrophiles to provide substituted aziridines, 193 <05OL1153>. In all cases, the products had the trans geometry about the aziridine ring. Related work on the lithiation of carboxylate substituted aziridines <05AG(I)6169> and aziridinium ions <05MI1294> was also reported.
THF, -78 °C, Electrophile
O S O N C5H11
H
O S O N C5H11
N Li
192
Electrophile TMSCl PhCHO DMF CO2
R 193
Yield (%) 86 38 63 63
R SiMe3 CHOHPh CHO CO2Me
2-Aziridinemethanols were resolved using porous ceramic (Toyonite)-immobilized lipase (PS-C II) <05JOC1369>. This report is significant in that few examples of the lipasecatalyzed reaction for such 2-aziridinemethanols having two stereogenic centers at β– and γcarbons are known, and none of these types of resolutions with aziridine derivatives without N-protection have been reported. Ph
H N
H
Me OH
Me 194
H N
Ph
OH H
195
lipase PS-C II Acetone -40 °C
Me
H N
Ph
OAc H
Ph
H N
H OH
Me
196
197
90% ee
87% ee
Kimpe et. al., have found that (2-bromomethyl)-N-alkyl aziridines react with organocuprate reagents to provide largely the product of bromide displacement, 199 <05SL931>. Most aliphatic organocuprates (e.g. R = Me, n-Bu) provide good yields of the displacement product 199. When R = allyl, the sole product is 200 (40%), presumably via a competing electron transfer or metal-halogen exchange reaction which then leads to ring opening.
103
Three-membered ring systems (2005) Ph
Ph R2CuLi, Et2O
N Br
R
198
Yield (199:200) R 76:0 Me 54:10 n-Bu
N H
R
N
200
199
Aziridine 2-carboaldimines, 201, have been used to provide ready access to a variety of diamines <05T9281>. A number of nucleophiles were added to imine 201 to provide products 202 and 203. Grignard reagents and a ketene silyl acetal added to the imine in very good yields when catalyzed with BF3•OEt2. The Strecker product, R = CN, was obtained in very good yield but with only moderate diastereoselectivity by reaction with TMSCN and BF3•OEt2. Ph
PMB N
Me
N
Ph
BF3•OEt2 Nucleophile
Me
Ph
PMB N
HN
Me
PMB N
HN
R H
R
H
201 Nucleophile MeMgBr TMSCN OMe
H
202 Yield (%) Ratio (202:203) 86 99:1 99 69:31
203 R CH3 CN CO2Me
87 OTMS
In addition to the nucleophilic addition reactions of 201 shown above, the imine can also participate in cycloaddition reactions <05T9281>. Keto-piperidine 205 could be prepared in very good yield through a Diels Alder reaction of 201 with Danishefsky’s diene. The observed stereoselectivity was rationalized through a chelation controlled transition state with re-face preference. Ph Me
PMB N
N
BF3•OEt2 OMe OTMS
H
204
Ph PMB N N Me O H 205
201
Ph PMB N N Me 81% yield 71:29
O H 206
3.2.4 REFERENCES 04JOC2042 05AG(I)1383 05AG(I)6169 05AG(I)6362 05CC118 05CC1426 05CRV1563 05CRV1603 05CRV3167 05EJO1354 05EJO2841 05EJO3946
H.-C. Guo, X.-Y. Shi, X. Wang, S.-Z. Liu, M. Wang, J. Org. Chem. 2004, 69, 2042. S.-s. Jew, J.-H. Lee, B.-S. Jeong, M.-S. Yoo, M.-J. Kim, Y.-J. Lee, J. Lee, S.-h. Choi, K. Lee, M.S. Lah, H.-g. Park, Angew. Chem. Int. Ed. 2005, 44, 1383. A.P. Patwardhan, V.R. Pulgam, Y. Zhang, W.D. Wulff, Angew. Chem. Int. Ed. 2005, 44, 6169. X. Wang, L. Shi, M. Li, K. Ding, Angew. Chem. Int. Ed. 2005, 44, 6362. H. Guo, X. Shi, Z. Qiao, S. Hou, M. Wang, J. Chem. Soc., Chem. Commun. 2002, 118. M. Pineschi, F. Bertolini, R.M. Haak, P. Crotti, F. Macchia, J. Chem. Soc., Chem. Commun. 2005, 1426. E.M. McGarrigle, D.G. Gilheany, Chem. Rev. 2005, 105, 1563. Q.H. Xia, H.Q. Ge, C.P. Ye, Z.M. Liu, K.X. Su, Chem. Rev. 2005, 105, 1603. A. Viso, R.F.d.l. Pradilla, A. Garcia, A. Flores, Chem. Rev. 2005, 105, 3167. E. Vrancken, A. Alexakis, P. Mangeney, Eur. J. Org. Chem. 2005, 1354. K. Krohn, D. Gehle, U. Floerke, Eur. J. Org. Chem. 2005, 2841. P. Restorp, P. Somfai, Eur. J. Org. Chem. 2005, 3946.
104 05EJO4557 05JA2147 05JA6540 05JA6964 05JA10812 05JA11252 05JA11426 05JA12222 05JA13444 05JA13672 05JA14198 05JA14668 05JA14911 05JA16366 05JA16416 05JA17170 05JOC227 05JOC932 05JOC1262 05JOC1369 05JOC1728 05JOC4166 05JOC4226 05JOC4300 05JOC4720 05JOC4833 05JOC5852 05JOC6537 05JOC6541 05JOC10515 05JOC10747 05MI1 05MI29 05MI59 05MI93 05MI181 05MI1294 05MI1827 05MI5260 05OL823 05OL987 05OL1023 05OL1153 05OL1745 05OL2201 05OL2305 05OL2579 05OL2787 05OL3191 05OL3247 05OL3267 05OL3295 05OL3509 05OL3649 05OL3749
S.C. Bergmeier and D.D. Reed
K. Krohn, D. Gehle, U. Floerke, Eur. J. Org. Chem. 2005, 4557. S.-y. Tosaki, R. Tsuji, T. Ohshima, M. Shibasaki, J. Am. Chem. Soc. 2005, 127, 2147. F. Hollmann, K. Hofstetter, T. Habicher, B. Hauer, A. Schmid, J. Am. Chem. Soc. 2005, 127, 6540. M. Marigo, J. Franzen, T.B. Poulsen, W. Zhuang, K.A. Jorgensen, J. Am. Chem. Soc. 2005, 127, 6964. M.R. Biscoe, R. Breslow, J. Am. Chem. Soc. 2005, 127, 10812. T. Mita, I. Fujimori, R. Wada, J. Wen, M. Kanai, M. Shibasaki, J. Am. Chem. Soc. 2005, 127, 11252. J.A.R. Schmidt, E.B. Lobkovsky, G.W. Coates, J. Am. Chem. Soc. 2005, 127, 11426. J.-C. Zheng, W.-W. Liao, Y. Tang, X.-L. Sun, L.-X. Dai, J. Am. Chem. Soc. 2005, 127, 12222. A.K. Feldman, B. Colasson, K.B. Sharpless, V.V. Fokin, J. Am. Chem. Soc. 2005, 127, 13444. P. Fristrup, B.B. Dideriksen, D. Tanner, P.-O. Norrby, J. Am. Chem. Soc. 2005, 127, 13672. H. Lebel, K. Huard, S. Lectard, J. Am. Chem. Soc. 2005, 127, 14198. A.R. Kelly, A.E. Lurain, P.J. Walsh, J. Am. Chem. Soc. 2005, 127, 14668. J. Justicia, J.L. Oller-López, A.G. Campaña, J.E. Oltra, J.M. Cuerva, E. Buñuel, D.J. Cárdenas, J. Am. Chem. Soc. 2005, 127, 14911. V.K. Yadav, V. Sriramurthy, J. Am. Chem. Soc. 2005, 127, 16366. S.-J. Jeon, H. Li, P.J. Walsh, J. Am. Chem. Soc. 2005, 127, 16416. G. Yin, M. Buchalova, A.M. Danby, C.M. Perkins, D. Kitko, J.D. Carter, W.M. Scheper, D.H. Busch, J. Am. Chem. Soc. 2005, 127, 17170. M. D'Hooghe, A. Waterinckx, N. De Kimpe, J. Org. Chem. 2005, 70, 227. T. Siu, C.J. Picard, A.K. Yudin, J. Org. Chem. 2005, 70, 932. A.E. Lurain, P.J. Carroll, P.J. Walsh, J. Org. Chem. 2005, 70, 1262. T. Sakai, Y. Liu, H. Ohta, T. Korenaga, T. Ema, J. Org. Chem. 2005, 70, 1369. N.N. Reed, T.J. Dickerson, G.E. Boldt, K.D. Janda, J. Org. Chem. 2005, 70, 1728. M. Davoust, J.-F. Brière, P.-A. Jaffrès, P. Metzner, J. Org. Chem. 2005, 70, 4166. W.-K. Chan, M.-K. Wong, C.-M. Che, J. Org. Chem. 2005, 70, 4226. J.L.G. Ruano, C. Fajardo, A. Fraile, M.R. Martin, J. Org. Chem. 2005, 70, 4300. A. Svennebring, N. Garg, P. Nilsson, A. Hallberg, M. Larhed, J. Org. Chem. 2005, 70, 4720. F. Mohr, S.A. Binfield, J.C. Fettinger, A.N. Vedernikov, J. Org. Chem. 2005, 70, 4833. V. Capriati, S. Florio, R. Luisi, F.M. Perna, J. Barluenga, J. Org. Chem. 2005, 70, 5852. X.-M. Deng, X.-L. Sun, Y. Tang, J. Org. Chem. 2005, 70, 6537. C. de Los Rios, L.S. Hegedus, J. Org. Chem. 2005, 70, 6541. S. Okugawa, H. Masu, K. Yamaguchi, K. Takeda, J. Org. Chem. 2005, 70, 10515. A. Barbero, P. Castreño, G. Fernández, F.J. Pulido, J. Org. Chem. 2005, 70, 10747. I.M. Pastor, M. Yus, Current Org. Chem. 2005, 1. L. Sun, C.-P. Du, J. Qin, J.-S. You, M. Yang, X.-Q. Yu, J. Mol. Catal. A-Chem. 2005, 234, 29. G. Kumaraswamy, N. Jena, M.N.V. Sastry, G.V. Rao, K. Ankamma, J. Mol. Catal. A-Chem. 2005, 230, 59. V. Mirkhani, S. Tangestaninejad, B. Yadollahi, L. Alipanah, Catal. Lett. 2005, 101, 93. K. Faber, W. Kroutil, Curr. Opin. Chem. Biol. 2005, 9, 181. C. Gaebert, J. Mattay, M. Toubartz, S. Steenken, B. Mueller, T. Bally, Chem. Eur. J. 2005, 11, 1294. T.M. Poessl, B. Kosjek, U. Ellmer, C.C. Gruber, K. Edegger, K. Faber, P. Hildebrandt, U.T. Bornscheuer, W. Kroutil, Adv. Synth. Catal. 2005, 347, 1827. J. Kjellgren, J. Aydin, O.A. Wallner, I.V. Saltanova, K.J. Szabo, Chem. Eur. J. 2005, 11, 5260. B.M. Trost, D.R. Fandrick, Org. Lett. 2005, 7, 823. M.K. Tse, M. Klawonn, S. Bhor, C. Doebler, G. Anilkumar, H. Hugl, W. Maegerlein, M. Beller, Org. Lett. 2005, 7, 987. F. Carree, R. Gil, J. Collin, Org. Lett. 2005, 7, 1023. D.M. Hodgson, P.G. Humphreys, J.G. Ward, Org. Lett. 2005, 7, 1153. M.-Y. Lin, S.J. Maddirala, R.-S. Liu, Org. Lett. 2005, 7, 1745. A.P. Patwardhan, Z. Lu, V.R. Pulgam, W.D. Wulff, Org. Lett. 2005, 7, 2201. D.M. Hodgson, C.D. Bray, N.D. Kindon, Org. Lett. 2005, 7, 2305. A. Lattanzi, Org. Lett. 2005, 7, 2579. A.J. Catino, J.M. Nichols, R.E. Forslund, M.P. Doyle, Org. Lett. 2005, 7, 2787. G.-Y. Gao, J.D. Harden, X.P. Zhang, Org. Lett. 2005, 7, 3191. A.B. Smith III, D.-S. Kim, Org. Lett. 2005, 7, 3247. J.L. Bilke, M. Dzuganova, R. Fröhlich, E.-U. Würthwein, Org. Lett. 2005, 7, 3267. D.M. Hodgson, M.J. Fleming, S.J. Stanway, Org. Lett. 2005, 7, 3295. S. Minakata, Y. Okada, Y. Oderaotoshi, M. Komatsu, Org. Lett. 2005, 7, 3509. N. Azizi, M.R. Saidi, Org. Lett. 2005, 7, 3649. V. Capriati, S. Florio, R. Luisi, B. Musio, Org. Lett. 2005, 7, 3749.
Three-membered ring systems (2005)
05OL3829 05OL4593 05OL5325 05OL5545 05S1405 05SL489 05SL506 05SL842 05SL931 05SL1047 05SL1359 05T1069 05T2541 05T3251 05T3349 05T6009 05T6726 05T9281 05TL89 05TL339 05TL797 05TL1269 05TL1299 05TL1643 05TL2083 05TL2311 05TL2675 05TL3669 05TL4031 05TL4103 05TL4111 05TL4407 05TL5467 05TL5665 05TL6437 05TL6705 05TL7243 05TL8229 05TL8895 05TL9029
105
S. Rodríguez-Escrich, D. Popa, C. Jimeno, A. Vidal-Ferran, M.A. Pericàs, Org. Lett. 2005, 7, 3829. S. Azoulay, K. Manabe, S. Kobayashi, Org. Lett. 2005, 7, 4593. P. Li, C.D. Evans, M.M. Joullié, Org. Lett. 2005, 7, 5325. W. Zhu, G. Cai, D. Ma, Org. Lett. 2005, 7, 5545. D. Leca, K. Song, M. Albert, M.G. Goncalves, L. Fensterbank, E. Lacote, M. Malacria, Synthesis 2005, 1405. M.S. Reddy, M. Narender, K.R. Rao, Synlett 2005, 489. K. Surendra, N.S. Krishnaveni, K.R. Rao, Synlett 2005, 506. T. Kimachi, H. Kinoshita, K. Kusaka, Y. Takeuchi, M. Aoe, M. Ju-ichi, Synlett 2005, 842. M. D'Hooghe, M. Rottiers, R. Jolie, N. De Kimpe, Synlett 2005, 931. W. Adam, A. Zhang, Synlett 2005, 1047. V. Capriati, S. Florio, R. Luisi, Synlett 2005, 1359. R. Saladino, A. Andreoni, V. Neri, C. Crestini, Tetrahedron 2005, 61, 1069. T. Komiyama, Y. Takaguchi, A.T. Gubaidullin, V.A. Mamedov, I.A. Litvinov, S. Tsuboi, Tetrahedron 2005, 61, 2541. R. Luisi, V. Capriati, S. Florio, P.D. Cunto, B. Musio, Tetrahedron 2005, 61, 3251. A. Mordini, D. Peruzzi, F. Russo, M. Valacchi, G. Reginato, A. Brandi, Tetrahedron 2005, 61, 3349. K.-H. Tong, K.-Y. Wong, T.H. Chan, Tetrahedron 2005, 61, 6009. T. Tanaka, K. Hiramatsu, Y. Kobayashi, H. Ohno, Tetrahedron 2005, 61, 6726. H.-Y. Noh, S.-W. Kim, S.I. Paek, H.-J. Ha, H. Yunc, W.K. Leed, Tetrahedron 2005, 61, 9281. Y. Kita, S. Matsuda, R. Inoguchi, J.K. Ganesh, H. Fujioka, Tetrahedron Lett. 2005, 46, 89. S. Dinda, S.R. Chowdhury, K.M.A. Malik, R. Bhattacharyya, Tetrahedron Lett. 2005, 46, 339. R. Tirado, G. Torres, W. Torres, J.A. Prieto, Tetrahedron Lett. 2005, 46, 797. M. Fujita, M. Shindo, K. Shishido, Tetrahedron Lett. 2005, 46, 1269. M.S. Reddy, M. Narender, K.R. Rao, Tetrahedron Lett. 2005, 46, 1299. C. Ghiron, L. Nannetti, M. Taddei, Tetrahedron Lett. 2005, 46, 1643. U.K. Nadirm, A. Singh, Tetrahedron Lett. 2005, 46, 2083. J.S. Yadav, K. Rajasekhar, M.S.R. Murty, Tetrahedron Lett. 2005, 46, 2311. A. Kamal, R. Ramu, M.A. Azhar, G.B.R. Khanna, Tetrahedron Lett. 2005, 46, 2675. M. Yoshida, Y. Morishita, M. Ihara, Tetrahedron Lett. 2005, 46, 3669. G.F. Keaney, J.L. Wood, Tetrahedron Lett. 2005, 46, 4031. M.K. Ghorai, K. Das, A. Kumar, K. Ghosh, Tetrahedron Lett. 2005, 46, 4103. K. Surendra, N.S. Krishnaveni, K. Rama Rao, Tetrahedron Lett. 2005, 46, 4111. Y. Kim, H.-J. Ha, K. Han, S.W. Ko, H. Yun, H.J. Yoon, M.S. Kimd, W.K. Leeb, Tetrahedron Lett. 2005, 46, 4407. G. Righi, R. Antonioletti, S. Ciambrone, F. Fiorini, Tetrahedron Lett. 2005, 46, 5467. H. Yi, G. Zou, Q. Li, Q. Chen, J. Tang, M.-y. He, Tetrahedron Lett. 2005, 46, 5665. M. Somi Reddy, M. Narender, Y.V.D. Nageswar, K.R. Rao, Tetrahedron Lett. 2005, 46, 6437. M. Yoshida, H. Ueda, M. Ihara, Tetrahedron Lett. 2005, 46, 6705. S. Yoshida, M. Asano, Y. Kobayashi, Tetrahedron Lett. 2005, 46, 7243. A. McCluskey, S.K. Leitch, J. Garner, C.E. Caden, T.A. Hill, L.R. Odell, S.G. Stewart, Tetrahedron Lett. 2005, 46, 8229. B. Das, H. Holla, K. Venkateswarlu, A. Majhi, Tetrahedron Lett. 2005, 46, 8895. A.T. Placzek, J.L. Donelson, R. Trivedi, R.A. Gibbs, S.K. De, Tetrahedron Lett. 2005, 46, 9029.
106
Chapter 4 Four-membered ring systems Benito Alcaide Departamento de Química Orgánica I. Facultad de Química. Universidad Complutense de Madrid, 28040-Madrid. Spain
[email protected] Pedro Almendros Instituto de Química Orgánica General, CSIC, Juan de la Cierva 3, 28006-Madrid, Spain
[email protected] ______________________________________________________________ 4.1
INTRODUCTION
Strained four-membered heterocycles have received considerable attention for a variety of reasons. In addition to being key scaffolds in natural products as well as in compounds of biological and industrial interest, the use of four-membered rings as starting materials to prepare many different substances provides the motivation to explore new chemistry based on these compounds. Oxygen- and nitrogen-containing heterocycles, in particular β-lactams, dominate the field in terms of the number of publications. This chapter covers selected relevant aspects in this area. 4.2
AZETIDINES AND AZETES
A combined experimental and computational study of the photopreparation of fused 2,3-dihydroazetes 1 has been performed <05JOC7744>. The hybrid azetidine-oxadiazole based compound 2 has been identified as a potent sphingosine-1-phosphate-1 (S1P1) receptor agonist with minimal affinity for the S1P2 and S1P3 receptor subtypes <05JMC6169>. Cyclohexylglycine amides of various fluorinated azetidines have been prepared, displaying unexpectedly strong activity against dipeptidyl peptidase IV <05BMCL4770>. It has been reported that the intramolecular catalytic aldol cyclodehydration of 1,6-dialdehydes to the corresponding cyclopentene carbaldehydes can be promoted by azetidine-2-carboxylic acid 3 <05T267>. The preparation of palladium(II) complexes having sterically congested azetidines as ligands has been described <05JOM2306>. Combinatorial libraries of nonbiological polymers and drug-like peptides have been synthesized from unnatural amino acids such as azetidine-2-carboxylic acid, by exploiting the broad substrate specificity of ribosomes <05JA11727>. N
X N 1 (X = F, Cl, Br)
CO2H
N O
CO2H N H
N 2
3
107
Four-membered ring systems
Practical five- or six-step syntheses of both enantiomers of azetidine-2-carboxylic acid 3 have been developed starting from commercially available α-methylbenzylamine <05JOC9028>. Azetidine-2-carboxylic acid analogs possessing various heteroatomic side chains at the 3-position have been synthesized and designed to serve as tools for studying the influence of conformation on peptide activity <05MI298>. The asymmetric synthesis of 3substituted azetidine-2-carboxylic acids has been performed from hydrazones <05S3508>. The stereoselective synthesis of the cis-conformationally constrained glutamate analogue 5 containing an azetidine framework has been accomplished in seven steps in 15% yield from (S)-N-tosyl-2-phenylglycine. The key steps in the synthesis involved an N–H carbenoid insertion promoted by Cu(acac)2, and a Wittig olefination of an azetidin-3-one 4, followed by a highly stereoselective rhodium-catalyzed hydrogenation <05SL1559>. A set of ten azetidinic amino acids 6, that can be viewed as C-4 alkyl substituted analogues of trans-2carboxyazetidine-3-acetic acid and/or conformationally constrained analogues of (R)- or (S)glutamic acid, have been synthesized in a diastereo- and enantiomerically pure form from unsaturated amino esters through a straightforward three-step sequence <05OBC3926>. Ph
CO2H NHTs
i
O
Ph N
ii
iii
N
iv
Ts
4 (35%)
CO2Et
CO2H
HO2C
v
N H R 6 (31–45%)
vi
H
R
N Bn
5 (44%)
CO2H
HO2C
CN
Key: i) (a) (COCl)2; (b) CH2N2. ii) Cu(acac)2. iii) (a) Ph3PCHCO2Et; (b) H2, Rh/C. iv) (a) RuO4; (b) CH2N2; (c) LiOH; (d) Na/C10H8. v) LiHMDS. vi) (a) 6N HCl; (b) H2, Pd/C. Cyclization of a γ-azido-α-bromocarboxylic acid resulted in a synthesis of the 3,3dimethoxyazetidine-2-carboxylic acid 7 <05TL525>, which after reduction gave the corresponding 3,3-dimethoxy-2-(hydroxymethyl)azetidine. A practical synthesis of 2′deoxymugineic acid 8 has been developed via reductive alkylation of azetidine-2-carboxylic acid 3 with aldehydes <05TL1419>. β-Amino alcohols possessing an E vinylsilane moiety have been cyclized in the presence of N-bromosuccinimide to afford diastereoisomerically pure polyfunctional azetidines 9, which can be transformed into enantiopure β-amino alcohols with a Z vinylic bromide moiety <05TL8023>. CO2H MeO MeO
Br CO2H N3
i ii
MeO MeO
CO2H
CO2H
N
TMS
N
H 7 (41%)
R H
H
N
CO2H OH 8
Br
N H
Ph
HO 9 (38–64%)
Key: i) Ph3P, Et3N. ii) NaOH, THF–H2O, Δ. R = alkyl, aryl. Azetidine derivatives 10 were formed in an attempted aza-Baylis–Hillman reaction of N-tosylated imines with ethyl 2,3-butadienoate in the presence of DABCO <05JOC9975>. It has been reported that basic treatment of a bromoallene bearing a sulfonamide moiety gave azetidine 11 as the major product <05AG(E)1513>. Irradiation, in benzene or acetonitrile solution, of 3-allyl or 3-benzyl-2-acyl disubstituted perhydrobenzoxazines yielded azetidin-3ol derivatives in moderate chemical yields (50–60%) and good to excellent diastereoselection (64–96%) <05JOC1408>. Sterically congested 1-azabicyclo[1.1.0]butanes have been added to hydrazoic acid at 0–5 ºC to give 3-azidoazetidines in good to excellent yields <05HCA1658>. It has been proved that chelated ester enolates are suitable nucleophiles for 1,4 additions to nitroalkenes and that the intermediates formed are highly reactive and undergo clean cyclization to azetidine oxime esters 12 <05OL2643>. A practical
108
B. Alcaide and P. Almendros
chemoselective deprotection of allylic amines including azetidines catalyzed by Grubbs’s carbene has been reported <05S668>. R CO2Et CO2Et
H
i
ArCH=NTs +
Br
N
Ar
O N
ii N
NHTs
Ts 10 (45–69%)
Ts 11 (76%)
O
N t-BuOOC
Ts 12
Key: i) DABCO, C6H6, RT. ii) NaH, DMF. It has been observed that the [2+2] cycloaddition between ethyl vinyl ether and cyclic ketene imines afforded bicyclic azetidines 13 <05EJO3781>. The unusual tricyclic structure 14 has been isolated as a minor component from the reaction of benzonitrile oxide and a vinyl imidazole <05S2695>. The cis,cis,cis,cis-[5.5.5.4]-1-azafenestrane borane complex 15 has been efficiently prepared using a Mitsunobu reaction as key cyclization step <05AG(E)3732>. The preparation of 1,2-diazetidines from quadricyclane by the 2σ+2 σ+2π cycloaddition with azodicarboxylates has been explored in water <05AG(E)3275>. Thus, when a mixture of DMAD and quadricyclane is vigorously stirred, the reaction is complete within a few minutes at ambient temperature. Azeto[1,2-a]imidazoles are prepared by a formal intramolecular [2+2] cycloaddition of imino-ketenimines in which an ethylene chain links the nitrogen atoms of both functionalities, bearing a methyl and a phenyl group on the terminal carbon atom of the heterocumulene <05T1531>. The ring strain present in 2-aza-1phosphabicyclo[2.1.0]alka(e)nes has been calculated at the G3(MP2) level using homodesmotic reactions <05JOC8110>. The mode selectivity in the intramolecular [2+2] cyclization of ketenimines bearing N-acylimino units to give azeto[2,1-b]pyrimidinones 16 has been studied by ab initio and DFT calculations <05JOC1340>. It has been reported that the reaction of azetidinecarboxylate esters with metallocarbenes generated spiroazetidinium ylides, whose [1,2]-shift by the ester-substituted carbon furnished ring-expanded pyrrolidine products <05OL2949>. The preparation of an (E)-α,β-unsaturated ester bearing a terminal tosylamino group through the Arndt-Eistert reaction of L-N-tosyl-azetidine 2-carboxylic acid has been explored <05SC2535>. 2-tert-Butyldiphenylsilylmethyl-substituted azetidines 17 react efficiently with nitriles to generate tetrahydropyrimidine products 18 <05JA16366>. A new entry to enantiopure 3-aminopyrrolidines has been developed using a boron trifluoridemediated rearrangement of 2-aminomethylazetidines <05OL5861>. The regioselective opening of azetidinium ions with nitrogen and oxygen nucleophiles has been discussed <05SL1666>. The stereocontrolled synthesis of amino hydroxyalkyl diphenylphosphine oxides has been achieved starting from (2S,3S)-N,N-dibenzyl-3-hydroxy-2-methylazetidinium bromide <05TL4381>. The stereocontrolled synthesis of functionalized organo